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Last night it appeared in my dream again: 
I sat nakedly in lotus position on the top of a snowy mountain. 
 
The weather here is like a ligature of the spring and the winter.  
(The snowflake is as soft as velvet.)  
There is no noise or sound from Philistines. 
But only faint sounds from the time ruminates the time.  
There is no cobra, owl, or beast.  
But there are thorn apples, canarium trees, and Indian trumpet flowers.   
There is no word, latitude and longitude, or the thousand hands and eyes Guan Yin. 
You could feel a chaotic and silent strength.  
The day is as quiet and attractive as the night. 
The night is actually more colorful, munificent, and delightful than the day. 
 
However, it is as cold as wine; poems and the beauty are frozen. 
The black holes talk to stars about hollowness and emptiness. There is no judgment 
and no distinction.  
 
The past does not pass, and the future does not come. 
I am a servant for the present, and I am also a king of the moment.        
   
-Chou, Meng-Tieh (1921-2014). Lonely Land (published in 1959).  
Translated: Bronte 
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Chapter 1 
General Introduction 
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Tissue engineering 
To quote Langer, tissue engineering is “an interdisciplinary field that applies the 
principles of engineering and life sciences toward the development of biological 
substitutes that restore, maintain, or improve tissue function or a whole organ (1).”  
To engineer tissue it is essential to understand the principle of tissue growth and to 
apply this knowledge to repair or to maintain the function of organs (2). Nowadays 
tissue engineering is a field where stem cell biology, developmental biology, and 
material science merge to study cellular responses in artificial microenvironments 
using biomimetic smart materials to develop organ or tissue substitutes.  
Bladder tissue engineering 
The bladder is an elastic organ meant to store urine before voiding. Urine produced 
by the kidneys passes through ureters and enters the bladder trigone. The bladder 
trigone is a triangular area where ureters and urethra connect to bladder and it is 
sensitive to expansion. When the stored volume reaching 400 ml to 600 ml in adult 
humans, smooth muscle cells in the detrusor stretch and send signals to the 
parasympathetic system. This leads to bladder contraction and voiding via the 
urethral sphincter and urethra.  
Bladder replacement is needed for patients with muscle invasive bladder cancer 
after (radical) cystectomy, and bladder augmentation is needed for patients with 
trauma, congenital defect (bladder exstrophy), neuropathic bladder, small volume 
bladders, or inflammation. A tissue engineered bladder must serve as a low pressure 
system with high capacity and urinary continence to protect the kidneys from reflux. 
The ultimate goal is to maintain a high quality of life for patients. 
The first bladder replacement was performed in 1899 by Rutkowski and Mikulicz 
independently. They augmented bladders with ileal tissues in patients who had an 
exstrophic bladder. The storage space for urine successfully increased with ileal 
tissue (3, 4). Since then, gastrointestinal segments are frequently used to create a 
neobladder after cystectomy (5-8). However, the function of the epithelial layer 
from the gastrointestinal segment is different from the bladder and complications 
such as metabolic disorders, bladder perforation, stone formation, infections, 
hematuria-dysuria syndrome and potential development of cancer due to 
metaplasia can occur (9). The urinary tract reconstruction after cystectomy involves 
an incontinent (Bricker) or a continent diversion or a bladder replacement. In a 
continent diversion patients need to perform intermittent catheterization to empty 
the bladder. Sometimes this is also needed in a bladder replacement when 
emptying is not complete. Clearly, alternative biomaterials for bladder 
reconstruction are needed to improve current strategies.      
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Since the early 1900s investigators have attempted to tissue engineer bladder with 
various materials. In 1917, Neuhof was the first to report on bladder augmentation in 
dogs using fascial transplantation (10). Several studies described  other materials 
which were tested in animals or in clinical trials including natural materials: skin (11), 
human dura (12), bladder submucosa (13), omentum (14, 15), placenta (16), and 
small intestine submucosa (17-19); and non-biodegradable synthetic materials: 
silicone sheaths (20), teflone (tetrafluoroethylene) (21), polyvinyl sponge (22), and 
biodegradable synthetic material: PGA/PLGA [poly(glycolic acid) /poly(lactic-co-
glycolic acid)] (23), and collagen/PGA (24). 
The animal studies culminated in clinical studies aimed at bladder augmentation. 
Unfortunately the clinical outcome of these studies in children was unsatisfactory, 
albeit that the initial experience was very positive (24). In a phase 2 study 
biodegradable materials with autologous cells were used (25), and in the other study 
decellularized materials were used (26). The capacity of the bladder was not 
improved sufficiently and bowel obstruction and/or bladder rupture occurred. 
Apparently, although the bladder represents a relatively simple organ, replacing it is 
still challenging. 
Requirements for bladder tissue engineering 
There are three important issues for bladder tissue engineering- materials, stem 
cells, and the vasculature. The goal is to engineer a construct that can functionally 
mimic a normal bladder after implantation in humans. 
Biomaterials 
Materials need to be biocompatible, biodegradable, and provide sufficient 
mechanical strength for tissue regeneration. To date, three different types of 
biomaterials have been studied involving-synthetic, decellularized, and natural 
derived materials.  
For soft tissues, biodegradable material is preferred because the non-biodegradable 
synthetic materials may induce an immune-response after implantation (20, 27). On 
the other hand, the biodegradable materials or decellularized materials which are 
most similar to the native extracellular matrix showed promising results (28), but 
the varying amount of undefined components and the batches-to-batches 
difference influence the outcome (29, 30).  
Possible alternatives for natural biomaterials are biodegradable synthetic materials. 
For example, PGA and PLGA have been applied in animal studies and in human 
clinical trials. The advantages of synthetic materials are that mechanical strength, 
degradation rate, and adhesion motifs of the material can be modified. This 
tunability possibly allows the creation of an extracellular matrix mimic, and then the 
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desired microenvironment can be selected. Additionally to the former solid 
materials, biodegradable hydrogels have been introduced to tissue engineering.  
With different motifs attached, hydrogels polymerize and transform from solute to 
gel induced by light or temperature. The advantages of using hydrogels are that it 
provides a 3D environment for better cellular interaction than traditional 2D cell 
culture in vitro and in vivo and it can be delivered in a minimal invasive way (31). 
Representative hydrogels include polyethylene glycol (PEG) (32), poly(l-lactic acid) 
(PLLA) (33), polyethylene oxide (PEO) (34), and polyisocyanide (PIC) (35, 36). In 
chapter five, we studied the interactions between cells and PIC hydrogels.  
Natural derived type I collagen is the most common biomaterial for bladder tissue 
engineering. Collagen templates provide a structural accommodation for tissue 
regeneration and collagen has shown good biocompatibility with a low 
immunogenic response. The benefits of constructs prepared from natural derived 
biomaterials are the chemical homogeneity and the possibility to meet clinical 
requirements. However, the disadvantage of collagen templates is that during the 
preparation the interconnectivity is determined by chemical cross-linking which 
differs from the natural collagen. The poor interconnectivity hampers the cell 
distribution and the vascularization. The interconnectivity can be manipulated by 
lowering the concentration of collagen but this comes at the expense of the 
structural strength. For clinical application, it might be advantageous to include an 
elastic and supportive material to support the fluid pressure from stored urine. In 
chapter three, the construction of a collagen-PCL hybrid template was studied. 
Fibrin is a natural material derived from fibrinogen in the blood plasma and can 
polymerize with thrombin. Fibrin is the first material that cells encounter during 
wound healing (37-39). When fibrin is applied in tissue engineering, this fibrin-rich 
environment enhances fibroblast and endothelial in-growth (40), which may 
increase vasculogenesis. However, fibrin alone cannot be used for bladder 
reconstruction because it is structurally too weak. In chapter four, we analyzed the 
vasculogenesis of hybrid collagen-fibrin constructs and the possibilities of 
applications in soft tissue engineering. 
The vasculature 
Tissue engineering is aiming to restore functional organs or tissues and the 
vasculature is essential for this purpose. Nutrients, oxygen and signals are 
circulating in the blood and delivered to the new implanted area. Without an 
adequate vascularization grafts, in particular large grafts, do not survive as 
exchange of molecules is restricted to approximately 200 μm, the distance that can 
be overcome by diffusion (23, 41, 42).   
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Regardless of whether the grafts are cell seeded or unseeded, the survival of grafts 
relies on the vasculature. For example, when cystoplasty is more than 50%, without 
vascularization the outcomes of cell seeded or unseeded biomaterials are both not 
acceptable (43). Without vasculature, the implanted area will be limited to 0.5 cm2 
(44). However, the size of a human bladder is depending on the storage capacity. If 
50% of a human bladder needs to be replaced, a surface area of at least 10x20 cm2 is 
needed. 
The vasculature can be induced with several strategies: pre-vascularization in vitro 
or in vivo before implantation; or accelerated neo-vascularization through the 
activation of signal transduction pathways (45). Biomaterials can be vascularized 
with cells: endothelial cells, endothelial progenitor cells, mesenchymal stem cells, 
pericytes; or pre-vascularized by in vivo angiogenesis: pre-implanting biomaterials 
in an area rich with vessels (e.g. omentum) is quite successful in establishing a richly 
vascularized graft.  
The advantages of pre-vascularized biomaterials are that the survival is enhanced 
and the rate of functional anastomosis is faster than when angiogenesis is 
dependent on the host vasculature (46, 47). Nevertheless, , inclusion of adhesion 
peptides or components in biomaterials to promote angiogenesis in vivo is desirable 
as well, because no cell culture or donor cells are needed and the procedures can 
more easily adhere to EMA and FDA regulations. The potential of these strategies 
and possibilities of applications are discussed in chapter four and chapter five.   
Stem cells 
Tissue engineering is based on biomaterials and cells. To avoid graft rejection, 
autologous HLA matched cells are needed. Autologous cells can be collected by 
biopsy (1-2 cm2) from a patient, but from cancer patients or children the source is 
limited or not available at all. Stem cells or progenitor cells are a new autologous cell 
source for tissue engineering. Such cells may differentiate to the desired cell type to 
maintain the function of lost tissues.  
Mesenchymal stem cells isolated from adipose tissues have become a favorite cell 
source in tissue engineering, because these can be harvested relatively easy by 
liposuction and contamination by tumor cells can be excluded (48). It has recently 
become evident that adult stem cell also reside in adult organs. In principle these 
may be a valuable source for tissue engineering.   
The niche of bladder stem cells is still elusive. The urothelium is a specialized 
transitional epithelium which serves as a barrier for urine to protect other tissues. In 
contrast to other epithelia, it does not secret mucus. Furthermore, the urothelium is 
composed of three cell layers: basal, intermediate, and superficial cell layers. Most 
of the studies hypothesize that the niche of bladder stem cells is the basal cell layer, 
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similar to the stem cell niche of the skin. However, this cannot explain the presence 
of potential progenitor cells in the urine (49, 50). 
The strategies for identifying bladder stem cells include fate-mapping, gene 
knockout animal models, biomarkers, and DNA labeling. With the labeling method, 
progenitor cells in other epithelia have been identified including prostate (51), skin 
(52), hair follicle (53), and cornea (54). Based on this technique, we studied the 
location of progenitor cells in the bladder in chapter six.  
Objections of the thesis  
The overall objective of this thesis is to improve the function of biomaterials for 
bladder augmentation by enhancing the cellular distribution and vascularization; 
and by discovering the niche of adult progenitor cells in the bladder; and by 
understanding the cell behavior in response to biomimetic materials.  
The current state of bladder tissue engineering is summarized in chapter 2 which 
included biomaterials, stem cells, and vasculatures in the field of regenerative 
medicine.   
The material for bladder replacement was improved by increasing the capacity of 
cell distribution and the mechanical strength was enhanced by combining collagen 
template with polymer knitting (Chapter 3).  
We studied whether pre-vascularization could enhance graft survival and performed 
functional studies to demonstrate that the pre-vascularized network anastomosed 
with the host blood vessels by magnetic resonance imaging (Chapter 4).  
Cell behavior was studied in the 3D environment in nano-scales of a chemically 
defined thermo sensitive material which mimics the natural extra cellular matrix. 
Combinations of this hydrogel with mechanically stronger scaffolds might provide 
the possibility to produce complex smart hybrid scaffolds with cell-instructive 
capabilities (Chapter 5).  
In vivo labeling studies were performed to determine the niche of bladder 
progenitor cells providing more information on the possible donor cells in the 
bladder (Chapter 6).  
In chapter 7 the results were summarized and future perspectives were discussed.  
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Abstract 
Tissue engineering of the bladder has a longstanding history. This is (partly) due to 
the medical need to replace bladder tissue after cystectomy for bladder cancer but 
also due to the need to augment bladders with small capacity and the need to repair 
bladder exstrophy, a birth defect in which the bladder grows outside the abdominal 
wall. Current state-of-the-art technologies are restricted to the use of autologous 
tissues to create a neo-bladder and primary closure. These approaches come at the 
expense of several complications such as metabolic disorders, bladder perforation, 
stone formation, infections, hematuria-dysuria syndrome, and potential 
development of cancer due to metaplasia. Obviously this affects the quality of life of 
patients. Here we will discuss the function and the composition of native bladder 
tissue and bladder tissue engineering; material design and techniques for bladder 
tissue engineering; the role of stem cells for tissue engineering; review animal 
studies and clinical trials; and discuss future possibilities.  
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The urinary bladder: Function and structure  
During development the bladder is formed from the endoderm (1). It is an elastic 
organ meant to store urine before voiding. When the stored volumes reach 400 ml 
to 600 ml, smooth muscle cells in the detrusor stretch and signal to the 
parasympathetic system. This leads to bladder contraction and voiding via the 
urethral sphincter and urethra. Clearly, although the bladder represents a relatively 
simple organ, replacing it is challenging since coordinated signaling is required for 
contraction. A schematic artist impression of the urinary system is shown in Figure 1. 
 
Figure 1. The gross anatomy of human urinary system.  
 
At the microscopic level the bladder is composed of the urothelium, the detrusor 
muscle - consisting of three layers of smooth (involuntary) muscle fibers: external 
layer with fibers arranged longitudinally, the middle layer with fibers arranged 
circularly and the internal layer with fibers arranged longitudinally -, blood vessels, 
and nerves. The urothelium is a specialized transitional epithelium which serves as a 
barrier for urine. In contrast to other epithelia, it does not secret mucus. The 
urothelium is composed of three cell layers: basal, intermediate, and superficial cell 
layers (see Figure 2a). Superficial cells (also known as umbrella cells) form a barrier 
against waste products excreted by the kidneys.  These cells can stretch toward an 
elliptical shape when the bladder is filled (Fig. 2b). Basal cells are cylindrical or flat 
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when the bladder is filled (Fig. 2c). Cells from superficial cell layer are frequently 
exfoliated into the urine. Urothelial cells maintain a slow turnover rate but most of 
the urothelial cells are quiescent (2). However, after infection these cells become 
highly proliferative (3, 4).      
 
Figure 2. Urothelial cell layers. (a) Urothelial layers are composed of superficial cells, intermediate cells, and 
basal cells. Yellow line indicates the superficial layer, blue line indicates intermediate layer, and black line 
indicates basal layer. Intermediate and basal cells were stained with cytokeratin 7 in brown. (b) Superficial 
cells line the lumen. They are often stretched and appear elliptical in shape (see arrow). Frequently there 
are two nuclei in one cell (arrowhead). (c) Basal cells are cylindrical or flat when the bladder is stretched. 
Basal cells reside on the basal lamina. All nuclei are stained with hematoxyline in light blue. Original 
magnification 40x.  
 
Bladder reconstruction, augmentation  
Bladder reconstruction, augmentation and complete replacement is indicated for a 
variety of clinical indications, ranging from bladder cancer, trauma, congenital 
defect (bladder exstrophy), neuropathic bladder, small volume bladders, or 
inflammation (5). Current state-of-the-art methods rely on surgical techniques 
where autologous gastrointestinal tissues are harvested to augment bladders or 
create neobladders. The incompatibility of the gastrointestinal tissue (mostly ileum) 
with the bladder environment can lead to complications such as metabolic disorders, 
bladder perforation, stone formation, infections, hematuria-dysuria syndrome and 
potential development of cancer due to metaplasia (6). The ideal outcome of 
bladder augmentation is a continent compliant bladder with self control (7).  
When a cystectomy needs to be performed, for instance in case of muscle invasive 
bladder cancer, an ileal conduit or a continent reservoir will be created. Rarely, a 
male patient will be able to urinate by pelvic floor relaxation and in both men and 
women, greatly distended bladders can occur with the passage of time after 
continent urinary diversion. Regular self-catheterization is required to prevent 
neobladder distension. In view of the current complications and decreased quality of 
life of these patients, new alternative therapeutic approaches are needed and tissue 
engineering may offer innovative options for bladder reconstruction by the use of 
biomaterials, supplemented with cells and/or growth factors.  
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Materials for bladder tissue engineering  
Since the 1900s autologous tissue harvested from the gastrointestinal tract has 
been applied for urogenital reconstruction. The nature of the intestinal epithelium 
causes metabolite disorders after operation (6) and therefore alternative materials, 
synthetic as well as biomaterials and combinations thereof have been investigated 
(8). Additionally, materials have been combined with cells (9). Synthetic materials 
have clear advantages: degradation rates can be controlled and conjugation with 
various motifs is possible. Moreover, these materials can be produced relatively 
easy to meet strict clinical grade requirements.  
Synthetic materials which have been studied include silicone sheaths (10), teflone 
(tetrafluoroethylene as paste injection in the submucosa of ureters) (11), and 
biodegradable co-polymers PGA/PLGA [poly(glycolic acid) /poly(lactic-co-glycolic 
acid)] (12). The non-degradable silicone sheath and teflone have been tested in 
patients, but in several patients who received silicone sheaths serious complications 
were observed. Silicone sheaths used for bladder neck reconstruction resulted in 
erosion after 48 months and patients needed suprapubic tubes or a stoma to 
achieve continence after erosion (10). Most likely the non-degradable materials 
induced a more prominent immune response and chronic inflammation. 
Biodegradable material, such as PGA/PLGA was investigated in animals and the 
outcome was promising. Autologous cells were seeded into a pre-molded PGA in 
the shape of a bladder and implanted into beagles. Within 4 weeks, the volume of 
bladder was similar to the native bladder; and urothelium, submucosa, and muscle 
layers and neural cells were observed (12). The first bladder reconstruction study 
with biodegradable synthetic materials in dogs demonstrated the potentials of 
biomaterials as a structural vehicle to restore bladder function (13, 14).  
Various natural biomaterials are available for tissue engineering purposes. These 
include, amongst others, collagen, fibronectin, glycosaminoglycans, and fibrin (15). 
Type I collagen is a naturally derived material and has been widely used in soft tissue 
engineering: it is the most abundant component in the extracellular matrix, the 
immunogenic response is low, and it provides structural stiffness needed for tissue 
integrity. Collagen can be extracted from numerous sources such as bovine Achilles 
tendon, rat tail, porcine skin, porcine small intestine, jelly fish, or bacterial 
production. This biomaterial has the advantage that it can easily be combined with 
growth factors or other active agents to enhance tissue remodeling (16, 17). In most 
instances collagen scaffolds are prepared through lyophilization and cross-linking 
(18). Lyophilization is one of the methods to create a highly porous collagen scaffold. 
During lyophilization, acetic acid was vaporized leaving a porous structure of 
collagen. In general these porous collagen scaffolds are cross-linked by [(1-ethyl-3-
(3-dimethyl aminopropyl)carbodiimide)/(N-hydroxysuccinimide) reaction to form 
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amine bonds to enhance their mechanical strength. In one of our material studies 
for bladder augmentation, collagen scaffolds were sutured onto the defect (Fig. 3b). 
A few months later, the collagen scaffold was absorbed and the defect regenerated 
(Fig. 3c) showing that collagen can provide the structural stiffness for urine storage 
and biocompatibility for tissue regeneration.  
 
Figure 3. Pictures were taken during the operation of a material study for bladder augmentation. (a) A 
porcine bladder. (b) Type 1 collagen scaffold was sutured onto the defect of the bladder. Red dots mark the 
collagen scaffold. (c) Three months later, the defect was regenerated and the collagen scaffold absorbed 
completely. (Courtesy From Dr. Luc Roelofs)   
 
One of the known limiting factors of successful implantation of large scaffolds has 
been central necrosis and scar formation due to limited nutrient and oxygen 
exchange in the center zone of large constructs (19, 20). Thus, to improve the 
functional outcome of the bladder reconstruction and increase vascularization, the 
omentum has been incorporated during operation (7, 21). Additionally, constructs 
were conditioned in vitro in bioreactors enhancing the proliferation of urothelial 
cells and the maturation of smooth muscle cells through perfusion of oxygen and 
mechanical stimulation (22-24). Thus, for seeded materials constructs conditioning 
in a bioreactor mimicking the real physical impact is anticipated to stimulate cells 
and lead to an improved functional outcome.  The details of bioreactor –related 
aspects will be discussed later. 
Several investigators have used bladder acellular matrix derived from autologous 
tissue or from other species including dog (25), pig (26), rabbit (27), and rat (28) for 
bladder reconstruction. In this approach cells are removed mechanically and by 
chemical methods, leaving the structural matrix (mainly composed of collagen) 
intact.  The benefit of this type of acellular material is the preservation of functional 
and structural proteins in the extracellular matrix, possibly improving cell migration, 
differentiation, and proliferation (29). Several acellular matrices have been tested, 
including skin (30), stomach mucosa (31), and small intestine (32) for bladder tissue 
engineering.  
Porcine small intestine submucosa (SIS) is one of the acellular materials that have 
been tested widely. In a recent study SIS was compared with the synthetic material 
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poly (L-lactide-co-caprolactone, PLC) for bladder augmentation in a rat model. The 
outcome was better with SIS, possibly because the key ingredients (growth factors) 
in SIS accelerated tissue regeneration faster than the synthetic materials (33). 
Nevertheless, the drawbacks of using natural acellular materials are the differences 
between batches,  lot- to lot- differences and the unknown components left in the 
materials (34-36). Additionally, the regenerative ability from SIS may differ based on 
the harvested region. SIS obtained from the ileum showed lower inflammatory 
responses and better regeneration than SIS obtained from the jejunum (37). For 
clinical application in human, the drawback of SIS should be carefully considered.   
Cell-seeding  
Strategies for soft tissue engineering and regeneration are based on un-seeded or 
seeded biomaterials. Unseeded smart (biomimetic) materials provide a defined 
microenvironment for tissue in-growth and enhanced functional maturation when a 
partial cystoplasty (less than 30-40%) was performed (38, 39). Although this 
approach is attractive as cells do not need to be harvested and expanded, survival of 
large grafts is complicated by the limited nutrient exchange over large distances. 
This leads to fibrosis and necrosis (40) because the diffusible area or distance for 
nutrients and oxygen is limited to 200 μm (20). Without cell support, normal tissue 
regeneration beyond 0.5-1.0 cm is difficult (41). Several studies have compared 
unseeded biomaterials with seeded materials in vivo or ex vivo. The outcome of cell 
seeded materials preserved better function (smooth muscle cell bundle formation 
and distensible capacity) than unseeded materials (stone formation, shrinkage, or 
collapse) when the cystectomy was around 40%-60% (9, 42).  
In general cell-seeded constructs are created by combining in vitro expanded 
autologous cells with scaffolds. Static cell seeding and dynamic seeding are most 
commonly used. Static seeding, the most used cell seeding technique, includes  
surface seeding (43) and injection seeding (44). In dynamic cell seeding perfusion, 
spinner flask seeding (45), and bioreactor methods are available (46, 47). Additional 
conditioning of cell seeded constructs in a bioreactor may aid this approach: 
mechanical stimulation can be used to stimulate smooth muscle cells growth 
differentiate and orientation into fibril structures (48-50). With mechanical 
stimulation, the engineered bladder wall with cells would be more distensible 
compared to static conditions (51). 
In general, when seeded constructs for bladder reconstruction are prepared, smooth 
muscle cells, urothelial cells, and endothelial cells are needed to mimic the natural 
bladder wall. Primary cells are isolated from a biopsy-1-2 cm2- during operation. 
Smooth muscle cells, urothelial cells, and endothelial cells can be isolated from one 
biopsy with different enzymes or mechanical separation and expanded to the 
desired amount in two weeks after cell isolation (52, 53). The seeding density of 
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biomaterials is crucial for cell survival (54) and in general the seeding density for bio-
grafts is 1×106 per cm2 for urothelial cells and 5×106 per cm2 for smooth muscle cells 
(12). If the cell density is too low for signal transduction and cell survival, the 
engineered bladder wall will not function.    
Several animal studies have demonstrated that seeding of urothelial cells may not 
be necessary:  host urothelial cells will cover the luminal side of implanted materials 
(21, 30). This phenomenon is similar to skin wound healing which is called free edge 
effect (55). This implies that there is a pool of progenitor cells in the urothelial cell 
layer. The location of urothelial stem cells is still under debate. It appears that the 
majority of urothelial stem cells or progenitor cells are located in the basal cell layer 
of urothelia (4, 56). Recently bladder progenitor cells were also detected in the 
intermediate and the superficial urothelial cell layers (57, 58). Moreover, urothelial 
stem cells appear to reside predominantly in the trigone (59).   
The smooth muscle cell layer regenerates slower than the urothelial layer because 
the regeneration of smooth muscle cells is guided by mesenchymal-epithelial 
interactions (60). Smooth muscle cells have to de-differentiate to myofibroblasts or 
fibroblasts and then migrate into the adjacent graft (61). This is a tedious and slow 
process and most likely progenitor or stem cells are lacking or, alternatively, 
regeneration of smooth muscle cell layers is too slow, leading to formation of scar 
like tissue.  
The replacement of more than 90% of bladder tissue in dogs by large seeded or 
unseeded SIS (5x7 cm2) resulted in poor bladder regeneration regardless of cell 
seeding (62). In one of the latest clinical researches, 6 children with various bladder 
diseases were implanted with large unseeded SIS (7x10 cm2) for bladder 
augmentation. Only 2 patients had good bladder compliance and 4 patients had 
bladder stones and bladder rupture (63). This highlights the major hurdle or soft 
tissue engineering: rapid, adequate (neo) vascularizarion to permit graft survival. To 
overcome this problem large constructs have been wrapped in the omentum which 
enhanced neo-vascularization and graft survival (7, 21).  
Vascularization 
Pre-vascularization of large scaffolds before implantation may facilitate the blood 
flow into the center part of grafts. Anastomosis is a rapid process in which host 
capillaries connect to engineered micro-vessels in the biomaterials (64). 
Anastomosis of reconstructed skin with inclusion of engineered micro-vessels took 
4 days which was faster than neo-vascularization which took 14 days, showing that 
pre-vascularization can aid in facilitation of active blood flow, enhancing survival of 
implanted grafts.  
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Alternatively, growth factors [vascular endothelial growth factor (VEGF) or 
fibroblast growth factor (FGF)] have been added in the biomatrices to enhance neo-
vascularization/angiogenesis after implantation (19, 65, 66). In one of our studies, 
collagen scaffolds were pre-vascularized with endothelial cells and 
fibroblasts/smooth muscle cells in vitro and grafted into animals to enhance the 
survival of grafts achieve fast anastomosis. Microscopic analysis (Fig. 4a) and 
macroscopic analysis (Fig. 4b) revealed CD31+ or vWF+ capillaries covering the 
scaffold surface and cells were located at ~250 micrometers deep in the pre-
vascularized collagen scaffold. Blood flow in the scaffolds was monitored with 
Gadomer enhanced magnetic resonance images (MRI), which demonstrated that 
the micro-vessels in the scaffold improved diffusion on the surface and permeability 
in the center part of the scaffolds. When large bladder segments need to be 
replaced, pre-engineered grafts with omentum or pre-vascularization are most 
likely needed to achieve graft survival and also for the functional restoration of 
bladder.  
 
Figure 4. Pre-vascularization of collagen scaffolds. (a) Immunohistochemistry of pre-vascularized collagen 
scaffolds 2 weeks after implantation. Capillaries were CD31+ or vWF+. Pre-engineered capillaries extended 
up to ~250 micro meters deep in the scaffold. Arrows indicate capillaries in the scaffold. Scale bar 50 μm. (b) 
overview of the implanted prevascularized scaffold after 2 weeks on the abdomen wall. Please note 
prominent vasculature.  
 
In case of malignancy cell sourcing is limited. Cells harvested from adult tissues 
often proliferate slowly and procurement may be difficult and may lead to 
complications after an invasive biopsy).(67) Recent advances in stem cell research 
may solve (part of) this problem. The concept of stem cells was introduced in the 
19th century. In 1882, the German pathologist Cohnheim suggested that 
hematopoietic and mesenchymal stem cells in the bone marrow were responsible 
for the maintenance of blood cells and marrow (68). Almost a century later 
Friedenstein et al. and others demonstrated that mesenchymal stem cells could 
differentiate into osteoblasts, chondrocytes, adipocytes, and myoblasts (69, 70). 
Subsequently organ-specific stem cells sources have been described.  
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Stem cells in bladder tissue engineering  
Stem cells are capable to self-renew and most of the time stem cells are quiescent. 
Upon signaling from the environment stem cells undergo an asymmetric division 
leading to a transient amplifying cell and a stem cell. Transient amplifying cells will 
expand and differentiate to the desired cell type. Embryonic stem cells are 
pluripotent, but ethical considerations limit the use of these cells for tissue 
engineering. Recent developments in the field of stem cells research have lead to 
the generation of induced progenitor cells, which can be generated from somatic 
cells of every individual (71-73). These cells may eventually be the ideal source for 
tissue engineering, albeit that ethical issues and differentiation hurdles still exist. 
Adult tissue-specific stem cells or progenitor cells have the capacity to self-renew 
and generate functional differentiated cells that replenish cells but the number of 
replications is limited (74).  
Adipose tissues represent an accessible and abundant source for adult stem cells. 
Compared to collecting cells from other sources, harvesting adipose cells by 
liposuction is a minimal invasive procedure for patients. The amount of cells that 
can be harvested from adipose tissues is quite substantial (millions to billions of 
cells). These cells can differentiate into multiple cell lineages, including adipocytes, 
chondrocytes, myocytes, neurons and osteoblasts. The harvesting procedure can be 
streamlined to adhere to the good manufacturing practices (GMP) guidelines, which 
make this cell source of great value for tissue engineering. In current procedures the 
stromal vascular fraction (SVF) which is enriched for stem cells can be isolated 
within 4 hours. By flow cytometry  SVF are divided into groups: mesenchymal stem 
cells are CD44+, CD73+, and CD90+; endothelial cells are CD31+ and CD34+; 
progenitor cells of endothelial cells are CD31+, CD34+, CD45+, CD90+, and CD105+; 
mature endothelial cells are CD146+ (75).  
Injection of human SVF (1×106) in the vicinity of the urethra in a stress-incontinence 
rat model demonstrated differentiation of SVF into smooth muscle cells (alpha-
smooth muscle actin, α-SMA+) (76). Urodynamic tests demonstrated that the 
pressure in urethra and the bladder volume were improved after injection (77). 
Alternatively, SVF was cultured in smooth muscle cell inductive media and then cells 
were seeded on scaffolds (1×106 cells per PLGA scaffold, (Poly(d,l-lactic-co-glycolic 
acid)) followed by implantation into animals. Post implantation, SVF differentiated 
into smooth muscle cells and expressed mature smooth muscle cell markers, 
including α-SMA, SM22 alpha, calponin (marker for muscle contraction), and 
smooth muscle myosin heavy chain (MHC) (78).  
For bladder reconstruction SVF was seeded on autologous acellular bladder 
matrices and these cell-seeded matrices were used to repair bladders with a 50% 
defect. Post implantation, the regeneration of the bladder appeared complete, 
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including smooth muscle cells (α-SMA+), urothelial cells (AE1/AE3+), and nerve cells 
(S-100+) (79).  
In two recent bladder incontinence therapy studies for men or women with one-year 
follow up, autologous SVF was isolated via liposuction and cells were injected with 
or without collagen gel trans-urethrally. The outcome was promising since the 
capacity of the bladder increased (up to 500 ml), voiding frequency was decreased, 
and incontinence decreased (73, 80). One of the patients was fully continent. In 
conclusion, SVF appear promising for stress urinary incontinent therapy and bladder 
regeneration. 
Stem cells obtained from (voided) urine might also provide an alternative cell source 
for bladder tissue engineering. The phenotype of urine cells harvested from the 
upper urinary tract is similar to mesenchymal stromal cells: CD29, CD44, CD54, 
CD73, CD90, CD105, CD166, and STRO-1-positive (81, 82). These cells can be 
differentiated into urothelial cells (uroplakin+, cytokeratin 7+, and cytokeratin 13+) 
and smooth muscle cells (α-SMA+, desmin+, and myosin+). Urine derived stem cells 
showed a remarkable capacity to expand. Up to 60-70 population doublings were 
noted, cells had detectable telomerase activity and long telomeres which suggests 
that they represent progenitor cells. When cells derived from voided urine were 
seeded on scaffolds multi-layered tissue like structures formed after implantation in 
nude mice.(82) In an alternative approach multi-layered urothelial sheets were 
prepared from urothelial cells obtained after bladder washes. Samples from bladder 
cancer patients were excluded.  Mesenchymal α-SMA+ cells were excluded, because 
the aim of this study was to create multi-layers of urothelia.  The harvested cells 
formed a monolayer and by applying cell sheets and inducing cells with increased 
Calcium, urothelial cells stratified in vitro. The stratified cell culture consisted of a 
superficial urothelial cell layer (CK20+) and basal cell layer (p63+). The investigators 
suggested that this multi-layered urothelial sheet could be applied as flaps in open 
urethral surgery and that such multilayered sheets might be useful in endoscopic 
urethroplasty (83).  
For patients with bladder cancer harvesting of voided cells does not represent a 
valid option as malignant cells can be present. However, cells harvested from the 
upper urinary tract may provide an alternative as these have a normal karyotype 
without any chromosomal aberrations which contrasts to voided cells from the 
same cancer patients (84).  
Animal studies and clinical trials  
Despite its long standing history, clinical experience of bladder tissue engineering is 
limited. The vast majority of studies concerns animal studies in various species. In a 
recent systematic review which included all bladder tissue engineering research 
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from 1980 to 2014, 28 animal studies and 2 clinical studies were identified (85). The 
search was restricted to studies in which the cystoscopic bladder capacity outcome 
was reported, as this is a relevant clinical parameter. Not surprisingly, many 
materials were tested in animals, mostly acellular bladder matrices, PLGA, SIS, and 
collagen. These experiments were executed in very different species, including mice, 
rats, rabbits, dogs, pigs, and monkeys. With few exceptions, bladders were 
reconstructed in healthy animals. This systematic review showed that preclinical 
research in healthy animals suggested the feasibility of bladder augmentation by 
tissue engineering. Nevertheless, the authors also comment that new approaches 
should be evaluated in preclinical models with dysfunctional/ diseased bladders, 
because the outcome in diseased animals differed and favorable results in healthy 
animals may not be representative (30). For example, in one study a bladder outlet 
obstruction was created and acellular dermis scaffolds were grafted for bladder 
augmentation in healthy and diseased animals. Shrinkage of the grafted material 
and an inflammatory response were observed in all diseased animals, and the tissue 
regeneration was better in healthy animals (30). 
The first results of a human clinical trial was reported by Atala et al. in 2006 (7). 
Seven patients (aged from 4-19) received autologous cell seeded collagen/poly 
glycolic acid (PGA) scaffolds. The follow-up urodynamic studies (~46 months) 
demonstrated that the capacity, volume/continence, and compliance of bladder 
were improved with seeded biomaterials, albeit not in all patients. No metabolic 
complications and stone formation was observed and the mucus secretion was 
normal.   
After this feasibility trial a phase II clinical study was performed in children with 
spinal bifida and high detrusor pressure (86). Autologous cells were seeded in 
biodegradable biomaterial similar to the feasibility trial. Unfortunately, the 
autologous cell seeded biodegradable scaffold did not improve bladder compliance 
or capacity.  Bowel obstruction, and bladder rupture were observed in 4 patients, 
and the authors concluded that the serious adverse events surpassed an acceptable 
safety standard.  The discrepancy with the feasibility trial is remarkable, and might 
be due to e.g. differences in the patient population.  
Future perspectives:  a complete bladder? 
The ultimate goal for bladder tissue engineering is the regeneration of a complete 
bladder with intact continence and normal voiding. Thus far only bladder 
augmentation has been tested where 40%-60% of the bladder was regenerated 
with biomaterials. Clearly, tissue engineering a relatively simple organ like bladder 
still requires a substantial research effort as the engineered bladder should provide a 
normal capacity but also continence. Additionally, connection of appendices such as 
ureters and urethra needs to be achieved and kidney function must not be 
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compromised. The complexity of establishing an adequate vasculature and 
innervations still provide a major challenge to this field. Smart scaffolds with 
controlled topography need to be combined with an optimal cell source possibly 
pre-vascularized to create constructs for the engineering of functional bladder 
tissues in the near future. 
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Abstract 
Adequate cellular in-growth into biomaterials is one of the fundamental 
requirements of scaffolds used in regenerative medicine. Type I collagen is the most 
commonly used material for soft tissue engineering, because it is non-immunogenic 
and a highly porous network for cellular support can be produced. However, in 
general, adequate cell in-growth and cell seeding has been suboptimal. In this study 
we prepared collagen scaffolds of different collagen densities and investigated the 
cellular distribution. We also prepared a hybrid polymer-collagen scaffold to achieve 
an optimal cellular distribution as well as sufficient mechanical strength. Collagen 
scaffolds (ranging from 0.3% to 0.8% (w/v)) with and without a mechanically stable 
polymer knitting (poly-caprolactone (PCL)) were prepared.  The porous structure of 
collagen scaffolds was characterized using scanning electronic microscopy (SEM) 
and hematoxylin-eosin (H&E) staining. The mechanical strength of hybrid scaffolds 
(collagen with or without PCL) was determined using tensile strength analysis. 
Cellular in-growth and inter-connectivity were evaluated using fluorescent bead 
distribution and human bladder smooth muscle cells (HBSMC) and human 
urothelium seeding. The lower density collagen scaffolds showed remarkably 
deeper cellular penetration and by combining it with PCL knitting the tensile 
strength was enhanced. This study indicated that a hybrid scaffold prepared from 
0.4% collagen strengthened with knitting achieved the best cellular distribution.  
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Introduction 
Adequate cellular in-growth and acceptance and replacement of biomaterials are 
prerequisites for the successful engineering of soft tissues. It is one of the four 
fundamental needs of scaffolds as defined by Hollister (1). After filling the defect 
(form), it should temporarily support everyday functional demands (function), 
enhance tissue regeneration (formation) and this should be in such a format that the 
end user, the surgeon, can readily implant and attach to tissues surrounding the 
defect (fixation). Failure of cell in-growth into the implanted material is suggested 
to contribute to unwanted formation of scar tissue, resulting in little flexibility and 
pliability (2). This is true for situations where unmodified biomaterials are applied as 
well as for situations in which autologous cells are seeded onto the scaffold before 
implantation. 
Type I collagen is the most commonly used biomaterial for soft tissue. It is highly 
abundant in the human body, it is biocompatible (3), low-immunogenic, structurally 
supports cell growth (4) and provides a natural environment for cell growth, 
differentiation, and wound repair. These excellent qualities have made collagen a 
preferred material for regenerative medicine purposes for more than a decade (5). In 
general, collagen scaffolds are produced by lyophilization of collagen solutions 
followed by cross-linking to achieve better mechanical characteristics and to lower 
antigenicity (6). In earlier studies using collagen scaffolds prepared from 0.8% (w/v) 
type I collagen, we noticed poor cellular in-growth into the scaffolds (7). Thus, 
despite the highly porous character of collagen scaffolds, cell in-growth must be 
improved to achieve a better outcome.  
Many studies have been performed to enhance the cell distribution inside scaffolds: 
static seeding and dynamic seeding. Static seeding which is the most common 
technique includes surface seeding (8) and injection seeding into the scaffold (9). 
Dynamic seeding includes spinner flask seeding (10), agitation in a bioreactor (11, 
12), and perfusion (13). Dynamic seeding is effective and the cell proliferation might 
be improved by physical agitation (14). Another approach is to improve the 
characteristics of the construct. We hypothesized that scaffold interconnectivity, 
leading to improved cell penetration, can be enhanced by decreasing the collagen 
content. Nevertheless, by lowering the collagen content, the mechanical properties 
of the collagen diminish and handling becomes impossible (decreased fixation). 
Combining the scaffold with other materials like polymers may alleviate this 
problem. Many clinically applicable materials are available for this purpose, e.g. 
poly-glycolic acid (PGA), poly-lactic acid (PLA), and poly-caprolactone (PCL). In this 
study we introduced a new hybrid collagen-polymer scaffold with optimal cellular 
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distribution and mechanical strength. As an example for a multi-layered organ we 
used the bladder, and investigated the cell distribution in the novel construct and 
enhance the engineering of this organ. 
Materials and methods 
Collagen suspension 
Collagen scaffolds were prepared from purified type I collagen as described by 
Pieper et al (15). Insoluble type I collagen fibrils were purified from pulverized bovine 
Achilles tendon. The purification consisted of washings with diluted acetic acid, 
aqueous NaCl solutions, urea, acetone, and demineralized water. Collagen (0.3%, 
0.4%, 0.5%, 0.6%, 0.7%, and 0.8% (w/v)) was suspended in 0.25 M acetic acid and 
swollen overnight at 4oC. Then the collagen was homogenized on ice using a Potter-
Elvehjem homogenizer. Air bubbles were removed by centrifugation (10 min, 250g 
at 4oC) and suspensions were poured into 6-well plates.  
Polycaprolactone (PCL) 
PCL was purchased from Sigma-Aldrich. The molecular weight is 80,000 g/mol. 
Knittings were prepared from PCL threads (16) which were knitted into sheets 
according to the stockinet structure using knitting machinery (Lawson Hemphil, 
Swansea, MA, USA).   
Hybrid scaffolds 
For the hybrid scaffolds the bovine collagen solution was poured on top of the man-
made PCL knittings. Air bubbles were removed using an additional centrifugation 
step (10 min, 250g at 4oC). The scaffolds were subsequently frozen and lyophilized 
in a Zirbus Sublimator 500II (Bad Grund, Germany). Carbodiimide cross-linking was 
performed to cross-link the scaffolds (17). In brief, lyophilized scaffolds were pre-
incubated in 2-morpholinoethane sulphonic acid buffer in 40% ethanol (pH 5) 
overnight at 4°C. Cross-linking was performed with 33 mM EDC (N-ethyl-3-(3-
demethylaminopropyl)carbodiimide) and 6 mM NHS (N-hydroxysuccimide) in 50 
mM 2-morpholinoethane sulphonic acid (pH 5.0) containing 40% ethanol for 4 h at 
20°C. The scaffolds were then washed in 0.1 M Na2HPO4, 1 M NaCl, 2 M NaCl, water 
followed by 70% ethanol and stored at -20°C. Before use, the scaffolds were washed 
in 70% ethanol (4x 1 h, 1x overnight), followed by washings in sterile phosphate 
buffered saline (PBS, pH 7.4, 4x 1 h, 1x overnight), and followed by an overnight 
incubation in the culture medium. 
Scanning Electron Microscopy (SEM) 
The structure of hybrid collagen-PCL scaffolds were examined by a scanning 
electron microscope (SEM) (JSM-6310; JEOL, Japan). Scaffolds were fixed with 2% 
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(v/v) gluteraldehyde, then dehydrated by graded series ethanol (30-100%) and 
finally dried using the critical point dryer (Polaron, Quorum Technologies, UK). 
Samples were sputtered with gold for 60s by Scancoat Six SEM Sputter Coater 
(Temescal, USA) before being studied. 
Determination of cross-linking 
Samples were incubated with 4% (w/v) NaHCO3 in water for 30 min at 21°C, 0.5% 
(w/v) 2, 4, 6-trinitrobenzene sulfonic acid solution was added and the samples 
incubated for 2 h at 40oC. The degree of cross-linking was determined by the 
change of free amine groups by measuring the absorbance of resultant 
trinitrophenylated amine complex at 420 nm (Biorad, USA). 
Determination of water retention 
Samples were incubated with water for 24 hours at 21°C on the shaker. The weight 
of wet scaffolds was weighed after removing the excess water with blotting paper. 
The weight of dry scaffolds was determined after freezing and lyophilization (VirTis 
Sentry, USA) over night. At each percentage of collagen scaffolds, six samples were 
tested. The water retention was calculated according to the formula: 
Water uptake (wt %) 
 
,100u 
dry
drywet
W
WW
                               (1) 
where Wwet is the wet weight after blotting and Wdry is the weight after drying. 
Ultimate Tensile Strength (UTS) 
Samples were pre-incubated in 0.9% NaCl, cut into strips and placed between 
clamps in a bioreactor (Bose Electroforce Biodynamic bioreactor, Bose, USA). The 
measurements were recorded and controlled by the WinTest v4.1 (Bose, USA). The 
elongation speed was set at 20 mm/min and forces were recorded with a 22N load 
cell. The distance between clamps was 10 mm for collagen samples and 5 mm for 
PCL plus collagen samples. The valley and peak distance was 12 mm. The 
measurements were repeated at least 4 times for each scaffold of a particular 
collagen density. Measurement was valid when a sample broke in the middle. 
Distribution of fluorescent beads 
The scaffolds were washed five times in PBS before bead seeding. The fluorescent 
beads (10 μm diameter, 488 nm, Flow Check, Beckman Coulter, Brea, USA) were 
washed using 5% (w/v) bovine serum albumin (BSA, Sigma Aldrich, USA) in PBS. 
The fluorescent beads were seeded at a density of 2×106 beads/cm2 scaffold and 
incubated over night under continuous shaking at 21oC. The bead seeded scaffolds 
were collected and incubated 20 min in Tissue-Tek (Sakura Finetek Europe B.V., 
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Zoeterwoude, The Netherlands) and snap-frozen. Cryostat sections (5 μm) were 
collected on gelatin-coated slides (0.5% gelatin (w/v), 0.05% potassium chrome (III) 
sulfate (w/v), and demi-water), fixed with 100% methanol and air dried 1 hour at 21 
oC. 
Cell culture 
Human primary bladder smooth muscle cells (HBSMC) were purchased from 
Sciencell (Carlsbad, USA). HBSMC were cultured in smooth muscle cell medium 
(SMCM, Cat. 1101, Sciencell) with 2% (v/v) fetal bovine serum (FBS), 1% (v/v) 
smooth muscle cell growth supplement, and penicillin (100 iU/mL)-streptomycin 
(100 μg/mL). Human urothelial cells (ScaBER, derived from squamous cell 
carcinoma of human bladder) were cultured in RPMI-1640 medium (Cat. 21870, 
Invitrogen) with 10% (v/v) fetal calf serum (FCS), without glutamin, and penicillin 
(100 iU/mL)-streptomycin (100 μg/mL). Cells were cultured and expanded at 37oC 
and 5% CO2 in humid atmosphere air.  
Cell seeding 
Static seeding of HBSMC on the scaffold was performed using 2.6×106 cells/cm2. 
Cells were cultured for 14 days and medium was replaced every 2-3 days. Thereafter 
the scaffolds were incubated in RPMI-1640 medium overnight followed by an 
urothelial cell seeding step. ScaBER cells (6.6×106 cells/cm2) were seeded, and 
scaffolds were incubated for an additional 7 days. 
Immunohistochemistry (IHC) 
Cell seeded scaffolds were fixed in 4% (v/v) formalin in PBS overnight and 
embedded in paraffin. Four μm sections were cut (Microm, Heidelberg, Germany), 
deparaffinized in xylene, and rehydrated using a graded series of ethanol, and 
stained with hematoxylin-eosin (H&E). 
For IHC analysis, 5-μm cryostat sections slides were fixed in methanol for 10 min at -
20oC and air dried for 1 h at 21°C. Sections were blocked with 10% (v/v) normal goat 
serum in PBS for 1 h. Then, sections were incubated with various primary antibodies 
(rabbit anti bovine type I collagen (Millipore, USA; 10 μg/mL), mouse anti human 
RGE53 (MUbio BV, the Netherlands; 10 μg/mL), rabbit anti human vimentin 
(Pathology, UMC St Radboud Nijmegen, the Netherlands; 1:200) and mouse anti 
human CD90 (Dianova GmbH, Germany; 40 μg/mL) in blocking buffer for 1 h at 21°C 
in a wet chamber. The primary antibodies were developed with goat-anti rabbit 
Alexa-488 (Invitrogen, USA; 10 μg/mL) or goat anti-mouse Alexa 594 (Invitrogen, 
USA; 10 μg/mL). Nuclei were counterstained with DAPI in Prolong gold mount 
medium (Invitrogen, USA). The samples were evaluated by fluorescence microscopy 
(LEICA DC 300F, Germany). 
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Results 
Characterization of the collagen scaffolds 
SEM and H&E and images of the different collagen scaffolds are shown in Figure 1 
and 2. The scaffolds had the typical honeycomb morphology (18). The pore size of 
all collagen scaffolds ranged between 75 μm and 150 μm, and the degree of cross-
linking was approximately 43% (18), regardless of collagen density. The water 
retention capacity of the scaffolds was highly similar after 24 hour incubation. In 
general, different density scaffolds revealed more connections between pores in the 
lower density scaffolds as compared to the higher density scaffolds (Figure 1).  
 
 
Figure 1. Microscopic characterization of the cross-sectioned collagen scaffolds. Scanning electron 
microscopy (A-F) and H&E of different collagen scaffolds (E-K) indicate that the interconnection is related 
to the collagen content. Scaffolds with lower collagen content show more interconnectivity between the 
pores (more open lamellae).  
The hybrid scaffolds were prepared by pouring the collagen solutions on top of the 
PCL knitting. Despite the fact that no additional measures were taken, the collagen 
and PCL appeared to be adequately connected (see Figure 2). The woven structure 
of the PCL knitting may have aided in an adequate collagen distribution.  
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Figure 2.  Schematic overview of preparation hybrid scaffold. Type I collagen (A) pluses PCL knitting (B) is a 
hybrid scaffold (C). Collagen scaffold and PCL knitting was imaged by light microscopy (4x and 10x). 
Collagen is integrated into PCL knitting. Arrows indicate the collagen (D). Type I collagen and PCL were 
imaged by SEM (E). Collagen is adequately connected to PCL.  Take a close look of PCL, collagen is well 
distributed through it (50x and 250x). 
Tensile strength experiments were performed to determine the mechanical 
properties of the scaffolds with and without PLC knitting (Figure 3a). The strength 
of scaffolds increased slightly as the density of the collagen increased (R2=0.97; 
p=0.0008). Furthermore, hybrid scaffolds were much stronger compared to 
scaffolds composed of collagen alone (Figure 3b and c). Even at the highest tensile 
force applied the PCL-collagen scaffold did not break but deformed: the collagen 
layers broke and slid from the PCL and the morphology of the PCL knitting was 
irreversibly changed.  
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Figure 3. Tensile test of collagen scaffold with and without PCL (A). The mechanical strength increased 
slightly with the collagen density increased. The strength of scaffolds with PCL is higher than collagen 
alone scaffolds. B,C: Individual tensile strength measurements of 0.8% collagen scaffold without (B) and 
with PCL (C). Please note plateau value at 7.8 N in C, suggesting that beyond 7.8 N PCL distortion occurs. 
To further investigate the influence of the collagen concentration on the 
interconnectivity of the resultant different scaffolds, the distribution of fluorescent 
beads was investigated. To mimic cell penetration, 10 μm diameter beads were used, 
comparable with the size of animal eukaryotic cells. The distribution of the beads 
was highly dependent on the collagen density: at lower collagen densities the beads 
were more evenly distributed and penetrated deeper into the scaffold (see Figure 4). 
Beads presented throughout the 0.3% and 0.4% scaffold, a less homogeneous 
distribution was noted for the 0.5% and 0.6% scaffold, whereas the fluorescent 
beads were mainly on the surface of the 0.7% and 0.8% collagen scaffolds.  
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Figure 4. Bead distribution in collagen scaffolds (0.8%-0.3%). Type I collagen was developed by Alexa 594 
and the fluorescent beads were tagged with Alexa 488. Beads and collagen scaffolds were imaged by 
fluorescent microscopy (4x). Beads penetrate deeply into 0.3% and 0.4% collagen scaffolds. In 0.7% and 
0.8% collagen scaffolds, beads mainly stay on the surface of scaffolds.  
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Cell distribution  
To mimic multilayered cell growth, human bladder smooth muscle cells (HBSMC) 
were seeded onto the scaffolds followed by urothelial (ScaBER) cells. HBSMC were 
allowed to grow for 14 days, in an effort to generate scaffolds mimicking the urinary 
bladder wall, the natural stratum for urothelial cells. HBSMC were visualized with an 
anti-human smooth muscle cell marker (CD-90 and vimentin). The distribution of 
HBSMC inside the scaffolds was more homogeneous in the lower collagen density 
scaffolds (0.3% and 0.4% scaffolds) where they almost completely covered the 
depth of the scaffolds (see Figure 5 and 6). HBSMC in-growth of scaffolds of higher 
collagen content was less extensive, and less dispersed.  Inclusion of PCL did not 
influence the cell distribution.  
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Figure 5. IF analysis of cell distribution in different densities (from 0.8% to 0.3%) collagen scaffold. Type I 
collagen was developed by Alexa 594 (red), HBSMC was developed by Alexa 488 (green), and all nuclei 
were counter stained by DAPI (blue). HBSMC and collagen scaffolds were imaged by fluorescence 
microscopy (10×).  Smooth muscle cells (HBSMC) are located in the scaffold. More HBSMC cells are 
distributed through the 0.3% and 0.4% scaffolds and less cells penetrate 0.7% and 0.8% scaffolds. Cells on 
top of the surface which are not smooth muscle cells positive are urothelial cells. 
Seeding of bladder cells resulted in urothelial cell growth restricted to the scaffold 
surface, mimicking the build-up of normal bladder tissue. Even after 3 weeks of 
culture, the scaffolds supported the cells and did not lose integrity, regardless of 
collagen content. The distribution of the bladder cells was visualized with an anti-
human cytokeratin marker (RGE-53), (see Figure 6). Comparison of cell markers of 
cells grown under standard cell culture conditions did not reveal any difference with 
cells grown on scaffolds.  
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Figure 6. IF double staining of HBSMC and ScaBER in different densities (0.8%, 0.6%, and 0.4%) collagen 
scaffold. HBSMC was developed by Alexa 488 (green), ScaBER was developed by Alexa 594 (red), and all 
nuclei were counter stained by DAPI (blue). HBSMC and ScaBER in scaffolds were imaged by fluorescence 
microscopy (10x and 40x). HBSMC cells are located under the ScaBER cells as natural stratum for urothelial 
cells. ScaBER cells are always on top of the scaffolds regardless the collagen density. More HBSMC cells are 
distributed in the low density scaffolds.   
Discussion 
For soft tissue engineering, adequate cell colonization is crucial. Failure of cellular 
in-growth can lead to scar formation, and foreign body reactions leading to an 
undesired end result. Collagen has been applied as biomaterial for soft tissue 
engineering for many years, but the issue of adequate cell in-growth is still 
unresolved (7). Addition of migrational and differentiating cues may alleviate this 
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problem, but thus far success has been limited (19). One of the parameters that 
influence cell distribution is scaffold porosity and inter-connectivity. To improve the 
cell distribution in honeycomb collagen scaffolds and to optimize their use for soft 
tissue engineering, we prepared 0.3% to 0.8% (w/v) collagen scaffolds and included 
a rigid knitting to improve the mechanical and handling characteristics. The porosity 
of all scaffolds was similar, but lowering the collagen content resulted in higher 
inter-connectivity and improved cellular in-growth. Cells remained on the surface of 
the higher density collagen scaffolds, but almost completely invaded the scaffolds 
of the lowest density, leading to a scaffold almost homogeneously occupied with 
HBSMC. Thus, the functionality of the collagen scaffolds with regard to the cellular 
distribution was improved by lowering the collagen density.  
The low density collagen scaffolds were very fragile, which made them unsuitable 
for in vivo use. To improve the mechanical strength polymer knitting was 
incorporated. This resulted in a hybrid scaffold with significantly increased 
mechanical and functional characteristics: cell in-growth was greatly enhanced due 
to the lower collagen content whereas the hybrid scaffold could be handled easily 
due to the incorporation of the polymer. The polymer used, PCL, is frequently used 
as biomaterial. The degradation time of PCL is ~6 to 9 months in vivo, very suitable 
for implantable systems where scaffolds must provide temporary mechanical 
support for a longer period until the regenerated tissue can support mechanical 
loads (20). Incorporation of supportive materials other than PCL, for instance 
copolymers of e.g. lactic, glycolic acid or trimethylene carbonate by which the 
degradation time can be tailored (19, 21-23), should greatly enhance the 
implementation possibilities for soft tissues. Similar to our scaffolds, PLGA and 
PLLA-enforced hybrid scaffolds have been prepared for cartilage regeneration (24, 
25). In these hybrids a favourable cell distribution was observed, most likely related 
to the unidirectional orientation of the pores. In our honeycomb structured scaffolds 
which are needed to regenerate complex, multilayered tissues composed of 
multiple cell types, we needed to decrease the collagen content of the hybrid 
scaffolds to achieve a favourable cell distribution for soft tissue regeneration. 
Through small changes in collagen content we could control the cellular distribution.   
To further quantify the effect of lowering the collagen content, we studied the 
distribution of 10 μm diameter fluorescent beads. The distribution of the beads was 
identical to the distribution of cells, with better bead penetration at the lower 
collagen densities. This again demonstrates that the interconnectivity increased by 
lowering the collagen content. Obviously, the bead distribution does not truly 
reflect the cell distribution after cell seeding, as other factors such as cell surface 
influence this distribution. The obvious advantages of the beads is the rapidity with 
which the results are obtained, the consistency, because variability due to the use of 
different cells is lacking, the objectivity, with the possibility to vary bead size to 
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judge interconnectivity and measure bead penetration (26). Many studies have 
applied different seeding methods to improve the cellular distribution in 
honeycomb-like scaffolds. Different procedures of dynamic cell seeding have been 
attempted, including centrifugation (27), rotation (28), magnetic field (29), and 
vacuum (30) in a bioreactor. Nevertheless, almost invariably, the cell distribution 
was limited to the scaffold surface with little spreading throughout the scaffold. 
Coating of PET fabrics with 0.3% collagen (without cross-linking) demonstrated an 
even cellular distribution throughout 1.5 mm scaffolds (28) similar to our 
observations with 5 mm thick scaffolds prepared from 0.3% collagen. Our results 
suggest that the efficiency of cell colonization largely depends on the collagen 
density of the scaffold. Most likely, the higher interconnectivity in the scaffold 
facilitates cellular migration since collagen degradation is not necessary to colonize 
adjacent pores of the scaffold. Since cellular in-growth appears to be greatly 
dependent on the pore interconnectivity, it is not unexpected that static seeding at 
higher cell density did not lead to better and more homogeneous cell growth. 
Lowering the collagen content may be more beneficial in achieving a homogeneous 
cell distribution than active cellular seeding. However, cell in-growth in vivo is 
improved at lower collagen content scaffolds remains to be studied. In addition, 
active cell seeding in this low collagen content, polymer supported scaffolds may 
lead to a more homogeneous cell distribution.   
Conclusion 
In summary, the functionality of collagen scaffolds can be greatly improved by 
lowering the collagen content and including polymer knitting, leading to a versatile 
scaffold with new opportunities for soft tissue engineering.  
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Abstract 
Functional monitoring of the fate in implanted templates which restore the function 
of lost tissues is still a challenge. Whereas histology can give excellent insight in 
material and tissue remodelling, longitudinal studies are hampered by the invasive 
character. Non-invasive imaging techniques which allow longitudinal studies in the 
same individual and provide functional information might be beneficial.  
Here, magnetic resonance imaging (MRI) was applied as a non-invasive tool to 
monitor the progress of vasculogenesis and inosculation in in vitro pre-vascularized 
collagen/fibrin templates implanted in mice during four weeks. MRI results were 
compared with histological findings to evaluate whether the two technologies were 
complementary and to evaluate the added value of MRI. 
When in vitro pre-vascularized templates were implanted in mice histological 
analysis showed the presence of mouse blood cells in the engineered vessels two 
weeks after implantation. The MR images showed that template perfusion, a 
measure of vascularity became significant at three weeks.  
For tissue engineering purposes contrast enhanced MRI appears to be an attractive 
tool to evaluate the vascular outcome longitudinally without the need to sacrifice 
animals and the functional information can be superimposed on the static 
histological information.  
Keywords: Imaging, Endothelial cells, Angiogenesis and Vasculogenesis 
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Introduction 
New smart materials have been developed for both hard and soft tissue engineering. 
Such novel materials demand extensive in vitro and in vivo testing to investigate 
their clinical potential. Currently biopsies are needed to demonstrate the efficacy of 
the implanted material and in almost all studies animals are sacrificed to study the 
regenerative outcome of implanted materials. Quantitative, real-time, and non-
invasive imaging methods might greatly aid the evaluation because they allow 
longitudinal follow-up to study tissue remodeling in the same animals and they 
provide functional and anatomical information during the regeneration/remodeling 
process (1). A bystander effect of (multimodality) imaging is reduction in the 
framework of the 3Rs of animal use. 
Multiple imaging tools are available: single-photon emission computed tomography 
(SPECT), positron emission tomography (PET), ultrasound (US), x-ray computed 
tomography (CT), optical imaging (OI), and high field magnetic resonance imaging 
(MRI). MR imaging does not involve ionizing radiation, has a high spatial resolution 
without penetration problems (2), and the outcome of preclinical studies can easily 
be translated to the clinic (3). 
Pre-vascularization techniques have been studied to enhance the survival and to 
accelerate the remodeling of implanted materials, particularly for larger templates 
(4, 5). After grafting, the progress of vascularization/inosculation has been 
visualized with histology; however, this provides only an anatomical snap-shot of 
this highly dynamic process, and functionality can only be surmised. Through MRI 
different types of functional information can be obtained, which can be 
superimposed on the histological information (Fig. 1). For instance, it is possible to 
determine vascular functionality with administration of contrast agents (6). 
The goal of this study was to monitor the fate of in vitro pre-vascularized 
collagen/fibrin templates with emphasis on (time of) inosculation and functionality 
of the engineered micro-vasculature in the implanted templates with MRI. MRI was 
compared with histology to investigate the added value and complementarity of 
MRI and histology.  
Materials and methods 
Cell culture 
Human umbilical vein endothelial cells (HUVEC, a kind gift from Prof. Otto C. 
Boerman, Department of Nuclear Medicine, Radboudumc) were expanded in 
microvascular endothelial cell growth medium-2 (EGM-2MV, Lonza, Basel, 
Switzerland) with supplements (Lonza, CC-4147). Human bladder smooth muscle 
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cells (hbSMC, ScienCell, Carlsbad, USA) were expanded in smooth muscle cell 
medium (SMCM, ScienCell) with growth supplement, fetal bovine serum, and 
penicillin/streptomycin solution. hTERT-human urothelial cells (hUC, a kind gift 
from Dr. M.A. Knowles, Leeds, UK) were expanded in keratinocyte serum free 
media (KSFM, Invitrogen, Carlsbad, USA) with supplements including bovine 
pituitary extract, epidermal growth factor, and cholera toxin (Sigma-Aldrich, 
Schnelldorf, Germany). The media were replaced three times per week.  
Pre-vascularization  
Four types of hybrid templates were prepared: a blank template (Acellular), an 
urothelial cell seeded template (UC), a pre-vascularized template (Pre-V), and a pre-
vascularized template with urothelial cells (Pre-V+UC). 0.4% (w/v) type I collagen 
templates were prepared as previously described (7). Collagen templates were 
sterilized with gamma irradiation (Synergy Health, Etten-Leur, Netherlands). 
Fibrinogen solution (from bovine plasma, Sigma-Aldrich) was prepared to a final 
concentration of 10 mg/mL as described (8) and sterilized by passing through a filter 
(0.22 μm, Whatman, Little Chalfont, UK).  
To prepare pre-vascularized hybrid templates a dry 0.4% (w/v) collagen template 
was placed in the insert ring of a transwell system (0.4 μm polyester membranes, 
12-well plate, Costar, NY, USA). HUVEC (2.5x105 cells/mL) and hbSMC (2.5x105 
cells/mL) were encapsulated in 500 μL fibrinogen (10 mg/mL) mixed with 11 μL 
thrombin (Sigma-Aldrich, 50 U/mL), and applied on the dry collagen sponge. The 
mixture of cells and gel was absorbed by the collagen sponge. The hybrid template 
was incubated at 37oC for 1 hour in a humidified incubator containing 5% CO2 to 
stabilize. Thereafter a mixture of EGM-2MV: SMCM (1:1 (v/v)) was added to the top 
and bottom chambers of the transwell plate. To inhibit the fibrinolysis process, 12 
mM of Ɛ-aminocaproic acid (Sigma-Aldrich) was added (9). Medium was replaced 
three times weekly. Hybrid templates were cultured for 2 weeks before grafting.  
To evaluate the influence of hUC on the Pre-V templates, hUC cells were seeded 
(2.5 x 104 cells/mL) on the surface of Pre-V template one day before implantation. 
Additionally, UC templates were produced by seeding hUC on top of acellular 
templates. These templates were cultures for one day and implanted. These UC 
templates were included to study the possible influence of hUC coverage on the pre-
V templates and served as control for the non-vascularized templates.    
Scanning Electron Microscopy (SEM) 
Templates were fixed with 2% (v/v) glutaraldehyde, dehydrated by graded series of 
ethanol (30-100%) and dried using a critical point dryer (Polaron, Quorum 
Technologies, Loughborough, UK). Samples were sputtered with gold for 60 
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seconds by Gold/palladium coater (Cressington 208HR sputter coater, England, UK) 
and examined by SEM (JSM-6310; JEOL, Tokyo, Japan). 
Template grafting 
Animal studies were conducted in accordance with the principles laid out by the 
revised Dutch Act on Animal Experimentation and performed after approval from 
the institutional Animal Welfare Committee of the Radboud University Nijmegen 
(DEC-nr. 2012-118). Eight weeks old male Balb/c nu/nu mice (N=36) were purchased 
from Charles River (Sulzfeld, Germany). The template was grafted on the ventral 
abdominal wall with 3 sutures (Prolene, 6-0, Ethicon, Edinburgh, UK) on the edge of 
templates. Peritoneum and skin were closed using 4-0 Vicryl sutures (Ethicon) and 
sterilized staplers. Animals were evaluated 1, 2, and 4 weeks post implantation 
using MRI and sacrificed for immunohistochemical analysis. Grafting was as follows: 
blank hybrid templates (Acellular, N=6), hUC seeded hybrid templates (UC, N=10), 
pre-vascularized hybrid templates (Pre-V, N=10), and pre-vascularized hybrid 
templates plus hUC (Pre-V+UC, N=10). 
MRI  
MR measurements were performed on an 11.7 T horizontal bore small-animal MR 
system (BioSpec, Bruker BioSpin, Rheinstetten, Germany). A circular polarized 
resonator was used for signal transmission, and a receiver surface coil (1.5 x 1.5 cm) 
was placed adjacent to the template. Mice were placed in the MR system under 
sedation in a supine position. Body temperature was maintained at 37°C. The 
numbers of animals analyzed from each group were: Acellular N=4, UC N=5, Pre-V 
N=8, and Pre-V+UC N=5. The contrast agent, Gadomer-17 (InvivoContrast GmbH, 
Germany) was administrated [150 μmol/kg body weight] as a rapid bolus injection (< 
5 seconds) via the tail vein.  
T1 relaxation time were measured by a rapid acquisition rapid echo (RARE) 
sequence with variable repetition time (TR) (400, 800, 1500, 3000 and 5000 ms) and 
a fixed echo time (TE) of 30 ms. Parameters were: RARE factor = 2, field of view = 40 
× 40 mm, matrix size = 256 × 256, total acquisition time (TA) = 8 minutes.  
Dynamic contrast enhanced MRI was performed using a fast low angle shot (FLASH) 
sequence (10, 11). Imaging parameters were: TE = 1.602 ms, TR = 52 ms, flip angle = 
40°, field of view = 40 × 40 mm, matrix size = 256 × 256, slice thickness = 1 mm, 4 
slices in coronal directions. One baseline image was measured before contrast 
administration. Immediately thereafter, dynamic T1 weighted imaging was 
performed by repeating the same FLASH sequence of 5 seconds 499 times. The 
dynamic uptake of Gadomer-17 was monitored for TA = 42 minutes.  
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MR images were processed using a home-built program in MevisLab. The signal to 
noise ratio (SNR) was calculated on a manually drawn region of interest (ROI) at the 
location of the template. The SNR before and after injection of Gadomer-17 was 
recorded over time to track signal intensity (SI) changes. For semi-quantification 
purposes (an indication of the amount of Gadomer-17 in each implanted template), 
the area under curve (AUC) was calculated from the SI-time curve up to 2000 
seconds using GraphPad Prism 5 software.  
Data were presented as mean (±SD). Several ROIs were analyzed and the numbers 
of ROIs were determined based on the thickness of templates. Two-tailed t-test 
analysis was used to determine the significance of T1 relaxation times changes after 
Gadomer injection. The ability of MRI to identify different permeability levels was 
tested using two-way ANOVA analysis. Post-tests analysis of differences amongst 
means was based on Bonferroni. P<0.05 was considered significant.  
Immunohistochemistry (IHC) 
Antibodies are summarized in Table 1. Templates were fixed in O.C.T. compound 
(TissueTek, Leiden, Netherlands) and snap frozen. Specimen were cut at 5 μm and 
fixed with methanol for 10 minutes at 21oC. For laminin staining, slides were 
incubated in 0.15 mg/mL pepsin in 0.2 M HCl at 37oC for 10 min. Then slides were 
washed 3 times 10 minutes with Tris-saline. For human mitochondria staining, 
mouse on mouse blocking reagent (M. O. M., Vector Labs, Burlingame, California, 
USA) was applied to reduce background noise from mouse tissue according to the 
manufacturer’s instruction. 
Slides were incubated with 10% normal goat serum (NGS) in 1% bovine serum 
albumin (BSA) in phosphate-buffered saline (PBS, pH=7) for 1 hour at 21oC for 
blocking. Primary and Alexa fluor labeled secondary antibodies were incubated in 
1% NGS 1% BSA in PBS for 1 hour and 30 minutes at 21oC, respectively. Slides were 
mounted with Prolong Gold mount medium with DAPI (Invitrogen) and evaluated 
by fluorescence microscopy (LEICA DC 300F, Leica Microsystems, Wetzlar, 
Germany) or high content microscopy (LEICA DMI6000B).  
For whole template staining, templates were incubated with antibodies as 
previously described and the nuclei were stained with Hoechst 33342 (Invitrogen). 
Complete templates were scanned by confocal laser scanning microscopy (Olympus 
FV1000, Tokyo, Japan). Images were processed with Fiji (ImageJ, fiji.sc). The length 
of micro-vessels was estimated by comparing images with scale bar.  
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Table 1. Summary of antibodies 
Antibody Origin Clone React Dilution, final 
concentration 
Company 
Von Willebrand 
factor 
Rabbit Polyclonal Human 1:400 (7.75 μg/mL) Dako 
CD31  Mouse JC70A Human 1:100 Dako 
CD31 Rat 390 Mouse 1:200 (1 μg/mL) Invitrogen 
α-SMA Mouse 1A4 Human 
and 
mouse 
1:8000 (0.75 
μg/mL) 
Sigma 
Type 4 collagen Rabbit  Polyclonal Human, 
mouse, 
and 
cow 
1:200 (5 μg/mL) Abcam 
Vimentin Rabbit n. a. Human, 
mouse, 
and rat 
1:400 Abcam 
Ki67 Rabbit SP6 Human 1:200 Thermo 
Scientific 
Type 1 collagen Rabbit Polyclonal Bovine 1:100 (1 μg/mL) Millipore 
Fibrin/Fibrinogen Mouse MFB-HB Human 
and 
canine 
1:50 (10 μg/mL) Thermo 
Scientific 
Keratin 5 Mouse RCK103 Human 1:5 ALPCO 
Laminin Rabbit  Polyclonal Mouse 1:100 Organon 
Teknika 
Mitochondria Mouse 113-1 Human 1:100 Millipore 
Alexa-488 Goat  Mouse 1:200 Invitrogen 
Alexa-568 Goat  Rabbit 1:200 Invitrogen 
Alexa-488 Donkey  Mouse 1:200 Invitrogen 
Alexa-594 Donkey  Rabbit 1:200 Invitrogen 
Alexa-488 Donkey  Rat 1:200 invitrogen 
Alexa-647 Goat  Rabbit 1:200 Invitrogen 
 
Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
RNA was extracted with TRIzol (Invitrogen) according to the manufactures’ 
instruction. The central part of each template was evaluated and at every time point 
at least two templates were investigated. Primer sequences were designed to 
detect human vascular endothelial growth factor A (VEGF-A), mouse VEGF-A, 
human B2 microglobulin (B2M), and mouse B2M. cDNA was amplified with Q-PCR 
using Tag DNA polymerase. The primer sequences were as follows: Forward human 
VEGF-A (F): 5’-GAGGGCAGAATCATCACGA-3’ and Reverse (R) VEGF-A 5’- 
ATCTGCATGGTGATGTTGGA-3’; mouse VEGF-A (F)  5’- 
GCAGAAGTCCCATGAAGTGAT-3’ and VEGF-A (R) 5’-CTGCATGGTGATGTTGCTCT-
3’. VEGF to B2M ratios were calculated and presented as mean (±SD). Occasionally 
material was limited to 1 sample. 
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Results 
Figure 1 shows the preparation of the hybrid collagen/fibrin templates, in vitro 
vascularization, implantation procedure, and different analyses.  
 
Figure 1. The workflow of preparing materials, implanting in animal, and monitoring the implants with MRI. 
Smart materials with or without cells are grafted into animals to replace the lost tissues. The progress of 
tissue remodeling and vasculogenesis in smart materials can be monitored either with histology (invasive) 
or with imaging tools (non-invasive), MR imaging is particular useful as it can be performed non-invasively 
and provides a high-resolution anatomy (2D resolutions down to about 80 μm). With this technique signals 
of water protons are recorded and their intensities are displayed as a function of their location. Image 
contrast can be manipulated by T1 or T2 relaxation time weighting. In addition, contrast can be enhanced 
by using Gadolinium (Gd) or iron labeled contrast agents. These contrast agents can be used to visualize 
tissue perfusion after contrast agent infusion or can be tagged to compounds such as those used in 
templates or implants. Using these MR methods tissue, vasculature, or remodeling can be analyzed in live 
animals.  
Here, Gd contrast enhanced T1 and T2 MR images are shown that was used to localize the implant in 
cadavers. Orange dotted line indicates the location of the template. 
Hybrid scaffold 
SEM analysis showed open honeycomb-like structures of 0.4% type I collagen 
templates after cross-linking and freeze drying (Supplementary Information, SI. 1a-
b and enlarged images in SI. 1e-f). SEM of cell-loaded hybrid templates 
demonstrated that cells occupied the honeycomb-like structures (SI. 1c and 1g: top 
side of hybrid templates). When fibrin was applied to create a hybrid template, all 
collagen pores were equally coated throughout the complete collagen template as 
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evidenced by SEM and Masson trichrome staining (SI. 1d trans-axial view; 1h, 
Masson trichrome stain).  
 
SI_1. Hybrid templates. a and b: SEM images show the highly porous structure of 0.4% type I collagen 
sponge from the top side (a is enlarged in e) and the pan side (b is enlarged in f). c and g: After cells were 
seeded, cells occupied the porous structure. d: After fibrin gel was applied on collagen to create a hybrid 
template, the porous structure was coated with fibrin. h: Masson trichrome shows fibrin coating on all 
pores of collagen template. Fibrin in red and collagen in green. 
Cellular distribution in vitro 
After two weeks of in vitro culture HUVEC and hbSMC cells occupied the template 
up to a depth of 300-400 μm. Small capillary-like structures were formed with 
hbSMC supporting HUVEC and formation of a lumen (Fig. 2). Seeding of hUC on top 
of pre-vascularized and unmodified templates resulted in a single cell layer (SI. 2a 
and 2b).  
 
 
Figure 2. Pre-vascularization of hybrid templates and cellular distribution in vitro. a: Immunohistochemical 
image (Z-stack of 20 confocal microscope images) showing pre-vascularization of the hybrid collagen/fibrin 
templates. HUVEC (CD31+, green) and hbSMC (vimentin+, red) after two weeks in cell culture. Nuclei in blue 
(DAPI). b: Vasculature-like structures in the hybrid collagen/fibrin template. Co-localization of hbSMC 
(SMA+, red) with HUVEC (vWF+, green). c: Lumen-like structure in the hybrid collagen/fibrin template. 
HUVEC (CD31+, green). 
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SI_2. HE showing the hUC layer of cells on the UC template (a) and on the Pre-V + UC template (b). In the 
UC template a layer of hUC cells is visible on the surface of the template. In the Pre-V + UC template 
HUVEC and hbSMC are visible in the template and hUC cells are visible as a cell layer on the surface. 
In vivo analyses 
One week after implantation of pre-V templates cells distributed equally throughout 
the template, well beyond the pre-implant distribution. Small capillary-like 
structures (vWF+, pre-engineered, Fig. 3a, 1 week) containing exclusively human 
cells were present in the center of the templates. One week later mouse neo-
angiogenesis became apparent as evidenced by the presence of mCD31+ mouse 
endothelial cells on the template surface in the vicinity of pre-engineered 
microvasculature (vWF+, Fig. 3a, 2 weeks). One to 2 weeks later the number of small 
capillaries had increased as well as the length of the capillaries was increased to 200 
μm and the complete vasculature was of mouse origin (Fig. 3a, 3 and 4 weeks). 
Morphological analysis with HE (Fig. 3b) showed the presence of erythrocytes in the 
small capillaries two weeks after implantation. 
 
 
Figure 3. Analysis of Pre-V templates in vivo. a: 1 week after implanting the vasculature is located in the 
center of the template (vWF+, red). 2 weeks post-implantation, mCD31+ cells (red) became apparent in the 
Pre-V templates and located next to the pre-engineered vasculature (vWF+, cyan). 3 weeks post-
implantation, the vasculature (mCD31+, red; vWF+, cyan) was extending to 100 μm in length. 4 weeks post-
implantation, the vasculature (mCD31+, red; vWF+, green) became approximately 200 μm in length and 350 
μm in depth. Scale bar, 50 μm. b: Morphological analysis shows that erythrocytes were present in the small 
capillaries on the surface of templates 2 weeks post-implantation. 4 weeks post-implantation, more 
erythrocyte-filled luminal structures were observed in the Pre-V templates. Long and flat endothelial cells 
formed the wall of small capillaries. Arrows indicate the location of small capillaries. Scale bar, 50 μm. c: 
Changes in T1 relaxation time due to Gd contrast infusion in Pre-V templates between 2 to 4 weeks after 
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implanting. The T1 relaxation time (millisecond) is presented on the y-axis and the time of implantation on 
x-axis (weeks). When the implants are well perfused, the T1 relaxation time is shortened by the contrast 
agent in blood vessels and interstitial space. At two weeks the difference of pre- and post- contrast is not 
significant, which indicates that the implants are not yet perfused. At three and four weeks, the differences 
in T1 became significant showing that templates have become well-perfused. The data was analyzed with 
t-test (within group) and two-way ANOVA (between groups; **= p<0.01, ***= p<0.001).    
The surface of the Acellular templates was covered with newly formed vessels (Fig. 
4a) and mouse cells penetrated into the hybrid templates up to 200 μm four weeks 
after implantation. When hUC were seeded on top of the hybrid templates and 
evaluated 4 weeks later, the surface of the templates was covered with a cell layer 
of Krt5+ cells (Fig. 4a) and newly formed vessels (mCD31+). In contrast, the mouse 
vasculature (mCD31+) penetrated deeply into Pre-V and Pre-V+UC templates (300-
400 μm, Fig. 4a) and mature vascular structures were observed 4 weeks post-
implantation (Fig.  4a).  
To evaluate the functionality and inosculation of the pre-engineered vasculature 
MRI studies were performed. At 2 weeks post-implantation the T1 of the Pre-V 
templates decreased due to Gadomer-17 application, but this was not significant. 
However, at 3 and 4 weeks T1 was significantly decreased, which is a profound 
perfusion of the templates (p<0.01, Fig. 3c).  
MR analysis of the four templates showed that at four weeks the difference in T1 
due to Gadomer-17 was significant for all (p<0.001, Fig. 4b), albeit that the 
difference of T1 was more prominent for the pre-vascularized templates (Pre-V and 
Pre-V+UC). The percentage decrease in T1 was 34%, 48%, 67% and 66% for 
Acellular, UC, Pre-V and Pre-V+UC templates respectively (Fig. 4b).  
The sequential images acquired in the dynamic contrast enhanced MR four weeks 
post-implantation showed clear signal intensity changes (Fig. 4c). From the signal-
time curves, the time-to-peak, highest signal intensity and the area under curve 
(AUC) from 0 to 2000s were obtained. Both the highest signal intensity and AUC 
were larger for the Pre-V and Pre-V+UC than for the other templates (UC and 
Acellular) indicating more Gadomer-17 uptake and therefore more extensive 
vascularization (Table 2). The time-to-peak varied among the templates, but was 
highest in the Pre-V suggesting that Gadomer-17 was more rapidly taken up (Table 
2). 
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Figure 4. Analysis of different templates 4 weeks post-implantation. a: Acellular: host cells (DAPI, blue) 
penetrated into hybrid templates (depth approximately 200 μm). At higher magnification newly formed 
vasculature (mCD31+, red; col 4+, green) covering the surface of templates is visible. Arrows indicate the 
small capillaries. Scale bar, 50 μm. Dotted lines indicate the border between mouse tissue and hybrid 
template. UC: hUC (Krt5+, green) formed a single layer on the surface of templates and host cells (vimentin, 
red) covered the surface of the UC templates. The vasculature was of mouse origin (mCD31+, green). 
Arrows indicate the small capillaries on the surface of the template. Scale bar, 50 μm. Dotted line indicates 
the border between mouse tissue and hybrid template. Pre-V+UC: mouse vasculature (mCD31+, red) 
penetrated deeply into pre-vascularized templates (300-400 μm from the seeding side and 100 μm from the 
other side). Cells (DAPI, blue) distributed throughout the template. At higher magnification open and 
mature lumens (mCD31+, red) are visible. Scale bar, 50 μm. b: The pre- and post- contrast changes of T1 
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relaxation times were more substantial in Pre-V(+UC) templates than in neo-vascularized templates 
(Acellular and UC). The percentage decrease in T1 was 34%, 48%, 67% and 66% for Acellular, UC, Pre-V and 
Pre-V+UC templates respectively. The data were analyzed with two-way ANOVA (p<0.001, ***; p<0.01, **). 
c: Time-signal intensity curves obtained from dynamic MR images of hybrid templates due to Gadomer 
contrast infusion. The signal intensity (A. U.) is presented on the y-axis (seconds). The wash in and wash 
out of Gadomer was recorded for 2500 sec. i.e. 42 minutes. Clearly Gadomer induces the largest signal 
changes in the Pre-V template. In the Pre-V + UC and UC templates the signal intensity reached a plateau, 
possibly due to further contrast diffusion caused by urothelial cells. The signal intensity increase in Acellular 
templates was low and fluctuating likely due to breathing from the animal. 
 
Table 2. Analysis of MRI data 
Types of template Time to peak 
(seconds) 
Maximum signal 
intensity 
(arbitrary units) 
Area under curve (from 
0 to 2000s; arbitrary 
units)  
Pre-V 300 28000 4.906 × 107 
Pre-V+UC 800 23000 4.170 × 107 
UC 800 12000 2.481 × 107 
Acellular 300 15000 2.347 × 107 
 
A subset of dynamic contrast enhanced MR images of the four different hybrid 
templates 4 weeks post-implantation is shown in Figure 5. Clearly the SI 
enhancement in Pre-V and Pre-V+UC was rapid and strong; SI enhancement in 
Acellular and UC increased as well but the intensities were much lower than those 
observed in Pre-V and Pre-V+UC templates. As expected, the surrounding tissues 
also showed enhanced SI due to vascular extravasation and diffusion of the 
administered contrast agent. An animation of dynamic Gadomer-17 uptake in Pre-V 
template is presented in SI. 3.  
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Figure 5. Dynamic contrast enhanced MR images of 4 different types of templates 4 weeks after implanting. 
Images were recorded for 42 minutes after Gadomer administration, only the first pass between 5s-205s is 
shown. The well-perfused areas became bright rapidly which is most obvious in the Pre-V and Pre-V+UC 
templates (at 55 s); UC became bright during 55s to 105 s; the Acellular template stayed darker than the 
surrounding tissues. The different implants can be easily distinguished on the MR images. White arrows 
indicate the hybrid templates. Black dots mark ROI i.e. the hybrid template. 
Discussion 
Functional and quantitative studies may aid in the analysis of engineered/newly 
formed tissues, but in general analysis is limited to morphological and histological 
analysis which does not provide this information. Imaging tools enable a more 
objective analysis of the tissue formation and provide functional information of the 
biological responses (12). Implanted templates are becoming analogous to the 
tissue they replace, and classical imaging strategies are poorly equipped to image 
these implants. Consequently, the fate and effect of the implants, including 
vascularization, cannot be followed adequately. In this study the progress of 
vascular growth in hybrid templates was monitored with contrast enhanced MRI. 
The initial tissue uptake of the intermediate sized contrast agent Gadomer-17 
reflects tissue vasculature (blood volume and flow, and vessel permeability) (13, 14).  
Processed on: 18-10-2016
505481-L-bw-Sun
65 
 
Although MRI is extensively used in the clinic and in (pre-) clinical research (6, 15), it 
has been rarely used in studies addressing tissue engineering questions (13, 16). 
Several imaging tools have been used to monitor the degradation and 
vasculogenesis in scaffolds: near-infrared fluorescence microscopy (17), 
fluorescence microscopy (18), photo-acoustic imaging (19, 20), and intra-vital 
confocal imaging (21, 22). These imaging tools provide high resolution up to cellular 
level, but the penetration depth is limited, in contrast to MRI, and anatomical 
information is lacking. Here we demonstrate that MRI is very well suited to monitor 
in vivo tissue engineering approaches and to our knowledge, this is the first study to 
analyze the functional vascularity in cell seeded templates in vivo by MRI.  
Red blood cells were already detected in the pre-vascularized templates two weeks 
post-implantation, but in our experiments this did not yet result in a significant 
effect of the Gadomer-17 on T1 relaxation.  In the third week post-implantation the 
vasculature of pre-vascularized templates, as judged by this effect on the T1 
relaxation time, significantly increased and in the fourth week even more. This 
suggests the progressive extension of a functional blood vessel network connecting 
the host and the in vitro pre-engineered templates. The histology confirmed that 
more, and more mature vessels were present at four weeks: the extracellular matrix 
contained laminin and type IV collagen, indications of a mature vasculature, and 
formed a sleeve around endothelial tubes (mCD31+) reminiscent of a basement 
membrane (SI. 4). Clearly, once inosculation has occurred, contrast enhanced MR 
adequately visualizes the functional vasculature in the templates.  
 
SI_4. Extracellular matrix containing laminin and type IV collagen, indication of a mature vasculature, 
forming a sleeve around endothelial tubes (mCD31+) reminiscent of a basement membrane were observed. 
Scale bar, 50 μm.   
Further, AUC2000 values were higher in the pre-vascularized templates than in neo-
vascularized templates. Contrast shortening of T1 relaxation times was observed for 
all templates four weeks post-implantation. The data suggest that in neo-
vascularized templates the vasculature was restricted to the surface whereas in pre-
vascularized templates perfusion occurred throughout the template. IHC analysis 
confirmed that the surface of Acellular and UC templates was covered by newly 
formed vessels, explaining the contrast effect on T1 relaxation time. Thus, the MR 
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analysis correlated well with the histological observations and this shows that 
contrast enhanced MR can be used to distinguish pre-vascularization from neo-
vascularization. We conclude that contrast enhanced MRI is an attractive tool for 
longitudinal follow-up to evaluate the vascular outcome without the need to 
sacrifice animals. Moreover, the functional information can be superimposed on the 
static histological information.  
One limitation of MR is that it cannot distinguish host from donor cells. To study the 
degree of mouse endothelial cell involvement IHC was performed, demonstrating 
that human cells (hMt+) were lining the pre-vascular structures in the hybrid 
templates one week after implantation. One week later, mouse endothelial cells 
(mCD31+) and human endothelial cells (vWF+) were present simultaneously in the 
templates vasculature. Two weeks later, the template vasculature consisted 
exclusively of CD31+ mouse cells. This occupancy by mouse endothelial cells is most 
likely the consequence of the mouse blood flow that facilitated the process of 
mouse endothelial cell grafting and elimination of human cells.  
For future studies, multimodality imaging, e.g., MRI combined with PET or SPECT 
with antibody conjugated probes might enable distinction of human and murine 
cells (23, 24). Alternatively, human cells could be labelled with super-paramagnetic 
iron oxide (SPIO) or ultra-small SPIO (USPIO) in vitro (25), and be implanted in 
animals to permit MRI evaluations.  
It is well established that VEGF plays a crucial role in angiogenesis (26), and we 
envisioned that pre-seeded cells would release VEGF after template implantation 
because hypoxic conditions would prevail (27).  In general, Pre-V templates showed 
the lowest mVEGF-A level at all time points and mVEGF-A RNA levels decreased in 
time (SI. 5). It is likely that the lower VEGF expression levels are the consequence of 
vasculature in templates (i.e. a less hypoxic condition). This information again 
suggests changes in vascularity in the Pre-V templates, substantiating the MRI and 
histological observations.  
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SI_5. Analysis of mouse VEGF-A expression in different templates. VEGF-A expression levels were 
normalized using B2M as a reference gene. Error bars represent standard deviation. 
Because epithelial cells (hUC) seeded on top of pre-vascularized scaffolds may 
function as a barrier, influencing inosculation and neo-vascularization. By IHC 
analysis no major differences between epithelial-covered and non-covered 
templates was observed. However, the MRI did show that the permeability of the 
pre-vascularized template was higher than the epithelial-covered vascularized 
template. Thus, the MRI suggests that epithelial cells functioned as a barrier, 
influencing the vascularity of the template, probably by blocking inosculation and/or 
preventing connection of neo-vasculature to the engineered vessels. 
Studies have shown that inosculation of pre-vascularized fibrin- or collagen-based 
hydrogels was faster and the density of lumen was much higher than those achieved 
in our collagen/fibrin template (28-30). This slow progress might be explained by the 
fundamental difference between soft hydrogels where cellular outgrowth is not 
restrained from collagen sponges. This leads to a lower pre-vascular density in our 
templates and this diminishes the chances of inosculation. Moreover, the soft fibrin 
and collagen gels are more favorable materials for cell growth. Nevertheless, 
despite this slower inosculation, human endothelial cells survived for two weeks 
demonstrating that these pre-vascularized materials can provide a temporary 
environment for cellular accommodation and might be useful for larger grafts that 
require (temporary) mechanical support.  
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Conclusion 
MR is a valuable tool to monitor implanted materials in vivo in longitudinal studies. 
Moreover, with the use of contrast agent it represents a powerful non-invasive 
imaging tool to follow vasculogenesis in these implanted materials.  
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Abstract  
A new class of biomimetic hydrogel consisting of fibrillar oligo(ethylene glycol) 
polyisocyanopeptides (PIC) was studied as 3D template for cell culture. This novel 
thermo-responsive super hydrogelator mimics the biomechanics of the extracellular 
matrix (ECM), showing strain stiffening under mechanical deformation. 
Encapsulated cells readily formed spheroids in PIC gels at 1.5-2.5 mg/mL. GRGDS 
(Gly-Arg-Gly-Asp-Ser) was covalently coupled at different ratios to gels with 
stiffness ranging from 10-200 Pa yielding PIC-RGD with estimated spaces between 2 
to 55 nm, based on statistical considerations.  Encapsulation of cells in PIC-RGD with 
GRGDS at 10-23 nm spacing resulted in the formation of complex cellular networks. 
Inclusion of non covalent GRGDS in PIC gels had no effect on cellular anchoring. The 
synthetic ECM could be collapsed by cooling the gels below their transition 
temperature, allowing easy extraction of the formed cellular networks. When PIC 
and PIC-RGD were tested in vivo, host cells penetrated and assembled ECM in the 
PIC matrices which readily remodelled. In conclusion, PIC gels represent a very 
simple biomimetic tunable system ideal for 3D cell culturing, closely resembling the 
natural ECM. 
 
Keywords: Biomimetic material; 3D cell culture; Hydrogel; Thermally responsive 
material; Sol-gel techniques; RGD peptide   
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Introduction 
The interaction between cells and their extracellular environment dictates overall 
cell behaviour. Biomaterials play an important role in the success of tissue 
engineering since they provide the ‘artificial extracellular matrix (artificial ECM)’ for 
organ/tissue regeneration. Ideally, synthetic biomaterials mimic both the 
biochemistry and biomechanics of the native ECM as closely as possible in order to 
most closely approximate for natural tissue regeneration and functionality.  
Natural extracellular matrices provide cells with a physiologically relevant matrix 
and natural biomaterials such as fibrin and matrigel can support three dimensional 
(3D) cell culture (1, 2) and they possess many advantages. However, their use in a 
clinical setting is highly restricted as they have limited tunability, large variability 
between batches and are prone to disease transmission. Synthetic biomaterials can 
be tuned and are consistent. Several studies have indicated the potential use of 
synthetic materials for capillary formation and 3D culture.  For example, 
poly(ethylene glycol) (PEG) hydrogels modified with peptides support formation of 
endothelial tubules (3); self-assembling peptide gels promote network formation of 
endothelial cells (4, 5) and human pluripotent stem cells were grown in PNIPAAm-
PEG (6).  
Recently, Kouwer et al. described the mechanical physical properties of 
polyisocyanopeptides (PIC) with oligo(ethylene glycol) side chains (7). This PIC super 
hydrogelator (99.95 % water) exhibited responsiveness under mechanical 
stimulation that resembled natural ECM materials (7, 8). The hydrogel formed from 
this new class of polymer consists of a porous fibrous polymer network whose 
stiffness increases in a non-linear fashion under applied force, similar to that seen 
for collagen or fibrin (8, 9). This contrasts with other synthetic gels that are not or 
only poorly responsive to stress (i.e., their stiffness is constant over the entire 
relevant stress range). Other self-assembling hydrogels which also possess 
biomimetic structures (β sheet configuration) have been described (10, 11), but PIC 
is the first temperature responsive synthetic material which responds similarly to 
applied stress as natural ECM. The polymers gelate upon warming above 18oC, 
forming a 3D scaffold network that was used to encapsulate cells in this study. The 
temperature-dependent phase transition from solute to gel can be readily tuned 
and is fully reversible, allowing for ease of cell/tissue recovery after culture. A facile 
route to functionalization of the polymer gel has been elaborated that can easily 
yield bio-functionalization by the addition of peptide-sequences such as integrin 
binding motifs and growth factors (12). In principle, the modular and tunability of 
both the bio-functionality and biomechanics of these materials makes them ideal as 
a matrix for 3D cell culture and regenerative medicine. 
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In a previous report from our laboratory we postulated that the responsive 
properties of the gel formed from this polymer may have utility as an ECM material 
(7). The aim of this study was to test the hypothesis that the novel PIC hydrogel was 
not only biocompatible but through the correct application of bio-recognition 
groups could act as a 3D matrix material both in vitro and in vivo. The characteristics 
of cellular responses to the concentration and stiffness of PIC hydrogel, the optimal 
density of adhesion peptides, and the influence of the strain stiffening with fibrin 
mixtures for vasculogenesis were investigated in detail.    
Materials and methods 
Preparation of hydrogels 
PIC hydrogel was prepared using a modified procedure as described previously 
utilizing in this case a GRGDS functionalized spacer coupled to the PIC polymer (12). 
Details of polymer synthesis and characterization are described in supplementary 
information 1 (S1 file) and summarized in Figure 1. Briefly, the GRGDS peptide 
(Bachem, Switzerland) was functionalized via NHS coupling to a strained cycloctane 
spacer (N-[((1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-yl)methyloxy-carbonyloxy]-
succinimide, SynAffix BV, the Netherlands) BCN-NHS (S4) to yield BCN-GRGDS (S5). 
The BCN-GRGDS (S5) was added to a solution of the azide functionalized co-
polymer PIC (PIC-azide) and reacted for four days to reach full conjugation (PIC-
RGD) in molar amounts yielding PIC-RGD with RGD statistically spaced from 2 to 55 
nm, leaving most available azides unreacted. Different densities of GRGDS 
conjugated PIC, RGD2, RGD10, RGD23, and RGD55 (numbers indicate the estimated 
distance in nm on polymer backbone between RGD peptides) were prepared. The 
conjugate is hereafter referred to as PIC-RGD and the homopolymer containing no 
azide monomer is referred to as PIC. The average length of polymer molecules was 
determined using atomic force microscope imaging (nanoscope IIIa, Veeco, NY, 
USA) and evaluated with ImageJ. Polymers were prepared in aseptic environment 
and stored at -80oC. 
 Before in vitro and in vivo studies, polymers were freshly dissolved in cell culture 
medium [endothelial cell growth medium-2 (EGM-2MV, Lonza, Basal, Switzerland) 
with supplements (Lonza, CC-3202) and smooth muscle cell medium (SMCM, 
Sciencell, Carlsbad, USA) in ratio 1:1 (v/v)] for 16 hours at 4oC with rotational mixing. 
To study the optimal PIC concentration for cell culture purposes, PIC hydrogels were 
prepared at various concentrations (from 1.0 to 3.2 mg/mL). Based on the range of  
PIC concentration, the stiffness of PIC was between 10-1000 Pa (8). 
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Figure 1. Synthesis scheme of PIC-RGD. (i) Ni(ClO4)2 • 6H2O, Toluene, 72 hours, 50-91% production. (ii) 
GRGDS, Dimethyl sulfoxide/ 50mM borate buffer pH 8.4, 1 hour at 18oC, quantitative. (iii) S5, Acetonitrile, 
96 hours at 4oC, 80-95% production. 
 
PIC (or PIC-RGD)/ fibrin gels were prepared at different ratios. Fibrin (5, 2, 1, 0.2 
mg/mL) was mixed with PIC while keeping the final PIC concentration constant (2, 
1.6, and 1.28 mg/mL.). Hybrid PIC/fibrin gels were prepared at 50%, 20%, 10%, and 
2% fibrin. Fibrinogen from bovine plasma (Sigma-Aldrich, Schnelldorf, Germany) 
was reconstituted in 0.9% NaCl to desired concentrations and thrombin (50 U/mL, 
Sigma-Aldrich) was added. Immediately PIC hydrogel was added in fibrin and 
incubated at 37oC for one hour to stabilize.   
Cell culture 
Human umbilical vein endothelial cells (HUVEC, passages between 6-8, a kind gift 
from Prof. Dr. Otto C. Boerman, the Department of Nuclear Medicine, Radboudumc) 
were expanded in EBM-2MV (Lonza) with supplements (CC-4147) and 1% 
penicillin/streptomycin solution (p/s). Human bladder smooth muscle cells (hbSMC, 
passages between 5-8, Cat. 4310, Sciencell, Carlsbad, USA) were expanded in 
SMCM (Sciencell) with 1% growth supplement (SMCGS), 2% fetal bovine serum 
(FBS), and 1% p/s. Cells were cultured and expanded at 37oC and 5% CO2 in a humid 
atmosphere. The medium was changed three times per week. Cells were split when 
confluence was reached. Vasculogenesis and gel degradation were monitored daily 
by light microscope (Leica DC200, Germany).  
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Cell proliferation assay 
HbSMC (104 cells/mL, 6.06 x 103 cells/cm2) were cultured in PIC for proliferation 
assays. A standard curve to convert luminance value to cell density was used. On 
day 0, 1, 3, 5, 7, and 9, PIC with cells was transferred from 37oC to ice. Cells were 
harvested by centrifugation (173.2 g for 5 minutes at 4oC). The cell pellet was 
washed twice with 0.9% NaCl. CellTiter-Glo (Promega, Wisconsin, USA) and culture 
medium (1:1) were added to cell pellets and incubated for 2 minutes. The luminance 
units were measured with multi-channel reader 1420 (PerkinElmer, Waltham, USA). 
The value related to cell numbers is presented as mean with standard deviation.   
Cell mobility 
HUVEC (2.5 x 104 cells/mL, 9.1 x 103/cm2) and hbSMC (1 x 104 cells/mL, 3.6 x 103/cm2) 
were mixed with different hydrogels and cultured in insert rings (Ibidi, Martinsried, 
Germany). After cell culture for two days, cell mobility was recorded with time lapse 
microscopy for 50 hours (Nikon Diaphot 300 with Hamamatsu C8484-05G CCD 
Camera, Japan; Okolab 4 well CO2 stage incubator and Okolab 2D time lapse 
software, Italy).  
Pre-vascularization of hydrogels 
To pre-vascularize hydrogels, HUVEC (2.5 x 104 cells/mL, 1.9 x 104/cm2) and hbSMC 
(1 x 104 cells/mL, 7.6 x 103/cm2) were mixed with hydrogels and cultured in insert 
rings (0.4 μm polyester membranes, Costar, NY, USA). Mixtures were incubated at 
37oC for 1 hour in a humidified incubator containing 5% CO2. Thereafter EGM-2MV: 
SMCM [1:1 (v/v)] was added to the lower chamber of the transwell plate. The 
medium was refreshed three times per week.  
3D cell culture harvesting 
After three days cell culturing in PIC, gels were liquefied by lowering the 
temperature and cells were collected at 0°C and transferred to PIC-RGD10. After six 
days culture in PIC-RGD10, cell structures were collected as described above. Excess 
of hydrogel was removed by centrifugation (173.2 g for 5 minutes at 4oC) and cell 
structures transferred to fresh PIC-RGD10. Co-cultures of HUVEC and hbSMC were 
studied and 3D structures were harvested using the same protocol described above.  
Biocompatibility study of hydrogels in vivo 
To study the biocompatibility of PIC and PIC in combination with other biomaterials 
(fibrin), animal experiments were performed after approval by the Animal 
Experimental Committee of the Radboudumc (DEC 2013-026), conducted in 
accordance with institutional and national guidelines. Twenty four female Balb/cByJ 
mice (8 weeks old) were purchased from Charles River (L'Arbresle, France). 
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Hydrogels (PIC-RGD10, 20% fibrin/PIC-RGD10, 20% fibrin/PIC, or PIC) were injected 
subcutaneously (N = 3 per group, volume = 100 μL). The injected area was tattooed. 
The following days, body temperature and weight were monitored daily. Implanted 
hydrogels were collected after one and two weeks. At predetermined end points, 
animals were killed with excess CO2. Hydrogels/surrounding tissues were collected 
and fixed in 3% paraformaldehyde and embedded in paraffin or immediately 
embedded in TissueTek®O.C.T.TM compound (Sakura, Leiden, the Netherlands) and 
snap frozen.    
Immunohistochemistry (IHC) 
To study cell growth in 3D, entire hydrogel constructs were washed with warm 
phosphate-buffered saline (PBS, pH=7), 4 times 20 minutes at 37oC. Non-specific 
reactivity was blocked with 10% normal serum (NS) in 1% bovine serum albumin 
(BSA) in PBS for 1 hour at 37oC. Antibodies are summarized in Table 1. Primary and 
Alexa fluor tagged secondary antibodies were incubated in 1% NS 1% BSA in PBS 
for 2 hours and 1 hour at 21oC, respectively. Nuclei were stained with hoechst 33342 
(5 μg/mL in PBS, Invitrogen) for 30 minutes. Whole constructs were analyzed with 
confocal laser scanning microscopy (Olympus FV1000, Tokyo, Japan). IHC was 
evaluated with fluorescence microscopy (LEICA DC 300F, Germany).  
Hydrogels and surrounding tissues harvested from the animals were cut at 4 μm for 
Hematoxylin and Eosin (H&E), Masson trichrome, and Giemsa stains. IHC was 
analyzed with digital microscopy (VisionTek®, Sakura, Japan). Cellular content and 
morphology (macrophage, lymphocyte, giant cells, fibroblast, angiogenesis, and 
production of extracellular matrix) were analyzed and scored by three independent 
observers unaware of treatments.  
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Table 3. Summary of antibodies. 
Antibody Origin Clone React Stock 
Concentration 
Dilution, final 
concentration 
Company 
Von Willebrand 
factor 
Rabbit Polyclonal Human 3.1 mg/ml 1:400 (7.75 
μg/mL) 
Dako 
CD31  Mouse JC70A Human n. a. 1:100 Dako 
α-SMA Mouse 1A4 Human 
and 
mouse 
6 mg/ml 1:8000 (0.75 
μg/mL) 
Sigma 
Vimentin Rabbit n. a. Human, 
mouse, 
and rat 
n. a. 1:400 Abcam 
Ki67 Rabbit SP6 Human n. a. 1:200 Thermo 
Scientific 
Alexa-488 Goat - Mouse - 1:200 Invitrogen 
Alexa-568 Goat - Rabbit - 1:200 Invitrogen 
Alexa-488 Donkey - Mouse - 1:200 Invitrogen 
Alexa-594 Donkey - Rabbit - 1:200 Invitrogen 
DAB - - - - - Immunologic 
n.a. = not available 
Results  
Cell proliferation in PIC hydrogels 
To investigate the biocompatibility in vitro, we first tested the cell proliferation of 
hbSMC in PIC hydrogel (1.6 mg/mL). HbSMC cell numbers increased in PIC hydrogel 
(Fig. 2a and 2b). Proliferating hbSMC formed spheroid structures which increased 
size in time. The cell proliferation was still evident after 4 weeks of culture (Fig. 2c).  
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Figure 2. Proliferation of cells in unmodified PIC. (a) Proliferation assay of human bladder smooth muscle 
cells (hbSMC) in unmodified PIC hydrogel (1.6 mg/mL). (b) Morphology of hbSMC in PIC. Cells proliferated 
and remained in compact spheres. Original magnification x10, scale bar=250 μm, original magnification 
inserts x40, scale bar = 50 μm. (c) Ki67 staining of hbSMC clusters after 28 days in PIC. Please note 
proliferating cells (arrows). Nuclei are counterstained with hematoxyline. Original magnification x10 and 
the scale bar is 50 μm. 
 
After cells were encapsulated to generate 3D cultures, cells moved in PIC hydrogel 
and interacted with other cells as evidenced by time-lapse microscopy (S2 file). 
These results demonstrated that hbSMC cells were unable to anchor and did not 
extend toward spindle cell type morphology in the PIC matrix; HUVEC were present 
as globular cells. 
 
 
S2 file. Time lapse images of HUVEC and hbSMC in PIC hydrogel for 50 hours. The tracking maps were 
showed with black background. HUVEC were tracked with blue and green lines and hbSMC were tracked 
with yellow, cyan, pink, and red lines. HbSMC did caterpillar motions and HUVEC moved circularly in the 
same field. When hbSMC interacted with HUVEC, HUVEC moved with hbSMC. Magnification is x10. 
 
Functionalization of PIC hydrogel 
The results with PIC indicated that an introduction of anchoring points was needed 
to achieve cell adhesion and cell sprouting. Functionalization of PIC was achieved by 
copolymerization of a methoxy-terminated and an azide-terminated isocyanide 
monomer to produce a random copolymer with a statistical spacing of azide groups 
of 2, 10, 23, and 55 nm. Functionalized BCN-RGD groups were coupled to the azide 
terminated polymer at ratios to yield PIC-RGD2, 10, 23, 55 and cell growth was 
investigated. When HUVEC and hbSMC were co-cultured in peptide functionalized 
PIC hydrogels cells sprouted and formed endothelial tubes depending on the 
GRGDS spacing (Fig. 3). When GRGDS was spaced at 10 nm or 23 nm distance 
vascular-like structures formed; at lower GRGDS density sprouting was not 
observed and at higher GRGDS density the gel appeared too weak and cells were 
deposited on the surface of the insert.  
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Figure 3. Cellular sprouting in GRGDS modified PIC hydrogels. Cells encapsulated in RGD2, 10, 23, and 55 
showed different sprouting. Only in PIC-RGD10 and PIC-RGD23 sprouting was observed. Original 
magnification x10, scale bar 250 μm. 
 
To investigate whether covalent GRGDS binding was required or whether the same 
effect could be achieved with free GRGDS (with or without linker ligands), GRGDS 
was added to PIC. Cells formed spheres and no morphological changes were 
observed, emphasizing that cellular docking can only be achieved when GRGDS is 
covalently attached allowing PIC to mimic natural integrins (S1 Fig.).  
 
 
S1 Figure. Dependence of cellular sprouting on conjugated GRGDS. Cells encapsulated in PIC-RGD10 (a), in 
PIC with un-conjugated GRGDS without side spacer added (b), in PIC. with GRGDS with side spacer added 
(c) and un-modified PIC  (d). Un-conjugated GRGDS had no effect on cell adhesion or sprouting. Original 
magnification x40, scale bar 50 μm. 
Optimal concentration of PIC hydrogels and cell densities 
One of the unique characteristics of the PIC hydrogel is the capability to form gels at 
very low concentration (0.0006 weight %); however the optimal concentration of 
PIC for cell culture was not yet defined in previous studies.  Cell growth was tested 
at different PIC or PIC-RGD10 concentrations (1.0-3.2 mg/mL). At high PIC 
concentration (3.2 mg/mL), cells stayed as single cells for 14 days; at low PIC 
concentration (1.6 mg/mL), cells formed spheres and spheres increased in size in 
time. At low PIC-RGD10 concentration (1.0 mg/mL), cells anchored and structures 
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formed rapidly (initiated within 24 hours) but the hydrogel construct collapsed 
within 7 days.  In contrast, at high PIC-RGD10 concentration (3.2 mg/mL) cells 
formed spheres only and no cellular structures formed within seven days. Thus, 
concentrations of polymer between 1.5-2.5 mg/mL were optimal for cell culture.  
The importance of cell density in 3D co-culture was studied as it is known that 
incorporation of too few cells may result in insufficient cell-cell interaction and too 
many cells may lead to the formation of a monolayer, i.e. collapse of hydrogel. In 
co-culture studies with HUVEC and fibroblasts with other matrix materials 2.5×105 
cells/mL per cell types were used (13). Therefore these cell densities were used 
initially. However, encapsulation of 2.5×105 cells/mL per cell types resulted in 
collapse of PIC-RGD10 constructs within two weeks and cells formed a monolayer. 
Additionally, hbSMC dominated the cell culture. When cell densities were lowered 
10-fold to 2.5×104 cells/mL for both cell types, tubular structures formed but hbSMC 
still dominated. After optimizing the ratio to 2.5×104 cells/mL of HUVEC and 1×104 
cells/mL of hbSMC, tubular HUVEC structures formed supported by hbSMC 
resembling vasculature structures and the PIC-RGD10 hydrogel remained intact for 
two weeks.  
To confirm that the observed cellular structures in the co-culture experiments 
consisted of different cell types, constructs were stained for CD31 and von 
Willebrand factor (vWF) to detect endothelial cells, vimentin and alpha smooth 
muscle actin (αSMA) to detect smooth muscle cells (S3 Fig.). This transparent PIC 
hydrogel (1.28-2.0 mg/mL) was mechanically sufficiently strong to handle for IHC 
and complete constructs could be stained. Based on IHC we were able to 
demonstrate the presence of a vascular-like network in PIC-RGD10: endothelial 
tubes (vWF+) extended and communicated with other cell clusters (Fig. 4a and S3 
file) and the endothelial tubes were supported by smooth muscle cells (SMA+, Fig. 
4b). In PIC-RGD23, branched capillary-like structures (vWF+) formed surrounded by 
hbSMC (α-SMA+) (Fig. 4c and S4 file). PIC-RGD10 constructs were fully pre-
vascularized (vWF+) with HUVEC and hbSMC after 2 weeks (S5 file). In PIC, only 
cellular spheres were observed (Fig. 4e). In Fibrin gel, the co-cultures formed 
complex cellular colonies (Fig. 4f).   
 
 
S3 Figure. Cell phenotyping in 2D cell culture. HUVEC were stained for vWF and CD31. HbSMC were stained 
for vimentin and alpha-SMA. Nuclei were stained with DAPI. Original magnification x40, scale bar 50 μm. 
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Figure 4. Con-focal images of co-cultures. Cells were encapsulated in PIC-RGD10, PIC-RGD23, 20% fibrin/PIC, 
PIC, and Fibrin for 2 weeks.  Constructs were stained for vWF/α-SMA. Endothelial tubes are visible in green. 
Supporting smooth muscle cells were either scattered in the hydrogel or surrounded endothelial tubes 
(red). (a) PIC-RGD10; (b) PIC-RGD10; (c) PIC-RGD23; (d) 20% fibrin/PIC; (e) PIC; (f) Fibrin, and this image was a 
stacking of 4 confocal images. Original magnification is x20. Z-stack movies were attached in 
supplementary information, S3, S4, and S9 files. 
 
 
S3 file. Z-stack images of vasculature structures in PICRGD10 after two weeks in cell culture. Endothelial 
tubes were stained with vWF in green and nuclei were stained with DAPI in blue. Endothelial tubes 
branched and connected to cell clusters to form a network in the hydrogel. Magnification is x20. 
 
Processed on: 18-10-2016
505481-L-bw-Sun
83 
 
 
S4 file. Z-stack images of vasculature structures in PICRGD23 after two weeks in cell culture. Endothelial 
tubes were stained with vWF in green, smooth muscle cells were stained with alpha SMA in red, and nuclei 
were stained with DAPI in blue. Endothelial cells formed a branching structure in the hydrogel. Smooth 
muscle cells supported the vasculature structure and some smooth muscle cells scattered in the hydrogel. 
Magnification is x20. 
 
 
S5 file. Z-stack images of HUVEC and hbSMC in PICRGD10 after 2 weeks. a: immunohistochemical image 
(Z-stack of 10 confocal microscope images) showing the gel was fully pre-vascularized. Magnification is x20. 
b-e: Z-stack images presented the hydrogel from the surface to the bottom. Endothelial tubes were stained 
with vWF in green and hbSMC were stained with alpha SMA in red. Nuclei were stained with DAPI. 
Magnification is x10. 
 
Harvesting of cell constructs  
In order to demonstrate the possibility to harvest hbSMC or hbSMC/HUVEC and 
expose them to an individual signal, cells were cultured in PIC for three days 
resulting in small spheroid structures. After lowering the temperature, these 
spheres were easily harvested and transferred to PIC-RGD10. In this different 
microenvironment that provided the cells with the possibility to adhere, cells 
responded within one day. HbSMC in PIC-RGD10 immediately anchored and formed 
a network within seven days (Fig. 5). Furthermore, when spheroid structures of 
hbSMC/HUVEC were encapsulated in PIC-RGD10, cells protruded from spheres and 
anchored in the hydrogel within three days (S2 Fig.). This opens the opportunity to 
harvest cells after administration of singular cues or, alternatively, to harvest cells 
after different intervals or different differentiation signals provided longitudinally.  
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Figure 5. Harvesting of cellular structures from PIC hydrogels. hbSMC were cultured in unmodified PIC 
(2.0mg/mL) and formed spheres (scale bar 250 μm). Spheres were collected on day 3 and transferred to PIC-
RGD10. Once hbSMC were cultured in PIC-RGD10, cells stretched (second row, scale bar 500 μm). Cellular 
structures were transferred twice more without disturbance of morphology (third and fourth row, scale bar 
250 μm). When hbSMC were immediately cultured in PIC-RGD10, hbSMC formed bundles and were spindle 
shaped immediately after encapsulation (fifth row). After 6 days, hbSMC formed a network in PIC-RGD10 
(Fifth row, scale bar 500 μm).   
 
S2 Figure. Harvesting of cellular structures from PIC hydrogel. Co-cultures of HUVEC and hbSMC were 
cultured in PIC gel and spheres formed. On day 3, spheres were collected and transferred to PIC-RGD10. 
After 3 days in PIC-RGD10, cells sprouted from spheres. Arrow head indicates the cell sprouting. Original 
magnification x20, scale bar 50 μm.    
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Cellular mobility and fast vasculogenesis in PIC hydrogels 
Co-culture of HUVEC and hbSMC in PIC-RGD10 and PIC-RGD23 gels resulted in rapid 
sprouting, indicative of vasculature initiation within 24 hours (S4 Fig.). Addition of 
fibrin (2 mg/mL) in PIC-RGD10 and PIC-RGD23 did not influence the initiation of 
sprouting. However, whereas the addition of fibrin did not influence the length of 
tubular structures in PIC-RGD10, addition of fibrin to PIC-RGD23 did result in longer 
tubular structures. Light microscopy studies indicated that the complexity of the 
structures was higher in PIC-RGD10 than in PIC-RGD23 (S5 and S6 Fig.), and on day 9 
cell clusters connected in PIC-RGD10.  
 
S4 Figure. Rapid initiation of vasculogenesis. Images were taken 24 hours after encapsulation of HUVEC 
and hbSMC. Cell sprouting was observed when GRGDS was covalently attached to PIC and in mixtures with 
fibrin. Addition of fibrin did not influence the initiation rate in PIC-RGD10 (compare a,b and c,d.) Without 
RGD or fibrin, cells did not extend (f). Scale bar 50 μm. 
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S5 Figure. HUVEC-hbSMC co-cultures in PIC-RGD10. Cells anchored in the gel on day one, and on day four 
cells had migrated to form star-shaped structures. On day 9 cell clusters started to form a network. Arrow 
indicates connection.  
 
S6 Figure. HUVEC-hbSMC co-cultures in PIC-RGD23. PIC-RGD23 structures appeared less complex than those 
in PIC-RGD10 on day 9.  
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The transparency of the PIC hydrogel permitted live cell imaging to study cell 
migration with time lapse optical microscopy. As described for PIC (see section Cell 
proliferation in PIC hydrogels and S2 file) cells moved freely and interacted with 
other cells but could not anchor in PIC. In PIC-RGD10, hbSMC also moved as spindle 
shaped cells albeit much slower and HUVEC cells were immobile (S6 file). In contrast 
to PIC-RGD10, cells encapsulated in PIC-RGD23 anchored, did not migrate and 
formed lamellipodia (S7 files). 
 
S6 file. Time lapse images of HUVEC and hbSMC in PICRGD10 for 50 hours. Cells anchored in the hydrogel 
and displayed lamellipodium actions. Magnification is x10. 
 
 
S7 file. The time lapse images of HUVEC and hbSMC in PICRGD23 for 50 hours. Cells anchored at the same 
point and started to form star shape. Magnification is x20.  
 
Vasculogenesis in fibrin loaded PIC hydrogels 
In most vasculogenesis studies, fibrin is the ECM of choice (14). Vasculogenesis was 
studied in blends of fibrin and PIC (1.28, 1.6, or 2 mg/mL) at 50%, 20%, 10%, and 2%.  
Cells grown in mixtures of 50% and 20% fibrin/PIC produced vascular-like structures 
(S7 Fig.) regardless of the PIC concentration. When only 10% fibrin was added to a 
PIC gel it was possible to initiate the process, but at this low fibrin concentration cell 
sprouting which was observed at higher fibrin levels was absent. When the process 
was followed by live cell imaging cells anchored and formed a star shaped structure 
in PIC-RGD23 similar to 20% fibrin/PIC (S8 file). However, more cells interacted and a 
larger structure assembled in 20% fibrin/PIC. After 2 weeks of culture cell growth in 
PIC-RGD10 and PIC-RGD23 was comparable to 20% fibrin/PIC. IHC demonstrated the 
existence of endothelial tubes (vWF+) forming a network in 20% fibrin/PIC (Fig. 5d). 
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Branched tubular structures were observed clearly throughout 20% fibrin/PIC (see z-
stack images in S9 file).  
 
S7 Figure. HUVEC-hbSMC co-cultures in various fibrin/PIC hydrogel mixtures. The volume percentage of 
fibrin in PIC was varied between 50%-2% (the concentration of PIC was fixed at 2.0 mg/mL). 20% fibrin in 
PIC hydrogel is feasible for initiation of vasculogenesis during 7 days. Scale bars are 50 μm. 
 
 
S8 file. Time lapse images of HUVEC and hbSMC in 20% fibrin/PIC for 50 hours. Cells anchored at one point 
and stretched out and back several times. Magnification is x10. 
 
 
S9 file. Z-stack images of vasculature structures in 20% fibrin/PIC after one week in cell culture. Endothelial 
tubes were stained with vWF in green and nuclei were stained with DAPI in blue. Endothelial tubes 
branched and formed a network in the mixture. Magnification is x20.   
 
Since one of the advantages of the PIC material is the possibility to harvest cells 
after thermal transition, we tested whether cells could still be harvested when PIC 
was mixed with fibrin. At fibrin concentrations lower than 2 mg/mL cells could still 
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be recovered from the hydrogel.  When the fibrin concentration was 2 mg/mL or 
higher the constructs did not collapse when taken below the PIC transition 
temperature and cells could not be recovered. PIC did separate from the fibrin 
network, but apparently the fibrin network was sufficiently strong at fibrin 
concentrations of 2 mg/mL to withstand loss of PIC.   
Biocompatibility of PIC hydrogels in vivo 
The biocompatibility of PIC, PIC-RGD10, 20% fibrin/PIC, and 20% fibrin/PIC-RGD10 
hydrogels were tested by subcutaneous injection in mice. Hydrogels formed a bump 
under the skin which remained visible for two days. No adverse effects or systemic 
inflammatory responses were observed. In materials harvested one week after 
implantation, Masson trichrome stains showed that new collagen was deposited by 
host cells invading the hydrogels (Fig. 6). Evaluation of material harvested after two 
weeks showed that PIC-RGD10 and 20% fibrin/PIC-RGD10 degraded faster than PIC 
and 20% fibrin/PIC. For the mixture with PIC-RGD10 a slight immune response was 
observed in contrast to the low inflammatory responses for the PIC hydrogel or 
fibrin gel (S8 Fig.).  
 
Figure 6. In vivo biocompatibility of PIC hydrogels. Masson trichrome staining of PIC hydrogels after one or 
two weeks’ implantation. Collagen in green; nuclei in dark red; fibrin in red/pink. Host cells invaded into all 
the PIC hydrogels and produced their own extracellular matrix after one week. After two weeks, gels in 
which PIC-RGD10 was included were surrounded by host cells which produced a large amount of collagen. 
Scale bars 500 μm.  
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S8 Figure. Giemsa staining of PICRGD10 two weeks post implantation. Dot line indicates the remaining of 
the hydrogel subcutaneously. Giant cells, monocytes, and macrophages reacted to PICRGD10 and 
accelerated tissue remodeling and the degradation of hydrogels. Scale bar is 50 μm.  
 
Discussion 
A novel thermo-sensitive synthetic ECM which gelates to give a hydrogel with 
mechanical characteristics closely resembling the strain response of a natural ECM 
was studied for 3D tissue culture purposes (7). Cell growth was observed in the 
unmodified gel, but was restricted to sphere formation at material concentrations 
between 1.0-2.5 mg/mL. When cells were seeded at higher PIC concentrations they 
remained as single cells, did not proliferate and did not form spheres. It appears that 
the mechanical forces exerted on cells in this stiff gel are too high for cell 
proliferation to occur. At PIC concentrations of 1 mg/mL, the hydrogel is soft and 
cannot support extended 3D cell growth in the gels, and constructs collapsed after 1 
week. This observation underlines the importance of biomechanical characteristics 
in 3D. Cell proliferation in the stiff gels requires more energy to create space and 
apparently at high concentration the material can successfully withstand cell 
movement. At low material concentration it becomes structurally too weak for 3D 
cell growth.  
Upon warming the synthetic PIC hydrogel forms a non covalent self assembled 
network with extraordinary high water content (99.95%). It is fully transparent 
which makes observation of cell growth or cell migration easier than of other natural 
materials. In longitudinal studies with gel of 1.5-2.5 mg/mL PIC lasting for 3 weeks 
syneresis was noticed. This may be the result of redistribution of the material fibers 
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in combination with cell growth or material degradation. Whether this influences 
the rheology of the cell-gel construct is currently under investigation.  
Strain-stiffening is one of the unique characteristics of natural ECM such as fibrin 
(15). Natural materials stiffen when they are strained to prevent large deformation 
which could threaten tissue integrity and it is a reversible process (9). Fibrous 
networks of natural filaments stiffen at lower strain than synthetic materials (16). 
PIC is the first synthetic material that has nonlinear stress response and strain-
stiffening properties similar to natural filaments (8). Several studies have 
demonstrated that this mechanical property is one of essential components for the 
cellular microenvironment important in cell fate (17-19). Considering the favorable 
mechanical characteristics of PIC, it was anticipated that it would favor cell growth. 
Indeed, when cells were encapsulated spheres formed suggesting that cell-PIC 
interaction was poor. When the integrin motif GRGDS was introduced to increase 
cell-PIC interaction cells anchored and formed complex networks. GRGDS 
modification has been used successfully to functionalize materials in the past (20, 
21). It has been well established that the RGD motif enhances cell focal adhesion 
and recognition through the interaction with integrins (22, 23) and that RGD spacing 
is crucial for integrin clustering and activation (24). To study the effect of RGD-
spacing on 3D cell sprouting the spacing of GRGDS on PIC was varied. Cells 
encapsulated in PIC-RGD2, i.e. at very high GRGDS density, passed through the 
hydrogel and deposited below the gel. It is possible that at these very high GRGDS 
density GRGDS peptides on the side chain inhibit the PIC bundling structure and 
hence soften the hydrogel with insufficient strength to support cells. At low GRGDS 
density (PIC-RGD55) cellular networks were not formed most likely due to 
insufficient GRGDS anchoring possibilities.  
The GRGDS spacing in PIC needed to be 10-23 nm to achieve cell sprouting, which is 
similar to the values reported for natural ECM molecules such as fibronectin (25). 
Nevertheless, initially cells encapsulated in PIC-RGD10 migrated throughout the gel 
whereas in PIC-RGD23 migration was very limited. It is likely that the lower RGD 
content leads to less cell-hydrogel interaction, thereby preventing cell migration in 
PIC-RGD23 as cells have fewer anchoring possibilities. The higher migration capacity 
in PIC-RGD10 may lead to cell aggregation and may explain the formation of more 
complex structures and cellular networks formed in PIC-RGD10. 
Despite environmental differences between 2D and 3D culture similar RGD spacing 
was needed for cell sprouting and attachment. At too low GRGDS densities 
insufficient cell anchoring points may be available to adhere to the materials and 
cells cannot apply force on the material. This demonstrated that the tunability of 
the PIC hydrogel provides the opportunity to study the effect of ligand density and 
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effects of growth factors modified PIC on cell differentiation particularly because 
different signaling cues can be attached. 
At fixed GRGDS content, the sprouting of cells was also PIC concentration 
dependent. Concentrations between 1.5-2.5 mg/mL were the most optimal 
condition for cell culture with sphere formation prevailing at the higher gel 
concentration (3.2 mg/mL). This contrasted with the lack of growth observed in the 
unmodified PIC hydrogel at high concentration. The incorporation of GRGDS leads 
to a cellular microenvironment that might closely mimic the natural ECM with its 
abundance of, among others, integrins. This is apparently sufficient to overcome 
the mechanical restrictions leading to lack of cell growth at high gel concentration.   
In co-culture studies with HUVEC and hbSMC vasculature like structures formed in 
PIC-RGD10 and PIC-RGD23 gels. Endothelial cells were supported by smooth muscle 
cells as evidenced by IHC suggesting the formation of microvessel-like structures. 
Others have also reported on the possibility to grow vessel-like structures in 
hydrogels produced from natural occurring biomaterials such as fibrin (reviewed in 
(26)) and synthetic materials such as PEG (27), but to the best of our knowledge this 
is the first example of the formation of vascular-like structures in a synthetic 
thermo-sensitive hydrogel. Development of physiologically relevant 
microvasculature presents a challenge in the field of tissue engineering and this 
novel material provides a unique possibility to study vessel formation and possibly a 
device for pre-vascularize strategies.   
In general fibrin is the material of choice to study vasculogenesis as it enhances 
vasculogenesis both in vitro and in vivo (28, 29). Fibrin however degrades rapidly 
after grafting and the weak mechanical strength during tissue in-growth limits its 
applications. When fibrin is mixed with other materials, the degradation time and 
stiffness can be manipulated (30, 31). Based on this information we mixed 
unmodified PIC with fibrin and studied the initiation of vasculogenesis in two 
systems: PIC was diluted in fibrin mixtures or fibrin was mixed at a fixed 
concentration of PIC. At low fibrin concentration (2 mg/mL), vasculature-like 
structures were formed regardless of PIC concentration. Most likely, the fibrin fibers 
intertwine with PIC fibers, possibly forming an interpenetrating network, with cells 
using fibrin as a guidance to sprout. The likelihood that two independent networks 
are formed is substantiated by the observation that fibrin/PIC constructs do not 
collapse at fibrin concentrations of 2 mg/ml or higher when such constructs are 
incubated below the PIC transition temperature. Notably, the amount of fibrin in 
the fibrin/PIC gel to induce vasculogenesis was low in comparison to other studies 
where up to 80 mg/mL fibrin in fibrin/PEG gels was used (2, 30). Possibly the low 
fibrin amount needed to achieve cellular network formation can be explained by the 
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similarity of PIC to the naturally occurring ECM. The influence of the fibrin and PIC 
on the mechanics of the hybrid material is currently being investigated.  
3D templates resemble the biological condition of cells more closely then 2D 
templates and many studies have reported differences between 3D and 2D systems 
(32). The thermo responsive characteristics of this material allowed easy and fast 
recovery of complex cellular structures and the possibility of re-seeding. 3D cellular 
networks or spheroids were successfully harvested without damaging the structure 
by lowering the temperature. Studies in 3D cell culture have been hampered by the 
difficulty to harvest intact 3D cell structures and the PIC material provides the 
possibility to easily recover 3D structures exposed to different microenvironments. 
Further, when cells were encapsulated in fibrin/PIC or fibrin/PIC-RGD10, cell recovery 
was feasible provided that the fibrin concentration was below 2 mg/mL. Thus, if 
complex 3D structures need to be recovered, only PIC-RGD gels can be used as 
complex networks were only found at fibrin concentrations of 2 mg/mL or higher. At 
these fibrin concentrations cell recovery is not feasible anymore. Similar results 
were observed with PNIPAAm-PEG hydrogel (6). However, with PNIPAAm-PEG 
only spheroid formation was observed, most likely because the strain-stiffening 
characteristic differs from the natural ECM (33, 34). With PIC-RGD cell sprouting 
occurred. Thus this material with its close resemblance to ECM appears to be 
superior for 3D cell culture. The fully reversible gel-solute transition contrasts starkly 
with the gelation features of other materials generally used for 3D cultures such as 
fibrin, collagen, or Matrigel. Cell harvesting from those materials generally requires 
enzymatic treatment, which may influence the cellular microenvironment, 
particularly in 3D, and cellular phenotype (13, 14, 35, 36).  Additionally, modified 
PEG hydrogels that are also frequently used for 3D culture do not fully capture the 
mechanical properties that PIC hydrogel mimics from natural materials (37). Since 
the mechanical interaction matrix and cells is of vital importance (38-40), PIC and its 
derivatives may provide a unique opportunity for precise 3D studies.  
The biocompatibility of PIC, fibrin/PIC, PIC-RGD10 and PIC-RGD10/fibrin was tested in 
immuno-competent mice by subcutaneously injection. In all cases, influx of host 
cells was observed and cells deposited ECM as evidence by the Masson trichrome 
staining. PIC and 20% fibrin/PIC gels stayed intact for two weeks whereas PIC-RGD10 
and 20% fibrin/PIC-RGD10 gels degraded within 2 weeks. Based on the chemical 
composition of the material it is likely that it will be degraded in vivo. The 
observation that PIC and PIC/fibrin gels were not degraded was most likely due to a 
too short observation period. A mild immune-response was observed when GRGDS 
modified PIC hydrogel was injected. It is possible that the αvβ3 ligand expressed by 
monocytes or macrophages binds to the covalently attached GRGDS peptides and 
induces a somewhat higher inflammatory response (41). The GRGDS-induced 
immune response is however very moderate when compared to other synthetic 
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materials-such as PLGA/PVA hydrogel which induced encapsulation and infiltration 
with a large number of neutrophils (42). The in vivo influx of cells in the unmodified 
PIC was somewhat unanticipated, as in vitro cells encapsulated in PIC were only able 
to form spheres and were unable to sprout in the material. Apparently the dynamic 
tissue microenvironment permitted cell in-growth, a situation which is dissimilar 
from the passive cell encapsulation in the in vitro assays.  
Conclusion 
PIC hydrogel is an ideal biocompatible and biodegradable biomaterial of defined 
composition for 3D cell culture and for cell therapy. The combined favorable strain-
stiffness characteristics and tunability result in a synthetic material that is able to 
closely mimic the natural extracellular matrix. This hydrogel is excellently suited for 
3D structure harvesting, and permits more detailed insight into the importance of 
cell-cell and cell-matrix interactions. Finally, blends of differently modified PIC may 
serve as a toolkit for a variety of applications. Clearly PIC hydrogel serves as a 
synthetic extracellular matrix for regenerative medicine purposes, either alone or in 
combination with scaffolds to provide mechanical strength.  Furthermore by 
manipulating the gel-solute transition, multilayered gels can be created and it 
should be possible to create skin-like constructs for e.g. full thickness burn wounds, 
pressure wounds, ulcers etc.  
Acknowledgement 
The authors would like to thank Laura Puig Urrea for preparing the materials. The 
research leading to these results has received funding from the European 
Community's Seventh Framework Programme (MultiTERM, grant agreement nr 
238551), the Ministry of Education, Culture and Science (Gravitation program 
024.001.035), NRSCC, and Nanonext.nl. 
  
Processed on: 18-10-2016
505481-L-bw-Sun
95 
 
References 
1. Morin KT & Tranquillo RT (2013) In vitro models of angiogenesis and 
vasculogenesis in fibrin gel. Experimental cell research 319(16):2409-2417. 
2. Chung E, et al. (2015) Fibrin-based 3D matrices induce angiogenic behavior 
of adipose-derived stem cells. Acta biomaterialia 17(0):78-88. 
3. Leslie-Barbick JE, Moon JJ, & West JL (2009) Covalently-immobilized 
vascular endothelial growth factor promotes endothelial cell tubulogenesis 
in poly(ethylene glycol) diacrylate hydrogels. Journal of biomaterials science. 
Polymer edition 20(12):1763-1779. 
4. Sieminski AL, Semino CE, Gong H, & Kamm RD (2008) Primary sequence of 
ionic self-assembling peptide gels affects endothelial cell adhesion and 
capillary morphogenesis. Journal of biomedical materials research. Part A 
87(2):494-504. 
5. Rajangam K, et al. (2006) Heparin binding nanostructures to promote 
growth of blood vessels. Nano letters 6(9):2086-2090. 
6. Lei Y & Schaffer DV (2013) A fully defined and scalable 3D culture system for 
human pluripotent stem cell expansion and differentiation. Proceedings of 
the National Academy of Sciences of the United States of America 
110(52):E5039-5048. 
7. Kouwer PH, et al. (2013) Responsive biomimetic networks from 
polyisocyanopeptide hydrogels. Nature 493(7434):651-655. 
8. Jaspers M, et al. (2014) Ultra-responsive soft matter from strain-stiffening 
hydrogels. Nat Commun 5. 
9. Storm C, Pastore JJ, MacKintosh FC, Lubensky TC, & Janmey PA (2005) 
Nonlinear elasticity in biological gels. Nature 435(7039):191-194. 
10. Moyer TJ, Cui H, & Stupp SI (2013) Tuning nanostructure dimensions with 
supramolecular twisting. The journal of physical chemistry. B 117(16):4604-
4610. 
11. Korevaar PA, Newcomb CJ, Meijer EW, & Stupp SI (2014) Pathway selection 
in peptide amphiphile assembly. Journal of the American Chemical Society 
136(24):8540-8543. 
12. Mandal S, et al. (2015) Polymer-based synthetic dendritic cells for tailoring 
robust and multifunctional T cell responses. ACS chemical biology 10(2):485-
492. 
13. Arnaoutova I, George J, Kleinman HK, & Benton G (2009) The endothelial 
cell tube formation assay on basement membrane turns 20: state of the 
science and the art. Angiogenesis 12(3):267-274. 
14. Peterson AW, et al. (2014) Vasculogenesis and Angiogenesis in Modular 
Collagen-Fibrin Microtissues. Biomaterials science 2(10):1497-1508. 
15. Wen Q & Janmey PA (2013) Effects of non-linearity on cell-ECM interactions. 
Experimental cell research 319(16):2481-2489. 
16. Erk KA, Henderson KJ, & Shull KR (2010) Strain stiffening in synthetic and 
biopolymer networks. Biomacromolecules 11(5):1358-1363. 
17. Winer JP, Oake S, & Janmey PA (2009) Non-linear elasticity of extracellular 
matrices enables contractile cells to communicate local position and 
orientation. PloS one 4(7):e6382. 
Processed on: 18-10-2016
505481-L-bw-Sun
96 
 
18. Rape AD, Guo WH, & Wang YL (2011) The regulation of traction force in 
relation to cell shape and focal adhesions. Biomaterials 32(8):2043-2051. 
19. Tse JR & Engler AJ (2011) Stiffness gradients mimicking in vivo tissue 
variation regulate mesenchymal stem cell fate. PloS one 6(1):e15978. 
20. Quirk RA, Chan WC, Davies MC, Tendler SJ, & Shakesheff KM (2001) Poly(L-
lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). 
Biomaterials 22(8):865-872. 
21. Yang XB, et al. (2001) Human osteoprogenitor growth and differentiation on 
synthetic biodegradable structures after surface modification. Bone 
29(6):523-531. 
22. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell 
adhesion. Cell 69(1):11-25. 
23. Jeschke B, et al. (2002) RGD-peptides for tissue engineering of articular 
cartilage. Biomaterials 23(16):3455-3463. 
24. Ruoslahti E & Pierschbacher MD (1986) Arg-Gly-Asp: a versatile cell 
recognition signal. Cell 44(4):517-518. 
25. Humphries MJ, Akiyama SK, Komoriya A, Olden K, & Yamada KM (1986) 
Identification of an alternatively spliced site in human plasma fibronectin 
that mediates cell type-specific adhesion. The Journal of cell biology 103(6 Pt 
2):2637-2647. 
26. Hunt NC & Grover LM (2010) Cell encapsulation using biopolymer gels for 
regenerative medicine. Biotechnology letters 32(6):733-742. 
27. Cuchiara MP, Gould DJ, McHale MK, Dickinson ME, & West JL (2012) 
Integration of Self-Assembled Microvascular Networks with Microfabricated 
PEG-Based Hydrogels. Advanced functional materials 22(21):4511-4518. 
28. Urech L, Bittermann AG, Hubbell JA, & Hall H (2005) Mechanical properties, 
proteolytic degradability and biological modifications affect angiogenic 
process extension into native and modified fibrin matrices in vitro. 
Biomaterials 26(12):1369-1379. 
29. Montano I, et al. (2010) Formation of human capillaries in vitro: the 
engineering of prevascularized matrices. Tissue engineering. Part A 16(1):269-
282. 
30. Mason MN & Mahoney MJ (2010) A novel composite construct increases the 
vascularization potential of PEG hydrogels through the incorporation of 
large fibrin ribbons. Journal of Biomedical Materials Research Part A 
95A(1):283-293. 
31. Jiang B, Waller TM, Larson JC, Appel AA, & Brey EM (2013) Fibrin-Loaded 
Porous Poly(Ethylene Glycol) Hydrogels as Scaffold Materials for 
Vascularized Tissue Formation. Tissue engineering. Part A 19(1-2):224-234. 
32. Levinger I, Ventura Y, & Vago R (2014) Life is three dimensional-as in vitro 
cancer cultures should be. Advances in cancer research 121:383-414. 
33. Munster S, et al. (2013) Strain history dependence of the nonlinear stress 
response of fibrin and collagen networks. Proceedings of the National 
Academy of Sciences of the United States of America 110(30):12197-12202. 
34. Puleo GL, et al. (2013) Mechanical and rheological behavior of pNIPAAM 
crosslinked macrohydrogel. Reactive and Functional Polymers 73(9):1306-
1318. 
Processed on: 18-10-2016
505481-L-bw-Sun
97 
 
35. Matsumoto T, et al. (2007) Three-dimensional cell and tissue patterning in a 
strained fibrin gel system. PloS one 2(11):e1211. 
36. Artym VV & Matsumoto K (2010) Imaging cells in three-dimensional collagen 
matrix. Current protocols in cell biology / editorial board, Juan S. Bonifacino ... 
[et al.] Chapter 10:Unit 10 18 11-20. 
37. Raeber GP, Lutolf MP, & Hubbell JA (2005) Molecularly engineered PEG 
hydrogels: a novel model system for proteolytically mediated cell migration. 
Biophysical journal 89(2):1374-1388. 
38. Khachigian LM, Resnick N, Gimbrone MA, Jr., & Collins T (1995) Nuclear 
factor-kappa B interacts functionally with the platelet-derived growth factor 
B-chain shear-stress response element in vascular endothelial cells exposed 
to fluid shear stress. The Journal of clinical investigation 96(2):1169-1175. 
39. Vailhe B, Vittet D, & Feige J-J (2001) In Vitro Models of Vasculogenesis and 
Angiogenesis. Lab Invest 81(4):439-452. 
40. Manoussaki D (2003) A mechanochemical model of angiogenesis and 
vasculogenesis. ESAIM: Mathematical Modelling and Numerical Analysis 
37(04):581-599. 
41. Anderson JM, Rodriguez A, & Chang DT (2008) Foreign body reaction to 
biomaterials. Seminars in immunology 20(2):86-100. 
42. Morais JM, Papadimitrakopoulos F, & Burgess DJ (2010) Biomaterials/tissue 
interactions: possible solutions to overcome foreign body response. The 
AAPS journal 12(2):188-196. 
  
Processed on: 18-10-2016
505481-L-bw-Sun
98 
 
 
  
Processed on: 18-10-2016
505481-L-bw-Sun
99 
 
 Chapter 6 
Identification of Potential Bladder Progenitor 
Cells in the Trigone  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weilun Sun, Tilly Wilhelmina Aalders, and Egbert Oosterwijk 
Radboud University Medical Center, Department of Urology, Radboud Institute for 
Molecular Life Sciences, Nijmegen, The Netherlands  
 
Developmental Biology. 2014 Sep 1;393(1):84-92. 
Processed on: 18-10-2016
505481-L-bw-Sun
100 
 
Abstract 
Urothelial cells are specialized epithelial cells in the bladder that serve as a barrier 
toward excreted urine. The urothelium consists of superficial cells (most 
differentiated cells), intermediate cells, and basal cells; the latter have been 
considered as urothelium progenitor cells. In this study, BrdU or EdU was 
administrated to pregnant mice during E8-E13 for 2 consecutive days when bladder 
development occurs. The presence of label retaining cells was investigated in 
bladders from offspring. In 6 months old mice ~1% of bladder cells retained labeling. 
Stem cell markers as defined for other tissues (e.g., p63, CD44, CD117, trop2) co-
localized or were in close vicinity to label retaining cells, but they were not uniquely 
limited to these cells. Remarkably, label retaining cells were distributed in all three 
cell layers (p63+, CK7+, and CK20+) of the urothelium and concentrated in the 
bladder trigone. This study demonstrates that bladder progenitor cells are present 
in all cell layers and reside mostly in the trigone. Understanding the geographic 
location of slow cycling cells provides crucial information for tissue regenerative 
purposes in the future. 
Keywords: Bladder progenitor cells, bladder trigone, label retaining cells. 
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Introduction 
Urothelial cells are specialized epithelial cells in the bladder that serve as a barrier 
toward excreted urine and are derived from the endoderm (1). The urothelium 
consists of three cell layers: the superficial cell layer with the most differentiated 
cells, the intermediate cell layer, and the basal cell layer. During voiding or after 
damage of the bladder, bladder stem cells and bladder progenitor cells regenerate 
and repair all cell layers (2-5). The residence of bladder stem cells or progenitor cells 
is still under discussion (6). 
Stem cells divide asymmetrically to transit amplifying cells and stem cells. Transit 
amplifying cells give rise to intermediate and superficial cells, thus forming a 
complete epithelium (7). Traditionally epithelial stem cells reside in the basal cell 
layers. For example, stem cells have been identified cells in the basal cell layer of 
skin, prostate, and limbal (8-10). Scientists in the field of tissue engineering are 
aiming to engineer tissues to restore and maintain normal function in diseased and 
injured tissues. The use of adult stem cells for tissue engineering applications is 
promising, and it is obvious that it is important to define the residence of these cells.  
Based on label retaining study with rat bladders, potential progenitors cells of the 
bladder have been suggested to reside in the basal cell layer (11). In addition, in vivo 
cell lineage analysis has shown that p63-expressing cells (basal cells) are able to 
reproduce all epithelial lineages during development (12). In one of the few human 
studies multiple stem cell-related clonal units were described in the basal cell layer 
suggesting that basal cells maintain the capacity to turnover in ageing (13). 
Furthermore, after injury sonic hedgehog (shh) expressing cells reside in basal cell 
layer shift from quiescent cells to highly proliferative cells (5). Shh is considered as a 
signal pathway that controls proliferation of stem cells (14). However, one of the 
latest studies suggests that bladder progenitor cells which differentiate to 
superficial cells in the adult bladder are intermediate cells (Foxa2+ p63+ Shh+ Upk+ 
Krt5-) (6). In airway epithelia supra-basal cells (luminal secretory cells) can 
reprogram to multipotent stem cells and repair epithelial injury (15). Collectively, it 
appears that stem/progenitor cells may reside outside the basal compartment. 
The aim of this study was to identify bladder progenitor cells using the thymidine-
analogues BrdU (5-Bromo-2'-deoxy-uridine) or EdU (5-ethynyl-2’-deoxyuridine), to 
label slow cycling cells. Label-retaining studies have been successful in identifying 
potential epithelial stem cells in skin, intestine, and the endometrium of the uterus 
(16-18). In contrast to haematopoietic stem cells, these potential epithelial stem and 
progenitor cells retain the analogue for a long period because they are mostly 
quiescent and rarely divide (7, 19, 20). DNA analogues were injected at the 
gestational days when bladder development occurs to ensure labeling of all 
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potential progenitors. EdU/BrdU retaining cells were observed in all three cell layers 
of the urothelium throughout life of the animals, suggesting that progenitor cells 
shifted from the basal compartment towards the luminal compartment. Moreover, 
label-retaining cells were concentrated in the trigone of the bladder, the area where 
the ureters and urethra join the bladder and particularly present in close vicinity of 
the urethra.  
Materials and methods 
Animals  
All procedures involving animals were reviewed and approved by the Animal Ethics 
Committee (DEC), Radboud University Nijmegen. 16 weeks old CD-1 mice (14 
females) were obtained from Harlan Laboratories (Horst, the Netherlands). EdU (5-
ethynyl-2’-deoxyuridine, mw. 252.2) was purchased from Invitrogen (Carlsbad, US). 
BrdU (5-Bromo-2'-deoxy-uridine, mw. 307.1) was purchased from Roche (Basel, 
Switzerland). Pregnant mice were divided into three groups (see Fig. 1). EdU (50 
μg/g, dissolved in phosphate buffered saline (PBS)) was injected subcutaneously 
into the posterior neck to pregnant mice during 2 consecutive days on E8 + E9 
(group A, n=5), E10 + E11 (group B, n=4), and E12 + E13 (group C, n=5). BrdU (50 
μg/g, dissolved in PBS) was injected subcutaneously to pregnant mice during 2 
consecutive days on E12 + E13 (n=3). On E17, one mother from each group was killed 
and the embryos were euthanized. Embryonic bladders were collected. In short, 
bladders and the remains of the embryos were collected in medium [RPMI-1640, 
10% (v/v) FCS, 1% (v/v) P/S, and 1% (v/v) fungizone (Gibco®, Carlsbad, USA)], fixed 
in 4% paraformaldehyde (PFA) and paraffin embedded or embedded in O.C.T. 
compound (Tissue-Tek, Sakura, the Ntherlands) and snap frozen (21). The bladders 
from the offspring were collected 5 days post-natally (p5, N=15), 1 month (N=6), 3 
months (N=5), and 6 months post-natally (N=9). Additionally, 3 bladders from 
mother mice were collected. Tissues from the killed mice were embedded in O. C. T. 
compound (Tissue-Tek) and snap frozen or fixed in 3% PFA and paraffin embedded. 
At each time point, at least 3 animals were analyzed.   
 
Figure 5. Overview of BrdU or EdU injections (arrows) and day of pregnancy. Crosses indicate sacrifice of 
animals. E = embryonic days; p5 = post natal day 5; 1m, 3m, and 6m: 1, 3, and 6 months postnatally. 
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Immunohistochemical analysis (IHC)  
Paraffin sections (4 μm) were deparaffinized in xylene and rehydrated in gradient 
ethanol. Frozen sections (5 μm) were fixed with methanol at 21oC for 10 min.  
Paraffin embedded and frozen tissues were used for EdU and BrdU staining. 
Paraffin embedded tissues were used for CK7, CK14, CK20, p63, ki67, β-catenin, 
nestin, and LGR5. Frozen tissues were used for CD44, CD117, CD133, and trop2.  
For antigen retrieval, slides were boiled in EDTA buffer (1 mM, pH 9; to enhance 
signals of EdU in paraffin embedded tissues) or in sodium citrate buffer (10 mM, pH 
6; to enhance signals of BrdU in paraffin embedded tissues) for 10 min and cooled 
down to 21oC. For CD117, no heat treatment was needed. EDTA buffer was used for 
CK7, CK14, CK20, ki67, p63, and LGR5. Citrate buffer was used for CK7, CK14, CK20, 
β-catenin, CD44, CD133, and trop2.  
For mouse antibodies or double labeling with mouse anti BrdU, mouse on mouse 
blocking reagent (M. O. M., Vector Labs, US) was applied to prevent unspecific 
biding according to the manufacturer’s instruction. Endogenous peroxidase activity 
was blocked with PBS (pH 7.4) containing 0.3% H2O2/0.1% NaN3 for 15 minutes. Non 
specific binding was blocked with 10% normal serum from donkey, sheep, or goat, 
depending on the secondary antibody in PBS as appropriate for one hour in a humid 
chamber at 21oC.  
Slides were incubated with primary antibodies, (see Table 1) either PBS, or only 
secondary antibody (negative controls), followed by either vector® red, DAB 
(Bright-DAB, Immunologic, the Netherlands), or Alexa Fluor conjugates (see Table 
1). For double staining, slides were treated as described below. DNA was counter 
stained with DAPI or hematoxyline.  
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Table 1. Summary of primary and secondary antibodies. 
Name Source Clone Origin Dilution or concentration 
BrdU-POD Roche BMG 6H8 Mouse 1:10, 1.5 U/mL 
BrdU-biotin Abcam Polyclonal Sheep 1:200, 6.5 μg/mL 
Cytokeratin 7 (CK7) EuroProxima RCK105 Mouse 1:10, NA 
Cytokeratin 14 (CK14) Thermo LL002 Mouse 1:100, 2 μg/mL 
Cytokeratin 20 (CK20) ImmunoLogic - Rabbit 1:100, 2 μg/mL 
p63 Dako 4A4 Mouse 1:100, 5.9 μg/mL 
ki67 Thermo - Rabbit 1:200, NA 
trop2 R&D AF1122 Goat 1:20, 5 μg/mL 
CD44 BD IM7 Rat 1:100, 5 μg/mL 
CD117 Millipore ACK2 Rat 1:100, 5 μg/mL 
CD133 eBioscience 13A4 Rat 1:50, 10 μg/mL 
β-catenin BD 14 Mouse 1:1600, NA 
Nestin Millipore Rat-401 Mouse 1:100, 10 μg/mL 
G protein-coupled  
Receptor GPR 49 
MBL Lgr5 Rabbit 1:400, 2.5 ng/mL 
Alexa Fluor 488 or 594 Invitrogen - Goat 1:200, 10 μg/mL 
Alexa Fluor 488 Invitrogen - Donkey 1:200, 10 μg/mL 
Alexa Fluor 488 or 594 Invitrogen - Donkey 1:1000, 2 μg/mL 
Alexa Fluor 488 Invitrogen - Donkey 1:200, 10 μg/mL 
Vector® red Vector Laboratories - - - 
DAB Immunologic - - - 
 
BrdU staining 
Slides were incubated with 1N HCL on ice for 10 min,  transferred to 2N HCL and 
incubated for 10 min at 21oC, followed by incubation with 2 N HCL at 60oC for 30 
min. Finally the slides were neutralized with borate buffer, 0.1 M, pH 8.5, for 12 min 
at 21oC. Slides were incubated in 0.5% Triton X-100 in PBS for 20 min at 21oC for cell 
permeabilization.  
EdU staining 
EdU staining was performed with the Click-iT EdU imaging kit (Invitrogen) 
according to the manufacturers’ protocol. Slides were washed twice with 3% bovine 
serum albumin (BSA) in PBS and then incubated with the cocktail solution 
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containing reaction buffer, CuSO4, Alexa Fluor 594 Azide, and reaction additive for 1 
hour and protected from light. Slides were washed three times with PBS before 
mounting with DAPI mount media (Invitrogen).  
Slides were evaluated with fluorescence microscope (LEICA DC 300F, Germany) and 
scanned with high content microscope (LEICA DMI6000B, Germany). The 
percentage of positive cells was determined by manual counting. At each time point, 
at least 3 animals were analyzed. To calculate the percentage of double positive 
cells with a particular phenotype the number of double positive cells was divided by 
the number of marker-positive cells within a particular cell layer. 
Results 
Label retaining cells (RC) in vivo 
The percentage of RC and the expression of RC in urothelium at different cell layers 
from the offspring are summarized in Table 2 and Table 3. Expression of several 
stem cell and lineage markers (e.g., Trop2, CD44, cytokeratins) was examined to co-
localize RC cells.  
Table 2. The percentage of label retaining cells in urothelial cells at different ages of offspring. 
Groups E17 p5 1 month 3 months 6 months 
% 45.1% 11.4% 2.8% 1.3% 1.2% 
EdU+/UC (754/1672) (290/2551) (163/5735) (10/778) (84/7288) 
EdU+CK7+/IC 
EdU+CK7+/UC 
EdU+CK7-/UC 
53.76% 
48.95% 
5.53% 
13.86% 
9.86% 
2.82% 
2.36% 
1.63% 
0.18% 
NA 
NA 
NA 
1.09% 
0.9% 
NA 
EdU+p63+/BIC 
EdU+p63+/UC 
EdU+p63-/SC 
EdU+p63-/UC 
27.62% 
21.22% 
54.24% 
12.57% 
NA 
NA 
NA 
NA 
1.36% 
1.24% 
4.62% 
0.41% 
0.53% 
0.51% 
29.41% 
1.27% 
NA 
NA 
NA 
NA 
EdU+ki67+/ki67+ 
ki67+/UC 
EdU+ki67+/UC 
23.24% 
56.92% 
13.23% 
2.7% 
14.86% 
0.4% 
0 
1.79% 
0 
NA 
NA 
NA 
NA 
NA 
NA 
EdU+CK20+/SC 
EdU+CK20+/UC 
CK20+/UC 
58.82% 
2.39% 
4.07% 
23.08% 
2.13% 
9.22% 
30.77% 
0.88% 
2.86% 
NA 
NA 
NA 
2.03% 
0.06% 
3.00% 
EdU+CK14+/UC 
CK14+/UC 
2.62% 
6.55% 
1.27% 
32.28% 
0 
8.21% 
NA 
NA 
0 
0.79% 
CD117+EdU+/UC 
CD117/UC 
CD117 (stroma) 
NA 
NA 
NA 
0 
0 
2.68% 
0 
0 
0.56% 
NA 
NA 
NA 
0 
0 
NA 
          Urothelial cells = UC; intermediate cells = IC; basal and intermediate cells = BIC; superficial cells = SC.  
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Table 3. Summary of biomarkers in different cell layers from bladders obtained from animals of different 
ages. 
Biomarker/cell layer E17 p5 1 month 3 months 6 months Mother 
CK14/Basal ++ ++ + - - - 
Colocalize with EdU/BrdU + + + - - - 
Ki67/Basal +++ ++ + + + + 
Colocalize with EdU/BrdU ++ + - - - - 
CD44/scattered cells + - - - - na 
CD44/Basal membrane + + + + + na 
Colocalize with EdU/BrdU + + + + + na 
CD117/stroma - + +/- - - na 
Colocalize with EdU/BrdU - - - - - na 
Trop2/Basal, intermediate + + + + + na 
Colocalize with EdU/BrdU + + + + + na 
p63/Basal, intermediate + + + + + + 
Colocalize with EdU/BrdU + + + na na + 
CK7/Intermediate + + + na na + 
Colocalize with EdU/BrdU + + + na na - 
Lgr5/Umbrella na + na na na na 
Colocalize with EdU/BrdU na na na na na na 
CK20/Umbrella + + + + + + 
Colocalize with EdU/BrdU + + + na + - 
 
 
RC in bladders at E17 
RC in bladder at E17 were distributed throughout the developing bladder with more 
RC in close vicinity to the urethra. More than 45% of the urothelial cells (all cell 
layers) contained EdU. RC were CK7+ (Fig. 2a and enlarged in 2b), CK14+ (Fig. 2i), 
CK20+ (Fig. 2g) and p63+ (Fig. 2h) in the urothelium. CK14 was only expressed in the 
area close to the urethra. 56% of urothelia were ki67+ and 13% of urothelia were 
ki67+ EdU+. These ki67+ EdU+ cells (Fig. 2c and enlarged in 2d) were possibly 
representing highly proliferating cells in S phase. Trop2 was expressed 
homogeneously in all urothelial cells at E17 (Fig. 2j). Membranous, homogeneous 
Processed on: 18-10-2016
505481-L-bw-Sun
107 
 
CD44 expression was observed underneath the basal cells (Fig. 2e and enlarged in 
2f). Stronger intensity of CD44 was observed close to the urethra. 
 
Figure 2. RC in bladders at E17. Preferential location of RC close to urethra (a,b). RC present in 
umbrella cells (d), intermediate cells (e, h, j), and basal cells (f, j). Many RC proliferated (b and g). 
Homogeneous expression of Trop2 (h) and CD44 (c and i). Arrows indicate co-localized cells. 
RC at p5 
In bladders from p5 the amount of RC in the urothelium was reduced to 11%. RC 
were concentrated close to the trigone (Fig. 3a) and the cross section of the urethra 
showed that RC were present in all urothelial cell layers (Fig. 3b). RC were dual-
labeled with CK20 (luminal, Fig. 3c), CK7 and Trop2 (intermediate, Fig. 3d and 3e), 
CK14, CD44, and ki67 (basal, Fig. 3f, 3g, and 3h). CK14+ cells appeared to be 
restricted to the basal cells, with the vast majority of basal cells expressing CK14 
(66.4%) and 32.3% of all urothelia. Only 0.4% of ki67+ EdU+ cells were present in the 
basal layer of urothelia. Trop2 was homogenously expressed in the intermediate 
and basal cells at p5 and beyond, but the superficial cells were Trop2-negative. . 
CD133 expression was absent (supplementary information 1, SI 1). LGR5 was 
expressed in umbrella cells (SI1). CD44 was expressed predominantly by the basal 
cells. CD117 was exclusively expressed in the stroma and was not restricted to EdU.  
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Figure 3. Bladder (a) and urethra (b) from p5 showing preferential location of RC in the trigone. Arrows 
indicate RC in the luminal (c), intermediate (d,e), and basal (f, h) cell layers. Homogeneous expression of 
Trop2 (e) and CD44 (g) in all epithelial cells and cells underneath the bladder, respectively. Ki67+EdU+ cells 
are restricted to basal cells. Dash line indicates urethra in 3a and 3b. 
 
 
S 1. β-catenin, LGR5, and CD133/BrdU staining. a: Strong β-catenin staining of all urothelial cell 
layers in bladder from 1 month old animal, b: LGR5+ umbrella cells in bladder from p5 animal, c: 
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negative control, D,E,F: immunofluorescence staining for CD133 (red) and BrdU (green) of 
bladder tissue from p5 (d), 1 month (e), and 6 months (f) old animals. Please note absence of 
CD133-positive cells. Lines mark luminal side of bladders. 
RC in bladders from 1 month old mice 
RC in bladders from 1 month old mice were distributed throughout the urothelium, 
including luminal (Fig. 4b, 4c, 4f, and 4g), intermediate (Fig. 4c, 4d, 4e, and 4g), and 
basal (Fig. 4e and 4i) cells. RC were concentrated in the trigone (Fig. 4a). The 
amount of RC in the urothelium was reduced to 2.8%. The number of CK14-
expressing cells decreased significantly in comparison to p5 to less than 8% of 
urothelia. No ki67+ EdU+ cells were detected (Fig. 4h). Only 1.5% of the urothelial 
cells were EdU+Trop2+, but trop2 was not specific to RC. None of the RC was 
CD117+. EdU+ CD44+ were detected in approximately 4% of cells in the connective 
tissue sustaining the urothelium, but EdU+ CD44+ cells were not detected in the 
urothelium. CD44 appeared to be restricted to the basal cells of the urothelium. 
Trop2 and β-catenin (SI 1) were homogenously expressed in the intermediate and 
basal cells of urothelia. Nestin or CD133 expression was not observed.  
 
Figure 4. Sections of bladder from 1 month old animals. RC are preferentially located in the trigone (a). LRC 
in luminal (b), intermediate (c, d, e), and basal cell layers (e). Strong CK14 staining in basal cells of the 
urethra (i). Homogenous expression of CD44 in connective tissue (g). ki67 expression restricted to basal 
cells (h). Square dot dash line indicates urethra in 4a and round dot dash line indicates lumen in 4a, 4c, 4e, 
4f, and 4h. 
RC in bladder from 6 months old mice 
Urothelial RC were almost absent in bladders from 6 months old mice and the 
percentage of RC in urothelium was 1 %. The distribution of BrdU/EdU containing 
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cells was similar to younger animals and located along the urethra. The intensity of 
the BrdU/EdU signal was still strong. RC were observed in all urothelial cell layers, 
including in luminal (Fig. 5a, 5b, and 5c), intermediate (Fig. 5d and 5e), and basal (Fig. 
5f) cell layers. 
 
Figure 5. Sections of bladders from 6 months old animals. RC are present in all cell layers of the bladder, 
including luminal (a, b, c), intermediate (d, e), and basal (f) cells. CD44 is expressed in the connective 
tissues supporting urothelial cells. Round dot dash line indicates lumen in 5a, 5d, 5e, and 5f. 
Discussion 
This study suggests that slow cycling cells may be present in superficial cells of the 
bladder in adult animals, contrasting to the common view that these cells are 
present in the basal cell layer (11). Additionally, slow cycling cells were concentrated 
in the trigone, close to urethra. The confinement to this relatively small area is 
remarkable and contrasts with the presence of adult stem cells/progenitor cells in 
other epithelia where these cells appear to be evenly distributed (13). To obtain cells 
for tissue engineering purposes, it therefore seems advisable to harvest cells close 
to the trigone area of the bladder.  
For bladder tissue regeneration, and for large acellular constructs in general, 
acellular constructs may cause fibrosis in the central region (22). Stem cells 
combined with (biodegradable) matrices may significantly alter the perspective of 
tissue engineering because repair and remodeling of tissues depends on stem cells 
(23). In a landmark study in patients who needed cystoplasty, engineering of bladder 
tissues was described (24). Although the results were encouraging, the promising 
efficacy of the phase I study could not be substantiated in the phase II study (25). 
Based on our study, isolation of urothelial cells from trigone area may provide better 
chance of bladder regeneration. 
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Label retaining method is the first step to label slow cycling cells among all 
progenitor cells in the epithelia (9, 10, 16, 17, 26). However, label-retaining cells do 
not necessarily represent progenitor or stem cell populations. Immediately after 
administration of label EdU/ BrdU-positive cells will be present in all actively dividing 
cells. Thus, the initial presence of a substantial number of Ki67+ EdU+ cells (13%) 
was anticipated. As time progresses and label is diluted out from more rapid (non-
stem cells) diving cells, label-retaining cells represent the more quiescent cells. Thus, 
the BrdU or EdU retaining method is one of the accepted methods to label the slow 
cycling cells. 
Because we wanted to be certain that all potential progenitor cells in the developing 
bladder were labeled, BrdU/EdU was injected during the period when bladder 
development starts (around E10) and before bladder development is finalized (in 
E14). EdU was sparsely observed in bladder tissue from adults from group A 
(receiving injections at E8/E9) and group B (receiving injections at E10/E11). Most 
likely the injection time was too early and most cells, including stem/progenitor cell 
have undergone too many division cycles, diluting the label to undetectable levels. 
The fact that the time of administration influenced the distribution of label retaining 
cell is a reflection of the ongoing organogenesis, with the bladder developing. 
Bladder development is most prominent on gestational days E11-E13 (1, 27). Indeed, 
the amount of label retaining cells and label intensity was much higher in offspring 
from group C (injection E12-E13), showing that results of group C were most 
representative and informative for bladder organogenesis. Surprisingly, Colopy et al. 
did not detect RC in urothelium in one month old mice that had received BrdU 
between E10-E13 (28). The lack of RC can be explained by the lower BrdU dose in 
combination with shorter exposure time leading to lower BrdU uptake in slow 
cycling cells. In our 2-day exposure regimen RC were sparse in animals receiving 
label during E8-E11.  
RC were located in all cell layers of murine urothelium when animals received BrdU 
or EdU at P1 (new born) (28, 29). When animals received BrdU after P14 (up to 
adulthood), RC were predominately located in the basal cell layer (11, 28). Most 
likely BrdU administrated at P14 and beyond incorporates in proliferating (ki67+) 
basal cells that dominate the proliferative response in very young and adult animals. 
In our case labels were administered during bladder organogenesis and 
incorporated labels were diluted in rapidly and in slowly dividing cells. In agreement 
with Kurzrock et al., proliferating cells (ki67+) were exclusively present in the basal 
cell layer of new born and adult animals, whereas BrdU/EdU were distributed in 
other cell layers as well.  
In rat bladders, β4 integrin+ basal cells were more clonogenic and proliferative than 
β4 integrin-negative cells (11). β4 integrin expression was not observed in the 
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mouse bladders examined. Whether this is a species-specific marker for slow-
cycling cells remains to be established. 
It is conceivable that a small population of progenitor cells is present in the 
intermediate and superficial cell layers. We observed label-retaining cells, 
presumably progenitor cells, in all three cell layers of the urothelium: EdU was 
detected in basal cells (p63+), in intermediate cells (p63+ CK7+), and in superficial 
cells (CK20+) at all ages. In bladders from 6 months old mice, the percentage of 
superficial cells containing EdU was 2% (3/148, CK20+ EdU+/CK20+; 148 umbrella 
cells of a total of 4941 urothelial cells.). In agreement with our results, other studies 
have also shown that progenitor cells can be located in the intermediate cell layer 
and that these cells can produce superficial cells or, alternatively, superficial cells 
can reprogram to basal stem cells (6, 15). Moreover, human supra-basal and basal 
cells showed long term proliferation and the capacity to form full urothelial cell 
layers and Colopy et al. detected proliferating cells in intermediate and basal cell 
layers in murine bladders (30). Collectively this suggests that two distinct progenitor 
cell populations may exist that resides in the basal and intermediate cell layer and 
that these may be responsible for basal/intermediate cells and umbrella cells, 
respectively (28, 31). 
Shh-expressing basal cells of adult murine urothelium, presumably stem/progenitor 
cells, can differentiate to umbrella cells (5). When isolated, labeled murine basal 
cells demonstrated clonogenic capacity with the vast majority of large colonies 
being comprised of labeled basal cells (11). However, intermediate and superficial 
cell layers were not tested. Moreover, in p63-/- mouse basal cells are absent and the 
bladder is lined with a single layer of umbrella cells, suggesting that basal, 
intermediate, and superficial (umbrella) cells are not related hierarchically (32). In 
ΔNp63 animals murine basal cells were not essential for urothelial differentiation (to 
produce superficial cells) but did play a major role in survival of progenitor cells 
during urothelial development (12, 33). Finally, a fate mapping study of retinoid 
signaling in developing murine urothelium showed that basal cells rarely produced 
intermediate or superficial cells (6). During embryogenesis progenitor cells (Foxa2+ 
Upk+ p63+ Shh+ CK5-) resided in the intermediate cell layer; in adults in 
intermediate cells (Foxa2- Upk+ p63+ Shh+ CK5-) were identified as superficial cell 
progenitors (6). In view of this collective evidence and considering that cells isolated 
from bladder washing or from urine can produce all cell layers of the urothelium (34-
36), it is likely that a small population of progenitor cells is located superficially. 
In previous label-retaining studies animals received labeling compounds post natally 
four times and label was detected exclusively in the murine basal cell layer (11). 
Analysis of bladders from mother mice eight days after administration of EdU 
demonstrated that EdU was only detectable in the basal cell layer of the urothelium 
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in agreement with these earlier label-retaining studies (SI2) (11). This suggests that 
progenitor cells in the basal cell layer divide more frequently than progenitor cells in 
the intermediate and superficial cell layers.  
 
S 2. EdU retaining cells (RC) in bladders from mother mice. RC are mainly present in the basal cell layer (a). 
EdU RC were CK20- (b). EdU RC were under CK7+ cells (c). EdU RC were co-localized with p63 (d). EdU RC 
were Ki67- and were in the close vicinity to ki67+ cells (e). 
EdU retaining cells were not evenly distributed throughout the bladder, but were 
concentrated in the bladder trigone. In addition, the bladder trigone is associated 
with inflammatory and neoplastic conditions (37, 38). A rat bladder study showed 
that the colony formation capacity of cells isolated from the caudal bladder in the 
trigone was twofold higher than the colony formation capacity of cells from the 
cephalic bladder (39). This suggests that the bladder trigone is crucial in the 
maintenance of bladder progenitor cells.  
EdU containing cells were observed up to 6 months after injection. The number of 
retaining cells decreased steadily from 45% (E17) to 1% (6 months) (Table. 2). The 
remaining 1% of EdU containing cells may be bladder progenitor cells, but could 
also represent quiescent non-progenitor cells. Functional studies are needed to 
show whether this 1% of EdU labeled cells truly represent the bladder progenitor 
cells.  
Conclusion 
In summary, we propose that slow cycling cells, most likely representing progenitor 
cells of the bladder, reside mostly in the trigone of the bladder and that they are 
distributed throughout all urothelial cell layers. Understanding the geographic 
location of slow cycling cells provides crucial information for tissue regenerative 
purposes in the future. 
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S 3. Double labeling of BrdU (sheep anti BrdU) and CK7 (mouse anti CK7) in bladders from 1 month and 6 
months old animals. BrdU was developed with DAB and CK7 was developed with vector-red. Bladders from 
1 month are shown in a, c, e, and g. Bladders from 6 months were shown in b, d, f, and h. CK7 was 
expressed specifically in urothelial cells (a and b, original magnification 40x). Negative controls are shown 
in c, d, e, and f (original magnification 10x). In c and d, primary antibodies were omitted and secondary 
biotinylated sheep anti mouse was conjugated with vector red. Some background between muscle layer 
and stroma are present but no influence of CK7 staining for urothelia. In e and f, only vector-red was 
applied and no background signal present. Double labeling of BrdU and CK7 showing BrdU (g and h, 
original magnification 63X). Arrows indicate double labeling of BrdU and CK7. 
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Chapter 7 
Summary, General Discussion and Future 
Perspectives 
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Summary and general discussion 
Tissue engineering aims to replace and repair lost or diseased tissues with 
compatible template. This template will serve as a temporary accommodation for 
tissue to regenerate and to restore normal functions. The current treatment after 
(radical) cystectomy is the replacement of lost tissues with autologous 
gastrointestinal tissues creating an alternative storage space for urine. Because the 
epithelium of the gastrointestinal tract differs substantially from the urothelium in 
the bladder, complications may follow and consequently the quality of life of 
patients is reduced. Patients may be incontinent and may have to self-catheterize 
which is not desirable. Other possibilities for bladder replacement should be 
developed with emphasis on biocompatibility, degradability, and 
structural/mechanical properties.  
The aim of this thesis was to study the biomaterials for bladder reconstruction via 
three perspectives: materials, the vasculogenesis, and stem cells.  
Materials 
Type I collagen is the most commonly used material for soft tissue engineering, 
because collagen is a main component in the extra cellular matrix and is low 
immunogenic which fits the requirements of biomaterials for tissue engineering.  
Further, the preparation of collagen templates can meet the restrict requirements 
for clinical implementation (1), and they can be produced as an off-the-shelf product.  
During preparation, the interconnectivity of collagen templates is determined by 
cross-linking and the concentration of collagen. Low interconnectivity will lead to 
poor cell distribution or insufficient vasculogenesis after implantation. By lowering 
the concentration of type I collagen in templates the interconnectivity was 
increased, as shown with fluorescent beads, which enhanced the cellular 
distribution, particularly better penetration was achieved (Chapter three).  
However, templates prepared from a low percentage of collagen are structurally 
weak: when a 0.5% collagen template was applied to replace ureters in pigs the 
replaced ureters burst open one month after implantation (2). In a rabbit study, 
0.5% collagen tubular templates without cells were applied to replace urethra, but 
this resulted in strictures, possibly because the structure collapsed (3). Apparently, 
templates prepared from low concentrations of collagen (<0.5%) are too weak to 
support urinary contraction during urination.  Inclusion of a PCL knitting enhanced 
the mechanical strength of templates prepared from 0.4% type I collagen. The 
tensile strength increased to 10N (Chapter three) which is similar to human ureteral 
tissues (Janke et al., manuscript in preparation).  
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Vasculogenesis 
Vasculogenesis is crucial for implanted biomaterials, because the exchange of 
nutrients and waste will enhance the rate of tissue remodeling. Vasculogenesis of 
constructs can be enhanced by pre-implantation, pre-vascularization with cells, or 
by the addition of growth factors in templates. Currently the strategies of 
examining vasculogenesis in implanted templates are restricted to invasive methods 
which are based on histological examination, including micro-density assay, in-situ 
hybridization, immunohistochemistry, or RNA expression levels.   
In chapter four, hybrid collagen fibrin templates were pre-vascularized with human 
umbilical vein endothelial cells and these templates were grafted in mice. The 
vasculature networks were analyzed using contrast enhanced MRI and the 
outcomes of pre-vascularized templates were compared with none pre-vascularized 
templates. MRI studies showed that pre-vascularized networks anastomosed with 
host capillaries as evidenced by the higher amount of contrast influx and faster 
saturation rate compared with none pre-vascularized templates that are in the 
process of being neo-vascularized. The data were verified by immunohistochemistry 
and it showed that the engineered network cross connected with host vessels and 
vessels penetrated ~400 μm deep into pre-vascularized templates; however, the 
penetrating depth of capillaries into the non pre-vascularized template was limited 
to the surface. Additionally, in none pre-vascularized templates, angiogenic factor 
(VEGF-A) was induced and the level was higher than in pre-vascularized templates. 
Thus, in order to follow the progress of tissue remodeling in implanted materials 
contrast enhanced MRI represents a non-invasive tool providing functional 
information and the progress can be followed throughout life. 
Stem cells 
The importance of bladder stem cell study is not only to identify the niche of 
progenitor cells, possibly enabling harvesting a more potent cell source, but also to 
understand the development and maintenance of bladder epithelia throughout life. 
The basal cell layer as well as the intermediate cell layer of the urothelium has been 
proposed as the niche of urothelial progenitor cells (4, 5). In a fate-mapping study, 
two populations of progenitors in the intermediate cell layer for bladder 
development and for regeneration were distinguished (4).  
When DNA labeling compounds were administered to pregnant mice at the time 
while bladder organogenesis was induced, slow cycling cells in the urothelium could 
be detected. Labeled cells were observed in all cell layers of the urothelium, 
including basal, intermediate, and superficial cell layers (Chapter six). The 
percentage of labeled cells decreased to 1% of all urothelial cells in adult animals. 
Moreover, the labeled cells were concentrated in the bladder trigone. Functional 
Processed on: 18-10-2016
505481-L-bw-Sun
122 
 
studies have demonstrated that both basal and supra-basal cells can produce 
hierarchically organized and differentiated tissue similar to native urothelium (6). 
Thus, for bladder tissue engineering, the bladder trigone is the target area to isolate 
stem cells and cell layer origin appears less important.  
Future perspectives  
Hybrid materials 
In order to enhance the mechanical characteristics of collagen scaffolds prepared 
from low percentage collagen, PCL was included, but the degradation rate of PCL 
was not optimal for urethral reconstruction. Inclusion of PCL knitting in tubular type 
I collagen templates to replace urethra caused unexpected immune-responses after 
implantation (Arena et al., manuscript in preparation). The reason could be that PCL 
is a slow biodegradable polymer and takes four years to degrade in vivo (7).  
For soft tissue engineering, fast degradable polymers should be chosen, such as 
PGA, PLGA, or Vicryl which hydrolyzes within three months. Meanwhile, the 
plasticity, elasticity, and targeted tissues should be taken into account (8). For 
example, Vicryl may not be applicable for closure of congenital diaphragmatic 
hernia in lamb (9), but it showed good biocompatibility, low immune-response and 
good integration with porcine bladder tissues [(10) and Sloff et al., manuscript in 
preparation]. The reason might be that more elasticity was needed for the 
expansion of diaphragmatic hernia than in the bladder. Likely that choice is going to 
be partly determined by mechanical force. 
Further, Sloff et al. reported that different sterilization procedures influence 
mechanical strength and degradation rate in vivo. Thus, the choice of sterilization 
process should be analyzed for each specific application. 
Vasculogenesis 
The pre-vascularized hybrid collagen fibrin template described in this thesis has not 
been applied as a large surface for bladder replacement yet. Thus, before such 
templates can be implemented it is imperative that large pre-vascularized hybrid 
templates are implanted for bladder augmentation in a large animal model. Briefly, 
hybrid collagen templates can be prepared with supporting polymer, such as PGA or 
Vicryl to enforce the mechanical strength of the template, followed by, for instance, 
pre-vascularized with autologous adipose derived stem cells.  
However, when the area to be replaced/augmented is more than 50% of the original 
bladder, autologous cell seeding might be too difficult. In studies presented here, 
the endothelial cells were seeded at 2.5 x 105 cells/cm2, but the size of human 
bladder is much bigger than this surface area. Thus, other strategies of pre-
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vascularization for large templates should be considered. For example, coverage 
with omentum or pre-implant within the abdominal wall tissue, using the body as a 
natural bioreactor to pre-vascularize biomaterials in vivo might be a better strategy 
than using cells in culture and a combined advanced therapy medicinal products 
(ATMP) approach.  
For tissue engineering and the future application of the implanted PIC hydrogels, it 
may be advantageous to create a vascular network in the PIC hydrogel which can be 
collapsed on the collagen scaffold before implantation by temperature shifting. 
Possibly this can enhance the survival. Moreover, in preliminary studies we observed 
that inclusion of vascular endothelial growth factor (VEGF) modification on the PIC 
backbone accelerated vasculogenesis in vitro demonstrating the flexibility of this 
material. For future studies, other modifications should be studied which may lead 
to the establishment of a tool box amenable for various applications. 
Stem cells 
For replacement of large tissue surface area, cell support can be important for the 
survival of implanted materials. Indeed for bladder tissue engineering, template 
coverage with urothelial cells is crucial as they can form a barrier against toxic 
components in the urine. Although urothelial cells also do start to cover the edge of 
implanted material spontaneously (11, 12), coverage is incomplete for large defects 
leading to scar tissue formation or fibrosis (13).Thus, based on studies presented 
here, the bladder trigone should be the target area to collect donor cells when they 
are available for bladder reconstruction.  
Nevertheless, functional analysis of isolated cells from the trigone area should be 
performed, because labeled cells which were observed in the trigone area could be 
quiescent cells or progenitor cells without excessive growth potential. In preliminary 
experiments, cells harvested from the trigone area of pigs showed higher colony 
forming ability than cells residing in the dome region. Further investigations should 
include cell differentiation and repopulation of trigone-residing cells to a complete 
urothelial wall.  
Further, it is important to realize that other sources of progenitor cells are available 
as well. Recently the progenitor cells were found in the urine and they could be an 
alternative cell source. The benefit of urine derived progenitor cells is that it is a not 
invasive way of collection. Several studies showed that these cells differentiated 
into hierarchal cell layers of bladder wall (14, 15). The disadvantages are that the 
number of cells is limited and extensive cell culture is needed.  
Currently mesenchymal stem cells isolated from adipose tissues have become a 
favorite cell source in tissue engineering, because the isolation procedure is 
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relatively shorter with liposuction than taking biopsy and cells may not need 
expansion in cell culture, and the contamination by tumor cells can be excluded. 
Adipose derived stem cells have been tested in cell therapy and have been applied in 
different biomaterials for bladder tissue engineering (16-18).  
Thus, the next step is to test the combination of mesenchymal stem cells in hybrid 
biomaterials. Stem cell seeded hybrid biomaterials will be studied in animals and to 
see if these cells produce a functional bladder wall (including a functional vasculary 
and muscular tissues) and if the hybrid materials could support the process for tissue 
regeneration. Eventually this will serve as a better alternative than autologous ileum 
tissues for bladder replacement.      
  
  t i  i  a i als to see
if these cells produce a functional bl dder wall (including a functional vasculary and
muscular tissues) and if the hybrid materials could sup ort the proces   
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Samenvatting en Algemene Discussie 
Tissue engineering is gericht op het vervangen en repareren van verloren of ziek 
weefsels met een tolerante template. Deze template zal dienen als een tijdelijke 
accommodatie voor weefsel om te herstellen en om de normale functies te 
verkrijgen. De huidige behandeling na een (radicale) cystectomie is het vervanging 
van de verloren weefsel met autoloog gastro intestinaal weefsel. Maar omdat het 
epitheel van het spijsverteringskanaal aanzienlijk afwijkt van het urotheel in de 
blaas, kunnen complicaties volgen waarmee de kwaliteit van leven van de patiënten 
verminderd. Patiënten kunnen incontinent worden en moeten zichzelf 
katheteriseren, hetgeen niet gewenst is. Andere mogelijkheden voor de 
blaasvervanging moeten worden ontwikkeld met de nadruk op biocompatibiliteit, 
afbreekbaarheid, en structurele / mechanische eigenschappen. 
Het doel van dit proefschrift is om biomaterialen voor blaaswederopbouw te 
bestuderen vanuit drie perspectieven: materiaal, de vasculogenese en stamcellen. 
Materialen 
Het meest gebruikte materiaal voor soft tissue engineering is type I collageen. 
Omdat collageen een belangrijke component is in de extracellulaire matrix en 
omdat collageen laag immunogeen is, is dit biomateriaal uitermate geschikt als 
uitgangsmateriaal voor weefselregeneratie.  
Verder, de bereiding van collagene templates kan voldoen aan de strikte eisen die 
gesteld worden aan producten die gebruikt worden in klinische toepassingen. En 
zijn als “off the shelf product” produceerbaar. 
Tijdens het bereiden van de collageen wordt de interconnectiviteit bepaald door 
cross-links en de concentratie van collageen in het materiaal.  
Lage interconnectiviteit zal leiden tot een slechte verdeling van cellen of 
onvoldoende vasculogenese na implantatie.  
Door verlaging van de concentratie collageen type I werd de interconnectiviteit 
verhoogd die de cellulaire verdeling in de scaffold verbeterd, zoals aangetoond met 
fluorescerende beads. Er werd met name een betere penetratie van de template 
bereikt (hoofdstuk drie). 
Echter, templates bereid met een laag percentage aan collageen zijn structureel 
zwak: bij een studie met varkens werden de ureters vervangen met een 0,5% 
collageen template, de vervangen urineleiders sprongen één maand na implantatie 
open (2).  
Processed on: 18-10-2016
505481-L-bw-Sun
129 
 
In een studie met konijnen werden de urethra’s vervangen door 0,5% collageen 
buisvormige template zonder cellen. Dit resulteerde in vernauwingen, stenosis, in 
de urethra’s, misschien omdat de constructie was samengeklapt (3).  
Blijkbaar zijn templates, bereidt uit een lage concentraties van collageen (<0,5%), te 
zwak om de blaascontractie te ondersteunen tijdens het urineren.  
Het includeren van PCL knitting verhoogt de mechanische sterkte van de  templates 
bereid uit 0,4% type I collageen. De treksterkte wordt verhoogd tot 10N (hoofdstuk 
drie) wat overeenkomt met humane ureterweefsels (Janke et al., Manuscript in 
voorbereiding). 
Vasculogenese 
Vasculogenese is cruciaal voor geïmplanteerde biomaterialen, omdat de 
uitwisseling van voedingsstoffen en afval de snelheid van weefselvorming zal 
verbeteren. De vasculogenese in constructen kan worden verbeterd door pre-
implantatie, pre-vascularisatie met cellen of door toevoeging van groeifactoren in 
de templates. De huidige strategieën om vasculogenese in geïmplanteerde 
templates te onderzoeken is tot op heden beperkt tot invasieve methoden, deze 
methoden zijn gebaseerd op histologisch onderzoek, met inbegrip van micro-
density assays, in-situ hybridisaties, immunohistochemische kleuringen en het 
bepalen van  RNA expressie niveaus. 
In hoofdstuk vier werden hybride collageen-fibrine scaffolds vooraf gevasculariseerd 
met humane navelstreng endotheelcellen en geïmplanteerd in muizen. De 
gevasculariseerde netwerken werden geanalyseerd met behulp van contrast 
enhanched MRI en de resultaten van pre-gevasculariseerde templates werd 
vergeleken met niet pre-gevasculariseerde templates. MRI studies toonden aan dat 
gepre-vasculariseerde netwerken anastomooste met de gastheer capillairen. Dit 
blijkt uit de grotere hoeveelheid contrastmiddel instroom en de snellere 
verzadigingssnelheid ten opzichte van de niet gepre-vasculariseerde sjablonen 
welke bezig waren met neo-vascularisatie. Deze gegevens werden geverifieerd met 
behulp van immunohistochemie en dit toonde aan dat het gegeneerde netwerk 
kruisverbond met de gastheer’s vaten en dat deze vaten ~400 μm diep 
doorgedrongen in het gepre-vasculariseerde template; De infiltratie van de 
capillairen in het niet gepre-vasculariseerde template bleven beperkt tot het 
oppervlak.Bovendien in de niet gepre-vasculariseerd templaten werd angiogenese 
factor (VEGF-A) geïnduceerd en dit niveau lag hoger dan in pre-vasculariseerde 
templaten. Dus, om de voortgang van weefsel hermodellering te volgen in 
geïmplanteerde materialen, contrast MRI vertegenwoordigt een niet-invasieve 
methode om functionele informatie te verkrijgen en de voortgang te volgen 
gedurende het hele leven. 
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Stamcellen 
Het belang van blaasstamcel onderzoek is niet alleen om de niche van 
voorlopercellen te identificeren, waardoor we een potentieel betere bron van cellen 
aanboren. Maar ook om de ontwikkeling en instandhouding van blaas epitheel 
tijdens ons leven te begrijpen. De basale cellaag alsmede het tussengelegen cellaag 
van het urotheel is voorgesteld als de niche van urotheliale voorlopercellen (4, 5). In 
een fate-mapping studie zijn twee populaties voorlopercellen aangetoond die in de 
tussengelegen cellaag van het urotheel zitten en verantwoordelijk zijn voor de 
ontwikkeling en regeneratie van de blaas (4). Wanneer DNA bindende labels aan 
zwangere muizen werden toegediend, tijdens de organogenese van de embryonale 
blaas. Konden er langzaam delende cellen in het urotheel worden gedetecteerd. 
Deze gelabelde cellen werden waargenomen in alle cellagen van het urotheel, met 
inbegrip van de basale, intermediaire en oppervlakkige cellagen (hoofdstuk zes). Bij 
volwassen dieren daalde het percentage van gelabelde cellen tot 1% van alle 
urotheelcellen. Deze gelabelde cellen vond men in grotere mate in het blaas trigone. 
Functionele studies hebben aangetoond dat zowel de basale en supra-basale cellen 
hiërarchisch georganiseerde en gedifferentieerd weefsel kunnen produceren die 
vergelijkbaar is met het inheemse urotheel (6). Samenvattend, het blaas trigone is 
een doelgebied om stamcellen uit te isoleren voor blaasweefsel manipulatie, cellaag 
herkomst blijkt minder belangrijk te zijn. 
Toekomst perspectieven 
Hybride materialen 
Om de mechanische eigenschappen van collagene templates, bereid met een laag 
percentage collageen, te verbeteren, werd PCL inbegrepen in deze templates.  De 
afbraaksnelheid van PCL bleek niet optimaal te zijn voor urethrale wederopbouw. 
Het includeren van PCL netwerken in tubulaire type I collageen templates, voor het 
vervangen van de urethra, veroorzaakte een onverwachte immuun-respons na 
implantatie (Arena et al., manuscript in preparation). Een reden zou kunnen zijn dat 
PCL een langzaam biologisch afbreekbaar polymeer is, het duurt vier jaar om PCL in 
vivo af te breken(7). Voor zachte weefsel manipulatie, moet er voor snel afbreekbare 
polymeren worden gekozen, zoals PGA, PLGA of Vicryl welke hydrolyseert binnen 
drie maanden. Tegelijkertijd moet de plasticiteit, elasticiteit en het uiteindelijke 
doelweefsel in aanmerking worden genomen (8). Een voorbeeld, Vicryl kon niet 
toegepast worden voor de afsluiting van een congenitale diafragmatische hernia in 
een lam (9), maar het bleek een goede biocompatibiliteit, een laag immuunrespons 
en een goede integratie met varkens blaas weefsels te vertonen [(10) en Sloff et al., 
Manuscript in preparation]. De reden kan zijn dat er meer elasticiteit nodig was voor 
de groei van de diafragmatische hernia dan in de blaas. Verder, Sloff et al. 
rapporteerde dat verschillende sterilisatie procedures de mechanische sterkte en 
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afbraaksnelheid in vivo zouden beïnvloeden. Daarom moet de keuze van 
sterilisatieproces worden in ogenschouw worden genomen. 
Vasculogenese 
De ge-prevasculariseerde hybride collageen fibrine template, beschreven in dit 
proefschrift, is nog niet toegepast bij een groot oppervlakte vervanging in de blaas. 
Dus, voordat deze templates kunnen worden toegepast is het noodzakelijk om 
grote ge-prevasculariseerde hybride templates te implanteren in een blaas 
augmentatie model in grote dieren. In het kort,  hybride collageen templates 
kunnen worden bereid met een ondersteunende polymeer, zoals PGA of Vicryl om 
de mechanische sterkte van de matrix te handhaven, gevolgd door, bijvoorbeeld, 
pre-vascularisatie met autoloog adipeus verkregen stamcellen. Echter, wanneer het 
te vervangen/te augmenteren gebied meer dan 50% van de oorspronkelijke blaas 
omvat kan autologe cel behandeling moeilijk zijn. In studies, die hier gepresenteerd 
zijn, werden de endotheelcellen gezaaid met 2,5 x 105 cellen/cm2, maar de grootte 
van de menselijke blaas is veel groter dan het beschreven oppervlak. Dus moeten 
we andere strategieën voor pre-vascularisatie voor grote templates beschouwen. 
Zo kan bedekking met omentum, of pre-implantatie met buikwand weefsel met 
behulp van het lichaam als een natuurlijke bioreactor, voor de pre-vascularisatie van 
biomaterialen in vivo, een betere strategie zijn dan het gebruik van cellen in cultuur 
en een gecombineerd ATMP aanpak. 
Voor weefsel engineering en het toekomstig gebruik van de geimplanteerd PIC 
hydrogels, kan het voordelig zijn een vasculair netwerk in de PIC hydrogel te creëren 
en deze te plaatsen op een collageen template, voor implantatie, door middel 
temperatuur verschuivingen. Mogelijk kan dit de overlevingskansen  van de 
template verbeteren. Bovendien is in een voorlopige studie geconstateerd dat 
toevoeging van vasculaire endotheliale groeifactor (VEGF) modificaties aan de PIC 
backbone, versnelde vasculogenese in vitro aantoont en hiermee de flexibiliteit van 
ons materiaal demonstreert. 
In toekomstige studies moeten andere modificaties worden bestudeerd die kunnen 
leiden tot de oprichting van een toolbox, vatbaar voor diverse toepassingen. 
Stamcellen 
Voor het vervangen van grote opvlakten weefsel, kan de celdrager van belang zijn 
voor het overleven van de geïmplanteerde materialen. Voor blaasweefsel 
engineering is de dekking met urotheelcellen inderdaad cruciaal omdat deze een 
barrière vormt tegen giftige componenten in de urine. Alhoewel urotheelcellen de 
rand van geïmplanteerde materiaal spontaan bedekken (11, 12), is deze dekking 
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onvolledig bij grotere oppervlakten, dit kan leiden tot grote defecten als 
littekenvorming of fibrose  (13). 
Dus, gebaseerd op de hier gepresenteerde studies, zou de blaas trigone het 
doelgebied moeten zijn om donorcellen te verzamelen voor de blaas wederopbouw, 
wanneer deze beschikbaar is.Niettemin dienen functionele analyses, op de 
geïsoleerde cellen uit het trigonum, te worden uitgevoerd. Dit omdat de gelabelde 
cellen die in de trigonum gebied waargenomen zijn rustende cellen of 
progenitorcellen zonder overmatige potentiële groei kunnen zijn. In eerdere 
experimenten vertoonden cellen, geoogst uit het trigonum gebied van varkens, een 
hoger kolonievormend vermogen dan de cellen die verbleven in de koepel regio va 
de blaas. Verder onderzoek moet de celdifferentiatie en herbevolking, vanuit 
trigone verblijvende cellen, tot een complete urotheliale wand omvatten. Verder is 
het belangrijk te beseffen dat andere bronnen van voorlopercellen cellen ook 
beschikbaar zijn. Onlangs zijn er voorlopercellen in de urine gevonden en deze 
kunnen een alternatieve bron van cellen zijn. Het voordeel van uit de urine 
verkregen stamcellen is dat deze op een niet invasieve manier verzameld 
zijn.Verscheidene studies toonden aan dat deze cellen differentieerden in de 
hiërarchische cellagen van de blaaswand (14, 15). De nadelen zijn dat het aantal 
cellen beperkt is en er een uitgebreide celcultuur nodig is. Tegenwoordig zijn 
mesenchymale stamcellen, uit vetweefsel, een favoriete bron van cellen voor tissue 
engineering. Dit omdat de isolatie procedure uit een liposuctie relatief kort is 
vergeleken bij het nemen van biopsies en deze cellen niet geëxpandeerd hoeven te 
worden in een celkweek. Daarbij de verontreiniging door blaastumorcellen 
uitgesloten. Adipose afgeleide stamcellen zijn getest in celtherapie en zijn in 
verschillende biomaterialen voor blaas tissue engineering toegepast (16-18). 
  
s, e aseer   e ier e rese teer e st ies, z  e laas tri e et 
el e ie  ete  zij   rcelle  te verza ele  v r e laas e er , 
a eer eze esc ik aar is. Niettemin dienen functionele a alyses,  e 
eïs leer e celle  it et tri , te r e  it ev er . it at e ela el e 
c ll  i  i   tri  i  r  zij  r st  c ll  f 
r e it rcelle  z er ver ati e te tiële r ei k e  zij . I  eer ere 
ex eri e te  vert e  celle , e st it et tri  e ie  va  varke s, ee  
r l i v r  v r    c ll  i  v r l v  i   l r i  v  
e laas. er er erz ek et e cel iffere tiatie e  er ev lki , va it 
tri  v r lijv  c ll , t t  c l t  r t li l   v tt . r r is 
et ela rijk te eseffe  at a ere r e  va  v rl ercelle  celle  k 
esc ik aar zij . la s zij  er v rl ercelle  i  e ri e ev e  e  eze 
  lt r ti v  r  v  c ll  zij . t v r l v  it  ri  
verkre e  sta celle  is at eze  ee  iet i vasieve a ier verza el  
zij . ersc ei e e st ies t e  aa  at eze celle  iffere tieer e  i  e 
i r rc isc  c ll  v   l s  (1 , 1 ).  l  zij  t t t l 
celle  e erkt is e  er ee  it e rei e celc lt r i  is. e e r i  zij  
s c y l  st c ll , it v t fs l,  f v ri t  r  v  c ll  v r tiss  
e i eeri . it at e is latie r ce re it ee  li s ctie relatief k rt is 
ver eleke  ij et e e  va  i sies e  eze celle  iet eëx a eer  eve  te 
r  i   c l . r ij  v r tr i i i  r l st rc ll  
it esl te . i se af elei e sta celle  zij  etest i  celt era ie e  zij  i  
versc ille e i ateriale  v r laas tiss e e i eeri  t e e ast (1 -1 ). 
De volgende stap is het testen van de combinatie van mesenchymale cellen met de 
hybride biomaterialen.  De met stamcellen ingezette hybride biomaterialen worden 
ingezet in dierexperimenten om te bepalen of deze cellen een functionele 
blaaswand (inclusief functionele vaat en spierweefsels) kunnen produceren en of het 
biomateriaal het proces van weefsel regeneratie kan ondersteunen. Uiteindelijk zal 
dit leiden tot een beter alternatief voor blaaswand vervanging dan het huidige 
gebruik van autoloog ileum weefsel. 
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ᕴ่Ǵᆕӝ૸ፕǴаϷ҂ٰᜫඳ!
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ᕴ่ᆶᆕӝ૸ፕ!
ಔᙃπำࢂճҔᆶΓᡏ࣬৒ޑғނ׷਑Ǵڗж٠ЪঅൺӢࡺ܈ӢੰѨѐޑಔᙃǴ
ғނ׷਑ޑфૈࢂ៾ەӦගٮΑಔᙃӆғǴаϷࡠൺфૈޑޜ໔ǶҞ߻ӧ)ӄ*
ᆮાϪନޑЋೌࡕǴ΋૓ࢂᘏڗੰΓҁيޑλဉಔᙃǴ଺ࣁֿనኩӸޑඹжޜ
໔)Ψ൩ࢂΓπᆮા*Ƕՠҗܭλဉޑ΢ҜಔᙃǴکᆮાޑ΢Ҝಔᙃޑфૈᄒฅ
όӕǴ΋ޣࣁϩှ֎ԏǴќ΋ޣࣁߔᏲ௨ݧނ຾Εဎ๚ϣǴೌࡕՔᒿ๱ёႣය
ޑٳวੱǶٳวੱхࡴΑֿѨ࿣Ǵ܈ࢂੰΓѸ໪ԾρᏤֿǴ೭ኬޑٳวੱѸฅ
཮फ़եੰΓޑғࢲࠔ፦ǶӢԜǴҞ߻࡚ሡ໒วځдޑғނ׷਑ٰڗжԾᡏλဉǴ
Զว৖Бӛᔈ๱ख़ܭуம׷਑ჹܭΓᡏಔᙃޑ࣬৒܄Ǵӆޣࢂ׷਑཮ᒿ๱ਔ໔
ϩှǴ่ᄬ΢ᔈڀഢ܌ሡޑமࡋϷ໧܄Ƕ!
ҁፕЎޑࣴزБӛ఼ᇂΑΟঁሦୱǺ׷਑ǴՈᆅғԋǴаϷ༸ಒझǴ࿶җ೭Ο
Бय़ޑ௖૸຾Զׯ๓Γπᆮા܌ሡޑғނ׷਑ǶаΠஒࣁԜΟБय़ޑࣴز຾Չ
၁ಒޑ૸ፕǺ!
׷਑!
ಃ΋ࠠጤচೈқࢂȸ೬ȹಔᙃπำനதҔډޑ׷਑ǴځচӢࢂҗܭ୏ނೈқϐ
ύচҁ൩൤֖ጤচೈқǴಒझѦ໔፦ޑЬाԋϩΨࢂጤচೈқǴаϷځեխࣝ
চ܄ޑ੝܄Ǵ೭٤చҹ࡞ӳ಄ӝಔᙃπำჹܭғނ׷਑ޑሡ؃Ƕ٠ЪǴҞ߻ᇙ
೷ጤচೈқኳހޑၸำǴς಄ӝܭᙴᕍҔࠔ฻ભ(1)ǴΨё࠼ᇙࣁᒿਔёڗҔޑ
ԋࠔǶ!
ӧᇙ೷ၸำύǴϯᏢҬᖄޑೀ౛ǴаϷጤচೈқޑᐚࡋǴ،ۓΑ׷਑ϣᆛ๎ೱ
ᛠޑำࡋǴӵ݀׷਑ϣޑᆛ๎ό೯Ǵ཮೷ԋӧ౽෌ࡕǴಒझϩѲό֡ǴаϷߔ
ᛖՈᆅғԋǶҁፕЎύǴ࿶җफ़եጤচೈқޑᐚࡋǴךॺճҔᢀჸխࣝϩ݋ݤ
܌ҔᑻӀ੧ηޑϩթ௃׎Ǵ຾ԶזೲӦ᛾ჴኳހϣᆛ๎ޑೱᛠቚуΑǹಒझϩ
ѲჴᡍΨ᛾ჴǴಒझϩѲӦ׳֡ϬǴ੝ձࢂಒझவ߄य़ᅖ೸ډኳހϣ೽ޑుࡋ
ΨቚуΑ)၁ـಃΟക*Ƕ!
ฅԶǴҗեᐚࡋጤচೈқ܌ᇙԋޑኳހǴёႣයځ่ᄬமࡋࢂၨৡޑǺٯӵǴ
྽ךॺҔ 0.5%ጤচೈқ܌ᇙԋޑΓπᒡֿᆅڗж፜ᡏϣޑᒡֿᆅǴӧЋೌ΋ঁ
ДࡕǴΓπᒡֿᆅӢคݤ܍ڙֿనޑᓸΚԶઇཞ(2)Ƕӧ΋ಔټηޑ୏ނჴᡍύǴ
ךॺճҔؒԖಒझ౽෌ޑǴ0.5%ጤচೈқ܌ᇙԋޑᆅރኳހٰڗжֿၰǴ่݀
ࠅࢂᏤठֿၰ੟ઞǴځচӢёૈࢂӢࣁڗжޑ׷਑༥ഐ೷ԋֿၰ੟ઞ(3)Ƕࡐܴ
ᡉޑǴ྽ጤচೈқޑᐚࡋϼե)եܭ 0.5%*Ǵځ่ᄬ΢ޑமࡋǴόىаЍ࡭௨ֿ
ਔݜֿس಍္܌ౢғޑᓸΚǶӢԜǴӧҁጇፕЎύǴᆫςለЧ✊܌ጓᙃޑᆛηǴ
೏Ҕٰቚம 0.4%ಃ΋ࠠጤচೈқޑ่ᄬமࡋǴషӝࠠ׷਑ޑל܎மࡋӢᆫςለ
Ч✊ቚமډ 10 ФႥ)၁ـಃΟക*ǴԶ 10 ФႥ҅࣬྽ܭΓᡏޑᒡֿᆅಔᙃޑל
܎மࡋ(Janke et al.)Ƕ!
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Ոᆅғԋ!
ჹܭখ౽෌Εᡏϣޑғނ׷਑ԶقǴՈᆅғԋࢂߚதᜢᗖޑ؁ᡯǴӢࣁᎦϩǴ
਼਻ǴᗋԖቲకނҬඤޑೲ౗Ǵஒ཮،ۓ෌ΕᡏޑӸࢲǴаϷಔᙃঅൺޑೲ౗Ƕ
೯தՈᆅғԋёаᙖҗႣӃ෌ΕᡏϣǴᡣ୏ނ܈ΓᡏޑՈᆅӃՉၹѲܭኳހ΢Ǵ
܈ࢂᙖҗಒझ୻ᎦǴႣӃғԋ༾Ոᆅࡕ౽෌Ǵӆ܈ޣࢂճҔԋߏӢηᇨวǴ຾
ԶזೲӦᇨᏤғނᡏϣޑՈᆅၹѲܭኳހ΢ǶҞ߻ӵ݀གྷाᔠຎՈᆅӧ෌Εޑ
ኳހ΢ޑϩѲǴനதـޑБԄࢂճҔߟΕԄޑੰ౛Ꮲϩ݋ǴᢀჸՈᆅϩѲޑ௃
׎٠ໆϯǴځ߄౜БԄхࡴ༾Ոᆅஏࡋϩ݋ǴচՏᚇӝמೌǴխࣝಔᙃϯᏢݤǴ
܈ࢂ຾΋؁ճҔᆫӝ䁙᜘ԄϸᔈКၨਡᑗਡለޑ߄౜ໆǶ!
ӧಃѤകύǴಃ΋ࠠጤচೈқషӝᠼᆢೈқޑኳހǴ࿶ၸΓᜪᙏ஥ᓉેϣҜಒ
झౢғ༾ՈᆅࡕǴ෌Ε୏ނ٠ЪکᡏϣޑՈనس಍่ӝࡕǴךॺᙖҗᡉቹᏊᇶ
շޑᅶਁ೷ቹǴϩ݋෌Εࡕ༾ՈᆅᆛၡޑϩѲǶ٠ЪКၨՈᆅϩѲޑ௃׎Ǵӧ
ႣӃғԋՈᆅޑಔǴჹྣܭ҂ႣӃғԋՈᆅޑಔǶᅶਁ೷ቹޑ่݀ࡰрǴՈᆅ
ႣғԋޑಔǴӧௗӝ୏ނᡏϣޑՈనس಍ࡕǴᡉቹᏊޑໆаϷႫکࡋ೿К҂Ⴃ
Ӄғԋޑಔ)Ψ൩ࢂՈᆅཥғޑಔ*ଯǶቹႽኧᏵၗ਑೿ᆶխࣝಔᙃϩ݋ݤҬϕ
ჹྣКၨǴխࣝಔᙃϩ݋ޑ่݀ᡍ᛾ǴႣӃՈᆅғԋޑಔǴΓπ༾Ոᆅک୏ނ
ᡏϣޑ༾ՈᆅௗӝǴவᡏϣۯ՜຾ΕኳހޑՈᆅࣗԿుၲ 400 ༾ԯǹฅԶǴՈ
ᆅཥғޑಔǴՈᆅᗨฅۯ՜٠ЪၹѲӧኳހ߄य़Ǵࠅ҂ుΕځύǶԜѦǴՈᆅ
ཥғӢηޑໆǴՈᆅཥғಔࢂଯၸՈᆅႣғԋޑಔǶӧԜךॺёаᕴ่Ǵӵట
࡭ុӦᢀჸಔᙃख़ಔޑၸำǴΨ൩ࢂՈᆅௗӝࡕޑфૈǴᡉቹᏊᇶշޑᅶਁ೷
ቹගٮΑ΋ঁߚߟΕԄޑБݤǴ٠Ъёаಖғଓᙫኳހ෌ΕࡕޑᡂϯǶ!
༸ಒझ!
ᆮા༸ಒझޑࣴزǴځख़ा܄όѝࢂӧܭዴᇡ߻០༸ಒझӧᆮાύޑՏ࿼Ǵа
ճܭВࡕ௦໣ԾᡏಒझǴ຾Զ౽෌ډཥޑඹжғނ׷਑ǹӕਔΨᡣךॺ౛ှᆮ
ા੝ϯޑ΢ҜಒझࢂӵՖวػǴ٠Ъӧ΋ғύᆢ࡭ځֹ᏾܄Ƕӧᆮા΢Ҝಒझ
ޑ่ᄬ࣬՟ܭҜጥ΢Ҝಒझޑ߻ගϐΠǴᆮા΢Ҝಒझޑ୷ቫکύ໔ቫ΋ޔ೏
ᇡۓࢂ༸ಒझ܌ӧޑՏ࿼(4Ǵ5)Ƕӧ΋ಔखजวػࣴزύว౜٠Ъ᛾ჴǴԖٿಔ
ᆮા༸ಒझӧᆮા΢Ҝಒझޑύ໔ቫǴ΋ಔޑфૈࢂӧܭᆮાวػǴќ΋ಔޑ
фૈࢂӧܭВࡕޑঅൺ(4)Ƕ!
ҁጇፕЎύǴךॺஒёа኱ᇞӧಥ਼ਡᑗਡለ΢ޑϯӝނǴӧᆮાวػය໔Ǵ
ݙ৔ډᚶѫޑ҆Ⴕဎ๚ϣǴ຾Զ኱ᇞӧखज΢ಒझຼය጗ᄌޑ༸ಒझǴᙖԜё
аճҔխࣝࢉՅݤפډӧᆮા΢Ҝಒझύ೏኱ᇞޑಒझǶჴᡍ่݀ว౜Ǵಒझ
ຼය጗ᄌޑ༸ಒझϩѲӧ܌Ԗޑᆮા΢ҜቫύǴхࡴ୷ቫǴύ໔ቫǴکߘദಒ
झቫ)Ψ൩ࢂ߄ቫ*)၁ـಃϖക*Ƕ᏾ᡏԶقǴӧᆮા΢Ҝቫ೏኱ᇞޑಒझКٯǴ
ӧԋΓයफ़ࣁ 1%ǹ׳຾΋؁Ӧว౜Ǵ኱ᇞޑಒझ໣ύܭᆮાޑΟفӦ஥Ƕӧ΋
ಔᆮાфૈޑࣴزύ᛾ჴΑǴόፕࢂ୷ቫ܈ࢂߚ୷ቫޑಒझǴ֡ૈϩϯࣁᜪ՟
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ܭϺฅᆮા΢Ҝቫޑ่ᄬಔᙃ(6*ǶӢԜǴךॺёаᘜયрǴჹܭᆮાޑಔᙃঅ
ൺӆғԶقǴ྽Ԗሡ؃ܭ௦໣ᆮા΢Ҝ༸ಒझǴᔈଞჹᆮાΟفӦ஥௦໣Ǵฅ
Զவব΋ቫޑ΢Ҝቫ௦໣൩࣬ჹޑόख़ाΑǶ!
҂ٰᜫඳ!
షӝࠠ׷਑!
ࣁΑቚமեᐚࡋጤচೈқኳހޑ่ᄬமࡋǴᆫςለЧ✊ӧᇙբኳހޑၸำύ೏
షӝΕ׷਑ύԶቚуځ่ᄬமࡋǴՠࢂᆫςለЧ✊ޑϩှೲࡋࠅό፾Ҕܭݜֿ
ၰޑख़ࡌǴ྽ᆫςለЧ✊షӝಃ΋ࠠጤচೈқޑᆅރኳހ೏ҔܭڗжֿၰǴЇ
วΑόёႣයޑխࣝϸᔈ(Arena et al.)ǴёૈޑԋӢࢂӢࣁᆫςለЧ✊ӧᡏϣሡ
Ѥԃޑਔ໔ϩှǴԶߏਔ໔ϩှӧݜֿၰ৒ܰЇଆխࣝϸᔈ(7)Ƕ!
ӢԜǴჹܭȸ೬ȹಔᙃπำǴᔈᒧ᏷זೲϩှޑᆫӝނǴٯӵᆫᎽữለǴᆫك
ữለǴ܈ࢂᆫΌᎇ٢ለǴ೭٤׷਑֡ёӧΟঁДϣНှǶӕਔǴ׷਑ޑё༟܄Ǵ
ቸ܄ǴаϷ෌Εࡕڬᜐޑಔᙃ೿ाયΕԵໆ(8)ǶٯӵǴӧ΋ಔλԲޑჴᡍύ᛾
ჴǴᆫΌᎇ٢ለό፾ҔܭӃϺ܄ᐉᆰގ਻ޑЋೌ(9)Ǵՠࢂ೭׷਑ჹܭ፜ᆮાಔ
ᙃޑ࣬৒܄ࠅࡐӳǴեխࣝϸᔈ[(10)ǴSloff et al.]ǶёૈޑচӢࢂӧܭǴᐉᆰК
ᆮાሡा׳ӳޑۯ৖܄Ƕӧ׷਑ޑᒧ᏷΢ǴךॺёаᘜયрǴ่ᄬமࡋჴ፦΢
תᄽΑࡐख़ाޑفՅǶ!
Sloff et al/!׳຾΋؁ޑࡰрǴόӕޑྐ๵ၸำΨ཮ቹៜډ׷਑ޑ่ᄬமࡋǴа
Ϸӧᡏϣޑϩှೲ౗ǶӢԜǴ፾ӝޑྐ๵БԄΨѸ໪ाଛӝόӕޑᔈҔԶԵໆǶ!
Ոᆅғԋ!
ҁጇፕЎύ܌ෳ၂ޑಃ΋ࠠጤচೈқషӝᠼᆢೈқޑኳހǴۘ҂ӧεࠠ୏ނޑ
ᆮાෳ၂ǴӢԜǴڗжεࠠ୏ނᆮાಔᙃޑෳ၂ࢂ༈ӧѸՉǶᙁԶقϐǴషӝ
ޑғނ׷਑Ѹ໪ाԖᆫӝނ଺ࣁځ่ᄬ΢ޑЍ࡭ǴٯӵᆫᎽữለ܈ࢂᆫΌᎇ٢
ለǴௗ๱ǴճҔԾᡏᡏિ܌़ғޑ༸ಒझǴ೵ՉՈᆅႣғԋϐࡕӆ౽෌Ε୏ނ
ᡏϣǶ!
ՠࢂǴ྽ڗжޑ܈ࢂቚуޑय़ᑈεܭচҁᆮાޑ΋ъǴԾᡏಒझ౽෌৮ᜤа୺
ՉǴҁჴᡍύ܌ҔޑՈᆅϣҜಒझޑஏࡋࢂ 2.5 x 105!ಒझ0Ϧϩ 3ǴՠΓᆮાޑ
Ёκࢂᇻεܭ೭ঁय़ᑈǴӢԜךॺᔈԵቾځдёᔅշՈᆅғԋޑБݤǶٯӵǴ
ճҔ)गဉ*ᛠጢᙟᇂܭኳހ΢ǹ܈ࢂႣӃ෌Εဎ๚ᏛޑಔᙃǴճҔيᡏ଺ࣁϺ
ฅޑ୻ᎦኲǴᡣՈᆅߏᅈǴ٠่ӝӃ຾ᙴᕍ׷਑฼ౣ(ATMP)ࡕӆ౽෌ǴӵԜ΋
ٰ܈೚όѨࣁКಒझ౽෌׳ӳޑБݤǶ!
ӧܭಔᙃπำаϷ෌Εᡏϣޑᆫ౦⋸୷ᴏ两᜘Ꮙጤ(PIC)ޑᔈҔ΢ǴӃᡣΓπ༾
ՈᆅӧᏉጤύ׎ԋǴӆճҔྕࡋᡂϯ٬ᏉጤనϯǴᡣΓπ༾Ոᆅᆛ๎ޔௗᙟᇂ
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ܭጤচೈқኳހǴϐࡕӆ෌ΕᡏϣǶӵԜ΋ٰǴΨ೚ёауזӧᡏϣᆶՈనس
಍่ӝޑೲࡋǶӆޣǴךॺӧ߃؁ޑჴᡍύᢀჸډǴ྽ՈᆅϣҜғߏӢη
(VEGF)অႬܭᆫ౦⋸୷ᴏ两᜘Ꮙጤޑମࢎ΢Ǵёаߦ຾Γπ༾Ոᆅӧಒझ୻Ꭶ
ޑᕉნύғԋǶ೭Ψӕਔ᛾ܴΑᆫ౦⋸୷ᴏ两᜘Ꮙጤޑё༟܄аϷ҂ٰ׳ቶݱ
ޑᔈҔǶ҂ٰǴᔈෳ၂Ꮙጤ่ӝόӕޑғߏӢη܈ࢂᴏ两᜘Ǵёஒځຎࣁ΋ঁ
ӭфૈޑπڀጃǴᔈҔܭ׎׎ՅՅޑҔ೼Ƕ!
༸ಒझ!
྽ಔᙃπำाঅൺޑࢂεय़ᑈ܈ࢂεጄൎޑಔᙃǴࢂցԖಒझ౽෌ӧኳހ΢Ǵ
ࢂ΋ঁࡐᜢᗖޑ؁ᡯǶӧΓπᆮા෌ΕࡕǴૈזೲӦ೏ᆮા੝ϯޑ΢Ҝಒझᙟ
ᇂǴࢂ෌ΕᡏёցӸࢲޑᜢᗖ؁ᡯǴӢࣁ΢Ҝಒझ཮׎ԋ΋ቫߥៈࡀምǴߔᏲ
ֿనکځдԖࢥޑԋϩ຾ΕᡏϣǶᗨฅᆮા΢Ҝಒझዴჴ཮Ծ୏வᜐጔ໒ۈᙟ
ᇂ(11Ǵ12)Ǵՠӵ݀෌Εޑय़ᑈϼεǴคݤ೏ᙟᇂޑ୔ୱ཮ᠼᆢϯǴ٠ౢғࣞಔ
ᙃ(13)ǶӢԜǴ୷ܭа΢ޑჴᡍǴӵ݀Ԗᆮાಔᙃёගٮᆮા΢ҜಒझǴךॺࡌ
᝼வᆮાΟفӦ஥ڗಒझǴ٠ЪႣӃᙟᇂՐΓπᆮાޑ߄य़ࡕǴӆ෌ΕᡏϣǶ!
ฅԶǴவᆮાΟفӦ஥ڗрޑಒझǴᗋሡा࿶ၸ׳ӭޑфૈჴᡍᡍ᛾Ǵࢂց੿
ޑڀԖ༸ಒझޑфૈǴӢࣁ೏኱ᇞޑಒझࡐԖёૈѝࢂҶ઀ಒझǴ܈ࢂؒԖϩ
ϯૈΚޑ߻០༸ಒझǶӧךॺޑ΋ಔ҂ֹԋޑჴᡍύว౜Ǵவ፜ᆮાΟفӦ஥
܌ڗрޑಒझǴКவᆮાځдӦ஥ڗрޑಒझǴᜪ՟ܭ༸ಒझǴ཮׎ԋ׳ӭޑ
ಒझဂပǶךॺᔈ׳຾΋؁ޑᡍ᛾Ǵ೭٤ಒझࢂցёаϩϯࣁόӕޑ΢ҜቫǴ
٠ЪҔܭख़ࡌֹ᏾ޑᆮાǶ!
ӆޣǴךॺᔈ၀ዴᇡځд߻០༸ಒझޑٰྍǴӢࣁჴሞ΢ሡाΓπᆮાޑੰΓǴ
ҁيΨ೚คݤӆගٮҺՖᆮાಔᙃΑǶ߈ٰǴځдޑ஑ৎӧֿనύว౜Α߻០
༸ಒझǴ٠Ъ᛾ჴΑ೭٤߻០༸ಒझёаϩϯࣁόӕᅿᜪޑಒझǴவֿనύڗ
ள߻០༸ಒझޑӳೀࢂόሡा࿶ၸߟΕԄޑЋೌǴջёڗளಒझǶӳ൳ጇࣴز
ൔᏤࡰрǴ೭٤ಒझёаϩϯࣁόӕޑಒझ܌ಔԋޑᆮાᏛ(14Ǵ15)ǶՠલᗺࢂǴ
வֿన္ѝૈڗளϿໆޑಒझǴߏਔ໔ޑಒझ୻ᎦࢂคݤᗉխޑǶ߈ٰǴவᡏ
િެύڗளޑ໔፦༸ಒझǴςᝄฅԋࣁಔᙃπำύനڙᢋҞޑಒझٰྍǴচӢ
хࡴΑவᡏિެڗளಒझޑਔ໔ၨอ)੝ձࢂճҔ֎ڗԄ౽ନᡏિެޑੰΓ*Ǵ
ԶЪǴڗрޑኬҁёаό࿶ၸಒझ୻Ꭶ൩ޔௗճҔǴӆޣࢂ೭ኬޑಒझٰྍё
аᗉխᕎಒझޑԡࢉ)ሡाΓπᆮાޑ஻ޣǴԖόϿࢂӢࣁᑡ஻ᆮાᕎǴ܌аϪ
ନ᏾ঁᆮા*ǶҞ߻ᡏિެ܌ڗளޑ໔፦༸ಒझςᔈҔܭಒझݯᕍǴΨᔈҔܭό
ӕ׷፦Γπᆮાޑჴᡍύ(16-18)Ƕ!
ӢԜǴךॺޑΠ΋؁ǴѸ໪ाෳ၂྽໔፦༸ಒझᆶషӝࠠ׷਑่ӝǴࢂցёа
ԋࣁڗжԾᡏဉಔᙃ଺ࣁᆮાᏛǶךॺाᢀჸޑࢂǴ೭٤༸ಒझࢂցёаᙯϯ
ࣁԖᐒૈޑᆮાᏛ)хࡴΑֹ᏾ޑՈనس಍аϷёаԾך௓ڋޑԼԺಔᙃ*ǹӆ
ޣךॺाᢀჸޑࢂǴӧಔᙃӆғය໔Ǵషӝࠠ׷਑ࢂցගٮځЍ࡭ޑфૈǶന
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നࡕаϷന߃ाགᖴޑࢂךޑৎΓаϷܻ϶Ǵᚆ໒Ѡчޑ೭ΖԃٰǴวғΑ೚
ӭ٣ǴԶךࠅόӧգॺޑيᜐǴόፕғǵԴǵੰǵԝǴӭ׆ఈךૈਔਔڅڅഉ
ӧգॺޑي਒Ƕᚆ໒ዕ஼ޑᕉნٰډኻࢪۺਜаϷπբǴ΋ޔࢂך܌ኆኊǴᚆ
໒ਔΨวᇣाոΚπբᏢಞǴόा੮ΠᒪᏬǴӢԜ؂ԃѝԖอኩӦଶ੮ӧѠ᡼Ǵ
ਔ໔อډೱѠ᡼ޑᡂϯך೿࣮όమΑǴԋߏޑβӦϸԶᡂԋനዕ஼ࠅΞനढ़ғ
ޑӦБǶՠգॺޑӸӧᆶЍ࡭ǴᡣךԖৎёӣǴόፕࢂז኷܈ࢂᜤၸǴѝाགྷ
ଆգॺЈ္൩ཪǴ೭ኬ൩୼ΑǶ!
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੿ޑࡐ໒ЈǶ੝ձགᖴഉՔךߏεޑܻ϶ॺǴךޑ୯λǴ୯ύǴଯύǴεᏢǴ
ᅺγ੤ޑӕᏢаϷӳ϶Ǵ؂ԛӣѐ೿ૈـډཥғڮǴୖᆶգॺޑғڮаϷԋߏǴ
ᡣך᝺ளࡐᄪ۩ǶᗋाགᖴܫЋᡣךᚆ໒ޑܻ϶ǴӢࣁգޑᡏፊǴᡣך࣮ډό
ӕޑШࣚǶ!
೭ҁਜा᝘๏ךޑৎΓǴᖴᖴգॺޑЍ࡭Ǵ׆ఈ೭ҁਜࢂॶளךॺϩ໒೭ሶΦ
Զඤٰޑԋ݀Ǵך؂Ϻ೿ࡐགྷۺգॺǶς࿶࣮όډ೭ҁਜޑৎΓǴӭ׆ఈգૈ
ӧךي਒Ǵӭ׆ఈգૈ࣮ډ೭΋ϺǶ!!!!
!!!!!!!!!!!
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